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Mouse embryonic stem (ES) cells are pluripotent cells, meaning that they can give 
rise to all tissues in the body. This has catalyzed research in both early embryogenesis as a 
model system for mammalian development as well as regenerative medicine as a renewable 
source of unspecialized cells which can be converted into nearly any cell type required by 
a patient. ES cells have been an invaluable resource for advancing fundamental 
understanding of global transcriptional and epigenetic regulations, signaling pathways, and 
noncoding RNA in mammalian systems. However, the molecular mechanisms of how ES 
cells are differentiated remain much less understood. 
Differentiation is a complex process involving actions of ES cell core factors, 
lineage specific regulators, epigenetic modifications, and chromatin remodelers. Thus, a 
single reporter-based screen would have been inappropriate to identify novel regulators of 
ES cell differentiation. To overcome the problems, we have developed a unique signature-
based screen. This screen is capable of analyzing the expression of 48 genes simultaneously 
across dozens of different samples, and our gene list covers all three germ layers that arise 
during normal embryonic development, the trophectoderm, and epigenetic regulators of 
chromatin status. Our signature-based screen established several categories of genes based 
 vii 
on their comparative functions during the differentiation of ES cells. This will be a valuable 
information for other researchers interested in ES cell differentiation from various 
perspectives. 
We have identified two novel regulators of ES cell differentiation – Yap1 and Rbpj. 
Yap1 is a transcriptional co-activator of Hippo signaling pathway. We disproved past 
misconceptions in the field about the role of Yap1 concerning its function in ES cell self-
renewal, showing that like the inner cell mass, Yap1 is dispensable for long-term 
maintenance in culture. Conversely, we found that Yap1 is essential for proper ES cell 
differentiation. Rbpj is a transcriptional regulator of Notch signaling pathway. Consistent 
with previous observations of repressive role of Rbpj, Rbpj serves as a repressor of ES cell 
core factors in the absence of Notch signaling pathway. Repressive role of Rbpj is also 
required for proper differentiation of ES cells by silencing core factors.  
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CHAPTER 1: INTRODUCTION 
ESTABLISHMENT OF MOUSE EMBRYONIC STEM (ES) CELLS 
In the 1960s, several studies reported the existence of a population of pluripotent 
cells in mice with the ability to differentiate into the three germ layers, endoderm, 
mesoderm, and ectoderm (Gardner, 1968; Kahan and Ephrussi, 1970; Pierce and Verney, 
1961; Rosenthal et al., 1970). These pluripotent cells were initially identified in 
spontaneously occurring testicular teratomas in an inbred strain of mice (Stevens and Little, 
1954). The teratomas contained a range of differentiated tissues that could be transplanted 
into other mice. Cells isolated from teratomas are called embryonic carcinoma (EC) cells, 
and they can grow in tissue culture. EC cells can contribute to generate chimeric mice when 
injected into a blastocyst, demonstrating their pluripotency, and they can be induced to 
differentiate in vitro through the formation of an embryonic body, which resembles early 
embryogenesis. EC cells can also form teratomas when injected back into mice, allowing 
scientists to observe embryonic development in vivo. 
However, all EC cell lines have an abnormal karyotype, underscoring the need to 
identify pluripotent cells with normal karyotypes. In 1981, the British scientists M. J. Evans 
and M. H. Kaufman reported that they had successfully established pluripotent stem cells 
derived from the inner cell mass (ICM) of the developing blastocyst (Evans and Kaufman, 
1981). The established cell lines, which were named EK cells after the initials of the 
discoverers, are karyotypically normal and exhibit essentially the same characteristics as 
EC cells, namely, the ability to form a teratocarcinoma in vivo, differentiation into an 
embryonic body in vitro, and contributing towards the generation of chimeric mice when 
injected back into the mouse blastocyst. EK cells, which are currently referred to as 
embryonic stem (ES) cells, possess the advantages of EC cells for studying early 
 2 
development; however, they can also serve as a genetic tool to study individual genes in 
vivo. Shortly after the establishment of ES cells, chimeric mice containing disrupted genes 
or transgenes were generated to examine the functions of individual genes in vivo (Hooper 
et al., 1987; Kuehn et al., 1987). 
IMPORTANCE OF STUDYING ES CELLS 
The establishment of ES cell lines attracted the attention of scientific and clinical 
communities because of their two unique characteristics, self-renewal and pluripotency 
(reviewed in Young, 2011). Self-renewal is the process by which stem cells divide into 
daughter cells while maintaining the undifferentiated state, and pluripotency is the potential 
to differentiate into almost all cell types. Indefinite proliferation provides an unlimited 
source of normal cells that can be induced to differentiate into virtually all cell types. This 
is especially useful when specific cells are not vastly available or are difficult to culture in 
vitro. For example, testing the effect of drugs on heart cells is difficult because of the lack 
of a human heart cell line. However, ES cell-derived heart cells provide an effective 
platform to test and study the effects and toxicity of drugs on heart cells (He, 2003; 
Mummery, 2003). In addition, the pluripotency of ES cells is critical for the development 
of regenerative medicine technologies and to help understand early embryogenesis. 
Development of regenerative medicine 
Regenerative medicine is the process of creating functional cells or tissues to 
replace or repair tissues or organs damaged by age, disease, or injury. Several regenerative 
medicine-based therapies have received FDA approval and are commercially available. 
However, many of these therapies use tissues or cells derived from patients, which creates 
another wound, and their use is often delayed by the need to expand the cells in culture 
(Falanga and Sabolinski, 1999). ES cells are a suitable alternative because they provide an 
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ample source of cells that can differentiate into any type of cell. One notable example is a 
clinical trial by Advanced Cell Technology, in which human ES cell-derived retinal 
pigmented epithelial cells are used for the treatment of patients with Stargardt macular 
dystrophy (Schwartz et al., 2015). The preliminary results of the trial are promising, and 
no negative side effects were found. In addition, most phase 1 clinical trials of regenerative 
medicine passed the toxicity test, suggesting a bright future for this method (Alexey, 2015). 
Insights into early embryogenesis 
The pluripotency of ES cells provides developmental biologists with a model to 
study early embryonic development. Studying the differentiation of ES cells provides 
valuable information about early developmental stages that are difficult to access in the 
embryo. For example, ES cells were used to test the long-standing hypothesis that 
hematopoietic and endothelial lineages originate from a common progenitor (Haar and 
Ackerman, 1971). Studies show that the blood and endothelial lineages develop in close 
proximity at the same time in yolk sac blood islands, and immature hematopoietic and 
vascular cells share many gene expression patterns (Watt et al., 1995; Young et al., 1995). 
However, formal proof that a progenitor exists was first provided by the study of ES cell 
differentiation. Analysis of differentiated ES cells identified progenitor cells known as 
blast colony-forming cells (BL-CFCs), which can develop into hematopoietic and vascular 
progenitors (Choi et al., 1998; Nishikawa et al., 1998). A similar progenitor with the 
potential to develop into both hematopoietic and vascular lineages was later identified, 
demonstrating that the in vitro ES cell model can provide insight into early embryonic 
development (Huber et al., 2004). 
On the other hand, the development of specific lineages from ES cells is often 
guided by the knowledge gained from embryonic development. The development of a 
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cardiac lineage from ES cells results in a heterogeneous population that needs to be 
subsequently purified to generate a homogenous cardiac cell population (Klug et al., 1996). 
Established knowledge of cardiomyocyte markers such as α-cardiac MHC in the 
developing embryo allows the generation of ES cells with selection markers under the 
control of a cardiomyocyte promoter. The selection of ES cells at the appropriate 
developmental stage enables the isolation of highly enriched cardiomyocyte populations 
(Zandstra et al., 2003). Understanding the differentiation mechanisms of ES cells leads to 
greater understanding of early developmental biology and vice versa. 
Insights into gene regulation 
Because of the initial limitation of establishing ES cell lines, most ES cell studies 
were conducted in a nearly identical genetic background. This situation creates a uniform 
environment for genomics studies, which allows the safe integration of diverse datasets of 
ES cell lines for systematic analyses. For this reason, mouse ES cells are among the most 
widely studied mammalian model systems in studies of the global interactions between 
DNA, proteins, and RNA. For example, binding regions of more than 100 DNA-binding 
proteins, 10 different histone modifications, DNase-sensitive regions, DNA methylation, 
and long-range chromosomal interactions have been mapped to mouse ES cells. This was 
achieved using massive-parallel high-throughput sequencing combined with various 
genomic tools such as chromatin immunoprecipitation (ChIP), chromatin interaction 
analysis by paired-end tag (ChIA-PET), assay for transposase-accessible chromatin 
(ATAC), and Hi-C (reviewed in Beck et al., 2015). Integration of these data provides an 
extended view of global gene regulatory mechanisms that were previously unknown and 
provides a useful starting point for understanding global gene regulation in other cell types 
and species. For example, integrated analysis of transcription factor occupancy identified 
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transcriptional networks in which various transcription factors occupied the same genomic 
targets in predictable patterns. Groups of genomic targets occupied by functionally similar 
transcription factors became known as modules (Kim et al., 2008). Integration of genome-
wide DNA methylation patterns with extended transcriptional networks revealed different 
modes of gene regulation dependent on the presence of CpG islands (Beck et al., 2014). 
Comparison of ES cells and terminally differentiated cell types revealed that entry into 
productive elongation from a poised state is a general mechanism by which RNA 
polymerase regulates transcription upon differentiation (Min et al., 2011). The general idea 
of transcriptional regulation gained from the study of ES cells provides insight into other 
systems such as tumorigenesis (Kim et al., 2010), highlighting the advantages of studying 
ES cells to examine general gene regulatory mechanisms. 
REGULATORY MECHANISMS OF ES CELL SELF-RENEWAL 
Unlike terminally differentiated cells, ES cells can proliferate indefinitely while 
maintaining the differentiation potential. Various studies focused on elucidating the 
mechanisms underlying the self-renewal nature of ES cells. In 1998, Pou5f1, a member of 
the POU transcription factor family, was shown to be required for the maintenance of both 
the ICM of mouse embryos and ES cells (Nichols et al., 1998). In the mouse blastocyst, 
Pou5f1 is present exclusively in the ICM and is not detected in the trophectoderm, which 
becomes the placenta (Palmieri et al., 1994). The expression of Pou5f1 is high in ES cells 
and decreases upon differentiation. Pou5f1-deficient embryos undergo trophectoderm 
development but they are unable to form the ICM (Nichols et al., 1998). Furthermore, 
Pou5f1-deficient ES cells are unable to maintain self-renewal. 
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In addition to Pou5f1, several transcription factors including Nanog, Sox2, Klf4, 
and Esrrb play essential roles in the maintenance of the self-renewal of ES cells (Chambers 
et al., 2003; Jiang et al., 2008; Masui et al., 2007; Mitsunaga et al., 2004). These factors, 
which are referred to as core factors, form a transcriptional regulatory circuit, 
transcriptionally activating each other and regulate co-occupied downstream target genes. 
Polycomb repressive complex (PRC), which was initially discovered for its role in the 
regulation of drosophila development, is involved in the maintenance of ES cell self-
renewal by inhibiting the expression of lineage-specific genes (Boyer et al., 2006). 
One of the long-term goals of studying ES cells is to manipulate cell fate to produce 
the desired cell types. Although many intrinsic transcription factors can effectively 
determine cell fate, they are not readily available for biomedical purposes. Instead, 
researchers study signaling pathways that can be easily manipulated by changing media 
conditions and adding small molecules. Using signaling pathways to differentiate ES cells 
requires an understanding of how each signaling pathway is involved in cell specification 
and how specific pathways can be manipulated. Several pathways including LIF/Stat, 
Gsk3/Erk, and Wnt/-catenin play a role in the regulation of pluripotency (Huang et al., 
2015; Okita and Yamanaka, 2006). In this manuscript, we focus on describing the signaling 
pathways that are relevant to this study. 
 
Transcriptional regulation 
Screening to identify novel regulators of core factors 
The initial discovery of a handful of core factors required for the maintenance of 
ES cells stimulated researchers to perform screens to identify novel regulators of self-
renewal. Many of those screens used reporter systems containing promoters of well-known 
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core factors such as Pou5f1 or Zfp42 driving the GFP gene. Small-scale or genome-wide 
knockdown (KD) screens with various RNAi techniques including shRNA, siRNA, or 
esiRNA identified many factors that negatively regulate reporter levels upon depletion, 
thus controlling the self-renewal of ES cells (Ding et al., 2009; Hu et al., 2009; Ivanova et 
al., 2006). For instance, a shRNA-mediated screen with 70 candidate genes that are 
downregulated upon differentiation identified the novel transcription factors Esrrb, Tbx3, 
and Tcl1, which are required for the maintenance of ES cell self-renewal. ES cells with 
deficiencies in each factor grow slowly and show loss of alkaline phosphatase activity, 
morphology changes, and the induction of lineage-specific markers, indicating that these 
factors are indispensable for the maintenance of ES cells. However, there was an issue with 
reproducibility in these screening trials. In fact, the results of multiple genome scale RNAi 
screens overlap by only 8%, although fortunately, many of the unique hits in each screen 
were later validated in independent studies (Cinghu et al., 2014). This can be partially 
attributed to differences in the RNAi methods and reporter systems used in each screen 
trial. However, the lack of concordance also indicates that genome-wide screens have not 
reached saturation, and other critical factors remain to be discovered. In this regard, 
bioinformatics techniques have been applied to integrate published screening studies to 
identify novel regulators of ES cell self-renewal, which resulted in the identification of 
novel regulators such as Nucleolin (Cinghu et al., 2014). Candidate genes identified in 
bioinformatics studies are then tested by siRNA to examine their roles in the self-renewal 
of ES cells.  
 
Similar screens were performed with human ES cells. Some of the important 
regulators present in mouse ES cells such as Nanog, Tcl1, Zic3, and Zscan10 were 
rediscovered in human screens, indicating that human and mouse ES cells may share 
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similar transcriptional networks (Chia et al., 2010). However, the screens also identified 
novel regulators such as PRDM1 and NFRKB. KD of PRDM14 in human ES cells 
downregulates ES cell-associated genes such as POU5F1, NANOG, SOX2, and DPPA4. 
Analysis of global binding patterns of PRDM14 revealed that PRDM14 shares many 
targets with core factors such as POU5F1, NANOG, SOX2, and the co-activator p300. In 
mice, Prdm14 plays a critical role in the establishment of germ cells, although it is not 
required for the maintenance of mouse ES cells or early embryogenesis (Ma et al., 2011). 
Further analysis of Prdm14 revealed that it is required for the derivation of ES cells from 
the blastocyst. It would be interesting to understand the different roles of Prdm14 in mouse 
and human ES cells. Despite the fact that all the above factors are required to maintain the 
self-renewal of ES cells, most of the screens failed to identify factors that may work 
independently of known core factors. Integrating genome-wide RNAi screens with 
multiplexed high-throughput sequencing may help uncover novel regulators of ES cell 
identity. 
Transcriptional networks of core factors 
Advances in ChIP-sequencing techniques led to the identification of global targets 
of DNA-binding proteins including transcription factors and chromatin remodelers 
(Johnson et al., 2007). The discovery of downstream targets of core factors such as Pou5f1, 
Nanog, and Sox2 indicates that core factors co-occupy many gene promoters (Kim et al., 
2008; Loh et al., 2006). In addition, each core factor binds to its own regulatory locus and 
those of other core factors, leading to feed-forward regulation. Further analysis of their 
downstream targets revealed that multiple factor binding increases gene expression levels 
in ES cells, and their functions are enriched in stem cell maintenance and the regulation of 
transcription (Kim et al., 2008). One notable example of co-bound targets of core factors 
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is Sall4, which is regulated by many core factors including Pou5f1, Nanog, Sox2, Zfp42, 
and Dax1 (Yuri et al., 2009). An independent study showed that Sall4 is exclusively 
expressed in ES cells, and Sall4-deficient mice die shortly after implantation, emphasizing 
its role in early development (Sakaki-Yumoto, 2006). Furthermore, depletion of Sall4 
results in reduced proliferation both in the blastocyst and ES cells. Another study 
demonstrated that Sall4 binds to the promoter region of Pou5f1 and activates its expression 
(Yuri et al., 2009). Therefore, multiple core factor binding can serve as a robust indication 
of the functions of target genes. 
This notion was recently revisited by Whyte et al (Whyte et al., 2013). They coined 
the term super-enhancer, which defines large genomic domains occupied by multiple 
master transcription factors. Genes regulated by super-enhancers are essential for cell 
identity. The list of super-enhancer-associated genes includes Pou5f1, Sox1, Nanog, Esrrb, 
nMyc, Sall4, Prdm14, Dppa5a, Tbx3, and Zfp42, which are well-known factors that 
regulate self-renewal of ES cells. However, whether super-enhancer-associated genes are 
also involved in ES cell differentiation remains unclear. Because many multiple core factor 
co-bound targets and super-enhancer-associated genes are active but do not disrupt the self-
renewal of ES cells, it is intriguing to study their roles on the other characteristic of ES 
cells, differentiation potential. 
Epigenetic regulation 
The role of DNA methylation in ES cells 
An intriguing phenomenon in biology is the fact that the same genomic information 
can somehow lead to the generation of more than 200 functionally different cell types in 
the human body. Aside from the contributions of transcription factors to cell identity, 
epigenetic regulation provides another layer of complexity to cell identity, in particular the 
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self-renewal capacity of ES cells. DNA methylation occurs at the cytosine of the CpG 
dinucleotide (reviewed in Bird, 2002). DNA methylation patterns vary in different cell 
types, ultimately controlling the expression of many tissue-specific genes. The importance 
of DNA methylation is reflected in studies of Dnmt, DNA methyltransferase knockout 
(KO) embryos. Dnmt3a and Dnmt3b single or double KO embryos display developmental 
defects such as embryonic lethality, premature death, and rostral neural tube defects 
(Okano et al., 1999). Dnmt3a and Dnmt3b double KO embryos show loss of de novo 
methylation, indicating the essential role of de novo methylation in embryogenesis. 
Similarly, deletion of Dnmt1, which is required for the maintenance of DNA methylation, 
also delays development and results in embryonic lethality (Li et al., 1992). Interestingly, 
Dnmt1 KO ES cells can proliferate and maintain self-renewal, suggesting that DNA 
methylation only affects the differentiation potential of ES cells. Further study of global 
methylation patterns in differentiating ES cells may help our understanding of how DNA 
methylation affects the pluripotency of ES cells. 
The roles of histone modifications in ES cells 
Covalent modification of histone tails with acetyl, methyl, phosphatidyl, or 
ubiquityl groups serves as an epigenetic marker in eukaryotes. These modifications provide 
a favorable environment for the activation or repression of nearby genes, with the specific 
effect governed by the combination of modifications. For example, H3K4me3 and H3K9ac 
are active histone marks, whereas H3K27me3 is a repressive mark (Bernstein et al., 2002; 
Kuzmichev et al., 2002; Liang et al., 2004). ES cells possess a unique chromatin structure 
characterized by a wide open chromatin architecture with active histone markers such as 
H3K4me3 and acetylation-enriched histones compared with the structure of differentiated 
cells. In addition, lineage-specific regulators in ES cells possess distinct histone 
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modifications called ‘bivalent markers’ that contain both the H3K4me3 active mark and 
the H3K27me3 repressive mark (Bernstein et al., 2006; Rada-Iglesias et al., 2011). 
Bivalent-marked genes are generally inactive in ES cells, although they are rapidly induced 
upon differentiation. The H3K4me3 and H3K27me3 histone marks are generated by the 
Trithorax-group (TrxG) and PRC proteins, respectively. Deletion of Wdr5, the effector 
protein for H3K4me3, impairs the self-renewal of ES cells and somatic cell reprogramming 
(Ang et al., 2011). However, deletion of PRC2 subunits does not affect the self-renewal of 
ES cells, whereas it impairs differentiation, suggesting that the role of PRC is primarily the 
derepression of lineage-specific regulators upon differentiation. 
Enhancers are DNA elements that act over a long range to activate transcription of 
target gene. Active enhancers are generally occupied by transcriptional co-activators 
(Blackwood and Kadonaga, 1998), but recent studies also identify several other marks such 
as p300 occupancy, H3K4me1, and H3K27ac (Creyghton et al., 2010; Rada-Iglesias et al., 
2011, 2012). ES cells also possess poised enhancers marked by H3K27me3, which are 
rapidly activated upon differentiation. For proper differentiation of ES cells, enhancers 
associated by ES cell-specific genes need to be silenced. Kdm1a, a histone H3K4/K9 
demethylase binds to active enhancer in ES cells and silences their activities by 
demethylating active histone marks (Whyte et al., 2012). Even though Kdm1a-depleted ES 
cells maintain self-renewal, the cells do not undergo proper differentiation due to the 
sustained levels of Nanog, Sox2, and Dppa5. The example of Kdm1a-deficient ES cells 
supports the idea that two unique characters of ES cells, self-renewal and differentiation 
potential can be functionally separable. 
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Signaling pathways 
LIF/Stat pathway 
Initially, ES cells were maintained on mitomycin C-inactivated STO feeder cells, a 
mouse embryonic fibroblast cell line (Evans and Kaufman, 1981). Because the ES cells 
were mixed with the feeder cell lines, it was important to identify factors secreted by the 
feeder cells that contributed to maintaining the undifferentiated state of ES cells. In 1988, 
leukemia inhibitory factor (LIF) was identified as a factor supporting the self-renewal of 
ES cells (Smith et al., 1988). Addition of recombinant LIF allows ES cells to expand 
without undergoing differentiation under feeder cell-free conditions. Furthermore, active 
Stat3, a downstream transcriptional regulator of the LIF/Stat signaling pathway, is 
sufficient to maintain the undifferentiated state of ES cells, supporting the importance of 
the LIF/Stat pathway for the self-renewal of ES cells (Matsuda et al., 1999). Active Stat3 
induces pluripotency factor Klf4, which in turns activates Sox2 and Pou5f1, thus 
completing the signaling pathway from cytokine to ES cell self-renewal. 
The self-renewal of human ES cells, on the other hand, cannot be maintained in the 
absence of feeder cells regardless of the presence of LIF (Thomson, 1998). However, 
LIF/Stat is active in human ES cells, as evidenced by the presence of the LIF receptors 
gp130 and LIFRβ and the activation and nuclear localization of Stat3 induced by LIF 
(Daheron et al., 2004; Kidder et al., 2008). There are several explanations for the different 
roles of the LIF/Stat pathway in mouse and human ES cells. Human ES cells could be in a 
different developmental stage than mouse ES cells. Human ES cells are more similar to 
mouse epiblast stem cells than mouse ES cells at multiple levels, such as culture conditions, 
expression profiles, and epigenetic status (Brons et al., 2007). In addition, the recent 
discovery of the 2i culture condition, which does not rely on LIF for the maintenance of 
ES cells, suggests that LIF/Stat3 acts to block ES cell differentiation rather than enhancing 
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the self-renewal capacity (Ying et al., 2008). Further analysis of the roles of the LIF/Stat 
pathway is required to decipher the nature of the self-renewal of ES cells. 
Activin/Nodal/TGF signaling pathway 
The transforming growth factor (TGF)- family consists of approximately 30 
members that can be subdivided into several subgroups, including TGF, the activins, 
Nodal, bone morphogenetic proteins (BMPs), and growth/differentiation factors (GDFs) 
(reviwed in Heldin and Moustakas, 2016). These ligands activate heteromeric type I and 
type II receptors, which in turn activate Smad2 and Smad3 proteins by phosphorylation. 
Phospho-Smads interact with Smad4 and translocate to the nucleus to regulate a large 
number of downstream targets. The physiological outcomes of this pathway vary 
depending on cell type and the specific ligands, although they share common downstream 
effectors. For example, both Activin and TGF activate Smad2/3; however, mice deficient 
in each gene display different phenotypes. Activin A-deficient mice die within 24 h of 
birth, whereas TGF1 KO mice die at mid-gestation (Goumans and Mummery, 2000; 
Matzuk et al., 1995). 
Since many of the TGF components affect mouse development only at post-
implantation stages, it has been suggested that the TGF signaling pathway is not required 
for the establishment of pluripotency or the control of early cell fate, which mainly occur 
before implantation. However, other ligands in this pathway such as BMPs, GDFs, and 
Nodal play an important role in early mouse development. BMP signaling is required for 
many early developmental stages, including germ cell specification, differentiation of 
extra-embryonic tissues, and epiblast proliferation (Winnier et al., 1995). In addition, 
Nodal mutant embryos fail to gastrulate or form a primitive streak (PS) (Conlon et al., 
1994). In contrast to the roles of Activin in in vivo early developmental biology, addition 
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of recombinant Activin to differentiating ES cells activates mesodermal differentiation 
(Wiles and Johansson, 1999). Furthermore, TGF signaling is required for ES cell 
proliferation (Ogawa et al., 2006). Since the Activin/Nodal/TGF signaling pathway has 
different effects on in vivo early embryogenesis and in vitro differentiation of ES cells, in 
depth studies are required to elucidate the underlying mechanisms. 
Hippo signaling pathway 
The roles of the Hippo pathway in the development of ICM, the in vivo counterpart 
of ES cell, are well understood. The Hippo pathway is inactive in the outer layer of the 
embryo, which allows the nuclear translocation of Yap1 to activate downstream target 
genes, resulting in the differentiation of the outer layer cells into the trophectoderm 
(Nishioka et al., 2009). Yap1 is sequestered in the cytoplasm of the ICM of the blastocyst 
when the Hippo pathway is active. ES cells, which are derived from the ICM and grow as 
a colony, may also have an active Hippo pathway and cytoplasm-sequestered Yap1. 
However, Lian et al. argued that Yap1 regulates the self-renewal of ES cells, and depletion 
of Yap1 induces differentiation, which is not consistent with the functions of Yap1 in the 
ICM (Lian et al., 2010). A deeper understanding of the functions of Yap1 in ES cells is 
needed to clarify this issue. 
Notch signaling pathway 
Notch1 is expressed in ES cells but not in ICM (Hadland et al., 2004). Mesodermal 
differentiation studies show that transient activation of Notch1 blocks mesodermal 
differentiation, reducing the number of Flk1+ mesodermal cells (Schroeder et al., 2006). 
Activated Notch1 further blocks the generation of cardiac muscle, and endothelial and 
hematopoietic cells (Schroeder et al., 2003). However, depletion of Rbpj, a downstream 
transcriptional regulator of the Notch pathway, promotes differentiation into a 
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cardiomyocyte lineage. Taken together, these studies suggest that the Notch pathway plays 
a role in mesodermal differentiation. However, many questions remain unanswered, such 
as global target occupancy of Rbpj in ES cells, the effect of Notch signaling on core factors, 
and the effect of Notch inhibitors on ES cell differentiation. 
Fgf4/Erk signaling pathway 
In mouse ES cells, Fgf4 is the main stimulus activating the Erk1/2 signaling cascade 
(Kunath et al., 2007). Although inhibition of Fgf4 with the small molecule PD173074 or 
genetic ablation does not affect ES cell self-renewal, the differentiation potential of ES 
cells is markedly affected by blockage of Fgf4 signaling. Fgf4 KO or PD173074 treated 
ES cells are resistant to neuronal and mesodermal differentiation (Stavridis et al., 2007). 
The differentiation-inducing Fgf4 signaling pathway is active in self-renewing ES cells and 
is not inhibited by LIF, which promotes the self-renewal of ES cells (Ying et al., 2003b). 
Based on this observation, Ying et al. hypothesized that the self-renewal of ES cells can 
alternatively be achieved by inhibiting the active lineage commitment signal in ES cells. 
Indeed, ES cells can be maintained by inhibiting the Fgf4 and Gsk3 signaling pathways 
even without the addition of LIF (Ying et al., 2008). The 2i culture medium containing 
PD184362 and CHIR99021, which are inhibitors of Fgf4 and Gsk3, respectively, enables 
the culture of ES cells in a uniform and defined medium in a manner independent of serum 
and LIF. This indicates that ES cells have an active intrinsic circuitry that maintains the 
self-renewal of ES cells independently of extrinsic cytokines such as LIF or BMP. The 
presence of active differentiation pathways such as Fgf4 in self-renewing ES cells suggests 
that such signaling pathways may be one of the unidentified intrinsic regulators of 
pluripotency. 
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REGULATION OF THE DIFFERENTIATION POTENTIAL OF ES CELLS 
Many factors that are important for the self-renewal of ES cells have been identified 
in approximately 30 years of study after the establishment of ES cells. However, the 
mechanisms regulating the differentiation potential or pluripotency of ES cells are 
relatively less understood. The identification of transcription factors or signaling pathways 
involved in the exit from self-renewal or lineage specification is important for the 
application of ES cells to regenerative medicine and developmental biology. Upon 
differentiation, ES cells gradually lose pluripotency and become terminally differentiated 
cells. In correlation with decreased pluripotency, the expression of many active genes in 
ES cells also decreases, suggesting the existence of active regulators that control the 
pluripotency of ES cells. 
Suppression of lineage-specific regulators by PRC 
Most of the PRC downstream targets are lineage-specific regulators that need to be 
repressed to maintain the self-renewal of ES cells. Deletion of the PRC component Eed 
induces many PRC-bound lineage-specific regulators such as Gata4 and Gata6, although it 
does not disrupt the self-renewal of ES cells probably because of sustained core factors 
such as Pou5f1 and Nanog (Chamberlain et al., 2008). However, the differentiation 
potential is impaired in PRC-depleted ES cells. Suz12 deletion results in failure to form 
endodermal layers (Pasini et al., 2007), whereas Ezh2- or Eed-deficient ES cells display 
impaired mesoendodermal differentiation (Shen et al., 2008). Considering the repressive 
effects of PRC on lineage-specific regulators, it can be speculated that PRC deletion would 
enhance ES cell differentiation; however, it turns out that PRC also plays a role in silencing 
core factors upon differentiation (Li et al., 2010a; Walker et al., 2010). Therefore, it is 
important to understand how PRC inactivates core factors upon differentiation and why 
each PRC component selectively affects lineage specification. 
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Epigenetic plasticity of ES cells 
The zygote, the only unequivocally totipotent cell, undergoes extensive paternal-
specific demethylation (Mayer et al., 2000). Subsequent cell division in early embryonic 
development further reduces global DNA methylation up to the morula stage because of 
exclusion of Dnmt1 from the nucleus (Howell et al., 2001). De novo DNA methylation 
occurs before the blastocyst stage, which coincides with the very first cell fate decision 
(Santos et al., 2002). Since DNA methylation at promoter regions represses neighboring 
genes, global hypomethylation of totipotent cells may be one of the key features of 
pluripotency that allows any lineage-specific gene to be expressed upon differentiation. 
Consistent with the hypomethylation of the early embryo, global analysis of the DNA 
methylation patterns of ES cells and differentiated somatic cells shows that the genomes 
of ES cells are less methylated than those of somatic cells (Jackson et al., 2004). However, 
ES cells with demethylation caused by deletion of Dnmt1 or Dnmt3a and Dnmt3b display 
impaired erythrocyte and cardiomyocyte differentiation (Jackson et al., 2004). In addition, 
Dnmt3a and 3b double KO ES cells remain largely undifferentiated even under 
differentiation conditions. This could be due to the sustained levels of core factors that need 
to be silenced upon differentiation. 
ES cells possess unique chromatin structures such as expansive regions of open 
chromatin, bivalent histone marks, and a hyperdynamic chromatin structure. Evidence 
from electron microscope, DNase I, MNase assay, and heterochromatin histone 
modification studies indicates that the genomes of ES cells are largely open and accessible 
to DNA-binding proteins compared with those of differentiated cells. In addition, most of 
the repressed lineage-specific regulators contain both activating H3K4me3 and repressive 
H3K27me3 histone marks, indicating that these genes are poised to be expressed upon ES 
cell differentiation. Many structural chromatin proteins such as HP1 and regular histones 
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are more loosely bound to the chromatin of ES cells than to somatic cells (Meshorer et al., 
2006). These data reflect the high level of epigenetic plasticity of ES cells, which might 
contribute to the pluripotency of ES cells. 
Factors required for exit from pluripotency 
Tcf3, a repressor of the Wnt signaling pathway, is one of the first factors required 
for the proper differentiation of ES cells. Since Tcf3 represses core factors, Tcf3-deficient 
ES cells do not undergo proper differentiation because of sustained levels of pluripotency 
genes. After the discovery of Tcf3, genome-wide KD studies showed that Tfe3 and Zfp706 
are required for exit from self-renewal (Betschinger et al., 2013; Leeb et al., 2014). The 
regulatory mechanisms underlying differentiation of ES cells are to repress core factors, 
similar to that of Tcf3. Although ES cells deficient in these factors do not undergo proper 
differentiation because of high levels of core factors, whether they maintain differentiation 
potential remains unclear. Furthermore, the expression of these factors decreases upon 
differentiation, indicating that they may not be able to actively repress core factors in 
differentiating ES cells. Therefore, the identification of factors that affect pluripotency 
and/or the active downregulation of core factors is important to improve our understanding 
of the regulatory mechanisms underlying ES cell differentiation. 
Direct differentiation of ES cells 
The use of ES cells as a source in regenerative medicine requires the design of 
differentiation methods to efficiently generate the desired homogenous cell populations. 
However, the plasticity that allows ES cells to generate all three germ layers also makes 
them difficult to control. Lessons from developmental biology studies on early 
embryogenesis provide insight into the control of ES cell differentiation. For example, 
studies of gastrulation in mice identified the critical roles of BMP4, Nodal, and Wnt in PS 
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formation and the subsequent generation of the mesodermal lineage (Ng et al., 2005; Park 
et al., 2004; Wiles and Johansson, 1999). The expression of Brachyury is often used as a 
marker to monitor the formation of PS-like cells through in vitro differentiation of ES cells, 
as Brachyury is specifically expressed in the PS. Addition of BMP4 to the differentiation 
medium effectively generates a Brachyury-positive PS-like population and subsequently 
Flk-1-positive mesodermal cells. Furthermore, addition of Wnt accelerates the formation 
of a PS-like population and cardiac mesoderm development (Ueno et al., 2007). Activation 
of the Nodal pathway also induces differentiation into a PS-like population and the 
subsequent formation of endoderm or mesoderm (Kubo, 2004). However, further studies 
are required to achieve precise control of cell fate, as generating a homogeneous cell 
population is often an obstacle limiting the development of cell therapies.  
AIMS OF THE RESEARCH PROJECT 
ES cells have been extensively studied in both scientific and medical communities 
due to its unique characteristics – self-renewal and pluripotency. The information gained 
from the studies helps to understand various research areas such as early embryonic 
development, transcriptional and epigenetic regulation, reprogramming of cell fate, and 
direct differentiation. However, most of the current studies focus on the molecular 
mechanisms underlying self-renewal of ES cells and only a few studies have been 
conducted to decipher the nature of pluripotency. Since understanding and controlling 
differentiation of ES cell is key to developmental biology and regenerative medicine, we 
decided to identify novel regulators that govern the pluripotency. 
In chapter 3, we have developed and validated signature based screen to identify 
novel regulators of ES cell differentiation. ES cell differentiation is a complex process that 
involves silencing of core factors, induction of three different germ layer specific 
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regulators, and re-distribution of epigenetic marks. Therefore screening regulators with 
single reporter system may not be able to cover the complicated differentiation process. 
Our signature-based screen allows to simultaneously monitor around 50 different gene 
expression levels so that we can measure the expressions of core factors, ectodermal, 
endodermal, mesodermal, and trophectodermal markers, and epigenetic regulators of more 
than 100 different samples. We first validated the screening system by comparing technical 
and biological repeats. After extensive optimization, we performed shRNA mediated KD 
screen to identify novel regulators of ES cell differentiation, separating them into distinct 
categories based on their overall functions. 
In chapter 4, we have examined the molecular functions of Yap1, a transcriptional 
co-activator of Hippo signaling pathway, on ES cell differentiation. Since we have 
observed that cell density significantly affected differentiation of ES cells and Hippo 
signaling pathway is responsible for sensing and responding to cell-cell contact and cell 
densities, we hypothesized that Yap1 may regulate differentiation of ES cells. First, we 
tested whether Yap1, and its associated factors, such as Tead family proteins and Taz are 
required for self-renewal of ES cells. Then, we examined the activity and localization of 
Yap1 upon differentiation of ES cells. Lastly, we determined the functions of Yap1 on 
differentiation of ES cells. 
In chapter 5, we have explored the roles of Pou5f1 repressors on ES cells 
differentiation. Until recently, only a few factors have been identified to repress Pou5f1 in 
ES cells. Tcf3 represses Pou5f1 and thus blocks proper differentiation of ES cells due to 
the sustained levels of core factors. Recently, we have reported that Tgif1 also represses 
Pou5f1 to counterbalance feed-forward activation of Pou5f1, thus maintaining optimal 
levels of Pou5f1. Misregulation of Tgif1 leads to abnormal differentiation of ES cells, 
suggesting the importance of Pou5f1 repressors on ES cell differentiation. To identify 
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Pou5f1 repressors, we have performed small-scale shRNA mediated screen with the 
candidate genes from published database. Then, we examined whether the positive hits are 
affecting the differentiation of ES cells. 
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CHAPTER 2: MATERIALS AND METHODS 
CELL CULTURE 
J1, E14, and CJ7 mouse ES cells were maintained in Dulbecco’s Modified Eagle 
Medium (DMEM, Gibco Ref. 11965) supplemented with 18% of fetal bovine serum (FBS), 
penicillin/streptomycin/L-glutamine (Gibco Ref. 10378), MEM nonessential amino acid 
(Gibco Ref. 11140), nucleosides (Millipore Cat. ES-008-D), 100uM β-mercaptoethanol 
(Sigma M3148), and 1000U/mL recombinant leukemia inhibitory factor (LIF, Millipore 
Cat. ESG1107). ES cells were cultured on 0.1% gelatin-coated plates at 37°C and 5% CO2 
and passaged every 2 days. HEK 293T cells were maintained in DMEM supplemented 
with 10% of FBS and penicillin/streptomycin/L-glutamine. To differentiate ES cells, cells 
were washed three times with the media without LIF and then incubated for 4 days while 
passaging every 2 days. 
REAL TIME QUANTITATIVE PCR (RT-QPCR) ANALYSIS 
Total RNA was isolated using the RNeasy plus mini kit (Qiagen Cat. 74134) and 
500ng of RNAs were reverse transcribed using qScript cDNA SuperMix (Quanta Cat. 
95048). RT-qPCRs were performed using 10 uL of PerfeCTa® SYBR® Green FastMix®, 
Low ROX™ (Quanta Cat. 95074), and 1uL of 5 X diluted cDNAs. RT-qPCR primers were 
designed to amplify the exon junction with amplicon size ~ 100 base pair. Primer sequences 
are listed in Appendix Table D-F. CT values of each primer were normalized against Gapdh 
using –ΔΔCt method to calculate fold change. 
SHRNA LENTIVIRAL PRODUCTION AND INFECTION 
HEK 293T cells were plated at ~6 X 106 cells per 100 mm2 and then transfected 
with 6ug of pLKO.1 shRNA vector (Sigma), 4ug of pCMV-Δ8.9, and 2ug of VSVG 
plasmids using 30ul of Fugene 6 (Promega Ref. 2692), according to the manufacturer’s 
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protocol. shRNA sequences are listed in Appendix Table A-C. After 24 hrs, HEK 293T 
medium was replaced with ES medium. 2 days after transfection, supernatant containing 
viral particles was collected and filtered through 0.45 um Supor® membrane (PALL Ref. 
4654). ~2 X 105 ES cells were plated on 12-well plate with virus containing media 
supplemented with 10ug/mL polybrene (Millipore Cat. TR-1003-G). After one day of 
infection, cells are selected with appropriate antibiotics and passaged every two days. Cell 
morphology, AP staining, protein and mRNA levels were examined two passages after the 
infection. 
WESTERN BLOT ANALYSIS 
Cells were lysed with RIPA buffer (G-BIOSCIENCES Cat. 786-490) with the 
addition of PhosSTOP (Roche P.N. 04906845001) and 100x Halt™ Protease Inhibitor 
(Thermo Scientific P.N. 1860932). After three times of sonication with 30 sec interval, 
lyses were centrifuged at maximum speed for 10 min at 4°C. Supernatant was transferred 
to clean tube and Laemmli sample buffer (Biorad Cat. 161-0737) was added. Following 
antibodies were used for Western blot analyses: Yap1 (1:1000, Santa Cruz, SC-101199), 
p-Yap1 (1:000, Cell signaling 4911S), Pou5f1 (1:1000, Santa Cruz, SC-5279), Nanog 
(1:1000, Abcam, ab21624), Gapdh (1:2000, Santa Cruz, SC-166545), Actb (1:20000, 
Abcam, ab20272), Tead1 (1:1000, BD Biosciences, Cat. 610923), Tead3 (1:1000, Abcam, 
ab75192), and Tead4 (1:1000, Abnova, H00007004-M01). 
FLUIDIGM 
cDNAs were synthesized from 300ng of RNAs using qScriptTM cDNA SuperMix 
(Quanta Cat# 95048-500) with total 20ul reaction. cDNAs were diluted 5-fold using 
Nuclease-Free water (Ambion AM9937) and 1.25ul cDNAs were preamplified using 2.5ul 
of 2X Taqman preamp Master Mix (Applied BioSystems Cat# 4391128), 0.5ul of 500nM 
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pooled primer mixture and 0.75ul of using Nuclease-Free water (Ambion AM9937). 
Preamplification program is 95°C for 10 min, 95°C for 15 s, 60°C for 4 min for various 
cycles.  Subsequently, preamplified cDNAs were incubated with 0.4ul of Exonuclease I 
(New England Biolabs Cat# M0293), 0.2ul of Exonuclease I reaction buffer, 1.4ul of water 
in 37°C for 30 min and inactivated in 80°C for 15 min. Exonuclease treated samples were 
further diluted 5-fold using TE (TEKnova PN T0224) and gene expression were analyzed 
with 48.48 Dynamic Arrays on a BioMark System (Fluidigm). 
CELL PROLIFERATION ASSAY 
1 X 103 ES cells were plated on 96-well plate. Every 24 h, 10uL of Cell Counting 
Kit-8 (Dojindo CK04) was added to the media. Absorbance was measured using Infinite® 
M1000 PRO microplate reader (Tecan) at 450nm after 2hr incubation. 
CORRELATION ANALYSES 
To generate the gene expression correlation map, log2 (FPKM) values were used to 
calculate Pearson correlation coefficients. Clustering analysis and visualization of the data 
were done by Cluster 3.0 and Java Treeview, respectively (de Hoon et al., 2004; Page, 
1996). 
GENE ONTOLOGY ANALYSIS 
For Gene Ontology (GO) analyses, differentially expressed genes were tested for 
enrichment of functional gene sets using Database for Annotation, Visualization and 
Integrated Discovery (DAVID) (Huang et al., 2009). Enrichment P-values were calculated 
using a modified Fisher Exact test. Similar GO terms are removed except the gene sets 
with the highest p-value.  
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GENERATION OF STABLE CELL LINES 
pEF1α-FLBIO vector containing Yap1 full length cDNA was introduced into BirA 
expressing ES cells (control cells) by electroporation (Kim et al., 2009). Positive clones 
were selected under the selection of puromycin and geneticin. Multiple single colonies 
were picked 7-10 days later, and then Yap1 overexpressing clones were confirmed by 
western blot assay using anti-streptavidin-HRP (1:2000 dilution, Sigma-Aldrich Mfr. 
RPN1231), and anti-Yap1 antibodies (1:1000 dilution, Santa Cruz sc-101199). Yap1-KO 
cell lines were generated using CRISPR-Cas9 system following manufacturer’s 
instructions (Life Technologies) (Cong et al., 2013; Mali et al., 2013). Briefly, GeneArt® 
CRISPR Nuclease Vector System (Life Technologies Cat. A21175) was used to edit 
genomic sequence in Yap1 gene locus. Two different target sequences are 
TGCCGTCATGAACCCCAAGA and ATTGAAGAGCGCCTCCAAGT followed by 
CGG (PAM sequence). J1 ES cells were transfected with the cloned CRISPR-Cas9 
nuclease construct using Lipofectamine® 2000 (Life Technologies Cat. 11668027) and 
incubated for 1 day. Transfected J1 ES cells were enriched by Dynabeads® CD4 Positive 
Isolation Kit (Life Technologies Cat. 11331D) and incubated for colonization. Each colony 
was picked, analyzed with Western blotting, and confirmed with sequencing for genomic 
editing at the target site. 
IMMUNOFLUORESCENCE 
~ 3 X 105/mL ES cells were plated on 0.1% gelatin pre-coated µ-Slide VI0.4 (Ibidi 
Cat. 80606). Slides were fixed with 3.7% paraformaldehyde for 15 min at room 
temperature and permeabilized with 0.5% Triton X 100 for 10 min. Slides were then 
incubated with blocking solution (3% BSA and 1% normal horse serum in PBS) for 1 hr at 
room temperature, Yap1 primary antibody solution (1:200 dilution, Santa Cruz sc-101199) 
overnight at 4°C, and secondary antibody solution (1:1000 dilution) conjugated to Alexa 
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Fluor 488 for 1 hr at room temperature. Lastly, slides were mounted with ProLong® Gold 
antifade reagent with DAPI (Molecular Probes P36935) and imaged on a Zeiss 710 laser 
scanning confocal and structured illumination microscope. 
LUCIFERASE REPORTER GENE ASSAY 
For the luciferase reporter gene assay, 2.5X105 J1 ES cells in each 24 well were co-
transfected with 100 ng of the GTIIC vector  or Pou5f1 enhancer luciferase vector 
(Dupont et al., 2011; Lee et al., 2015), and 5 ng of PGL4.75 vector containing a Renilla 
reporter gene as an internal control reporter using lipofectamine 3000 (Life Technologies, 
Cat. L3000008) and then cultivated for 24 hrs. To measure luciferase reporter gene activity, 
cells were washed 2 times with PBS, lysed, and the luciferase activities were measured 
using the Dual Luciferase® assay kit (Promega, E1910). 
QUANTIFICATION OF IMMUNOFLUORESCENCE IMAGE 
DAPI signal is used to distinguish nuclear portion from cytoplasmic portion of the 
cells. Total area of the cells is identified by pan-cadherin antibody. Intensity is calculated 
using ZEN software (ZEISS). 
RNA SEQUENCING AND DATA PROCESSING 
1ug of RNAs were used to generate illumina-compatible sequencing libraries using 
mRNA isolation kit (NEB, E7490L) and RNA library prep kit (NEB, E7530S) according 
to the manufacturer’s protocol. Adapter ligation was done with sample-specific barcodes. 
RNA-seq libraries were sequenced using an Illumina NextSeq 500 machine. Single-end 
reads from RNA-seq were mapped onto the mouse genome assembly (mm9) using default 
setting of Tophat2. Transcript-level expression analysis was performed using Cuffdiff to 
calculate FPKM (fragments per kilobase of transcript per million mapped reads) (Trapnell 
et al., 2010). 
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CHAPTER 3: IDENTIFYING TRANSCRIPTION FACTORS 
REGULATING DIFFERENTIATION OF EMBRYONIC STEM 
CELLS 
 
INTRODUCTION 
Although numerous studies have been dedicated to characterizing genes that 
promote self-renewal in ES cells, comparatively fewer studies have attempted to 
characterize genes that enable and control ES cell differentiation. Additionally, the studies 
that have been performed to explore factors impacting ES cell differentiation have typically 
lacked adequate functional characterization of positive hits. For example, previous 
genome-wide KD studies of differentiating ES cells identified that Tcf3, Tfe3, and Zfp706 
are required for exit from self-renewal in differentiating ES cells. Unfortunately, the 
authors did not further characterize their roles in differentiation potential or lineage 
specification into the three germ layers. To identify novel regulators responsible for proper 
differentiation of ES cells, we performed a small scale KD screen. Most of the candidate 
genes are robustly expressed in ES cells and diminished upon differentiation. However, 
KD of each of those factors did not significantly affect self-renewal of ES cells, which 
prompted us to hypothesize that some of them are involved in the regulation of other 
characteristics of ES cells, i.e. pluripotency or differentiation potential, rather than self-
renewal. 
To identify novel regulators responsible for maintaining and controlling 
differentiation potential of ES cells, we employed a unique signature-based KD screen 
rather than the traditional GFP-based reporter screens utilized in previous studies. 
Signature-based screen has been proven to be a powerful tool to identify molecules that 
can affect a whole pathway rather than a single component of the pathway (Hieronymus et 
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al., 2006; Shats et al., 2011). For example, a signature based screen identified a novel 
inhibitor of the androgen receptor (AR) signaling pathway which effectively blocks 
prostate cancer cell growth without leading to fatal drug resistance, which is the critical 
problem of known AR inhibitors. In this regard, signature-based screen on ES cell 
differentiation allows us to simultaneously monitor several different ES cell core factors as 
well as lineage specific regulators, identifying transcription factors that effectively 
regulates each lineage specification. 
 
RESULTS 
Genes bound by multiple core factors are actively expressed in ES cells and help 
maintain stemness 
Previously we have shown that multiple transcription factor bound genes are more 
likely to be critical regulators of cell identity (Kim et al., 2008). Genes bound by 4 or more 
factors among 7 core factors (Pou5f1, Nanog, Sox2, Klf4, Nac1, Dax1, and Tcf3) are 
highly expressed in ES cells, and their expressions are decreased upon differentiation. 
These genes are enriched for H3K4me3 active histone marks and depleted for H3K27me3 
repressive histone marks. In addition, they are generally enriched in developmental 
process. Some of these target genes were later re-discovered by other labs who explained 
their roles in ES cell identities. For example, Cbx1, a heterochromatin associated protein, 
is essential to maintain self-renewal and differentiation potential of ES cells (Mattout et al., 
2015). In addition, Cited2-deficient ES cells display abnormal glucose metabolism and 
impaired differentiation during hypoxia (Li et al., 2014). However, many of these target 
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genes have not yet been fully characterized with regards to their roles in ES cell 
pluripotency. 
 
First, we narrow down the gene list of previous study by selecting genes that contain 
DNA binding domain because cell identities are mainly determined by transcriptional 
regulators (Whyte et al., 2013) (Table 3.1). This list includes Pou5f1, Nanog, and Zfp42, 
which have already been shown to play essential roles in stemness. These positive hits help 
validate the list and show that the list is a credible research for exploring novel regulators 
Ankmy2 Ankrd10 Ankrd6 Anp32a Asxl1 Bach1 Basp1 
Bmp4 Brwd1 Cbx1 Cbx7 Cd38 Cdx1 Chd9 
Cited2 Creb3 Dido1 Dnmt3a E2f4 Eif4a2 Eno1 
Epc2 Etv1 Etv4 Etv5 Evx1 Eya1 Fgfbp1 
Fgfr2 Foxd3 Foxh1 Fubp3 Gbx2 Grhl3 Gsc 
H2afx H2afy2 Hes1 Hesx1 Hist1h1b Hist1h2an Hist1h2bb 
Hist1h2bp Hist1h3i Hnrnpu Hnrpdl Hopx Hoxb1 Hoxb13 
Hoxb4 Id1 Jarid2 Kdm2b Klf2 Klf9 Lmo4 
Max Med19 Mllt11 Mllt6 Msc Msh6 Msx2 
Mybl2 Mycn Myst2 Mzf1 Nanog Neurog1 Nfatc3 
Nfe2l2 Nfkbia Nkx2-2 Nolc1 Notch1 Notch4 Nr0b1 
Nrarp Olig2 Osr2 Otx2 Pax6 Pdlim1 Per2 
Phc1 Phtf2 Plscr1 Pou5f1 Rai14 Rarg Rax 
Rbbp5 Rbbp7 Rbm14 Rest Rfx4 Rlim Rpap1 
Rybp Sall3 Sall4 Set Sfrp1 Sox13 Sox2 
Sp3 Spic T Tbl1xr1 Tbx20 Tbx3 Tcea1 
Tcea3 Tcf7l1 Tfap2a Tfap2c Tfcp2l1 Tgif1 Tle3 
Trib3 Trp53bp1 Txlng Uba3 Uhrf2 Xrn2 Zfp13 
Zfp146 Zfp148 Zfp219 Zfp280c Zfp36l1 Zfp42 Zfp428 
Zfp532 Zfp57 Zfp704 Zic2 Zic5 Zscan10 
 Table 3.1 List of DNA binding domain containing genes co-occupied by 4 or more core factors. 
(Pou5f1, Nanog, Sox2, Klf4, Nac1, Dax1, and Tcf3) 
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of ES cell identity. We further validated the list by checking their activity and known 
functions. In consistent with previous work, their expression levels are significantly higher 
than genes bound by fewer transcription factors and their roles are enriched in stem cell 
maintenance and embryonic development according to gene ontology (GO) analysis 
(Figure 3.1 A, B). With this list, we decide to perform KD screen to identify novel 
regulators of ES cell identity. 
Signature-based screen to identify novel regulators of ES cell properties 
Most of the previous screens utilized a single reporter system to discover novel 
regulators of ES cell properties (Ding et al., 2009; Ivanova et al., 2006). In particular, GFP 
reporter under the control of promoter of ES cell core factors has been used to identify 
regulators of self-renewal. Novel regulators that promote self-renewal should thus reduce 
GFP expression when the cells are depleted of the potential regulators. This simple readout 
was used as a proxy for stemness. Positive regulators of the GFP reporter were further 
analyzed to check whether they affect ES cell properties such as alkaline phosphatase 
Figure 3.1 Common downstream targets of core factors are active and enriched in stem cell 
identities. (A) A box plot showing the distribution of expression levels of co-occupied targets of core 
factors. Occupied by 4 or more factors (left) or 3 or less factors (right). (B) Gene ontology (GO) 
analysis showing enriched biological process terms of common targets occupied by 4 or more core 
factors. 
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activity, round shape morphology, high proliferation rate, and core factor expression levels. 
This allowed researchers to confirm whether the hits were legitimate or not. Even though 
previous screens have identified several novel regulators of self-renewal of ES cells, they 
failed to find pluripotency or differentiation potential regulators that might act 
independently from core factors. In addition, single reporter system is not able to identify 
lineage specific regulators that are required for proper differentiation of ES cells to all three 
germ layers and trophectoderm, because differentiation into these four initial lineages is 
too complex to be measured with this approach. 
 
To overcome the drawbacks of single core factor reporter system, we have utilized 
signature-based screen to simultaneously monitor about 50 pre-selected gene set. The gene 
set includes core factors (Pou5f1, Nanog, and Sox2), endoderm lineage regulators (Gata4, 
Gata6, and Sox17), mesoderm lineage regulators (T, Gsc, and Gata1), ectoderm lineage 
regulators (Nes, Gli2, and Fgf5), trophectoderm lineage regulators (Cdx2, Hand1, and 
Eomoes) (Table 3.2). To rule out the possibility of off-target effect of shRNAs, we have 
selected top 2 shRNAs from 5 different shRNAs targeting each candidate genes (Figure 
3.2, Appendix Table A). Then we infected shRNA containing lentivirus to J1 ES cells and 
selected them with puromycin. shRNA expressing cells were split into self-renewing and 
differentiation condition media to examine the effect of candidate genes on ES cell 
properties. mRNA levels of pre-selected 50 genes were measured by Fluidigm from all the 
KD samples to identify novel regulators of ES cell properties. 
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Gene Note Gene Note Gene Note 
Ash2L Pluripotency Trp53 Pluripotency Gsc Mesoderm 
Chd9 Pluripotency Myc Myc Isl1 Mesoderm 
Esrrb Pluripotency p400 Myc T Mesoderm 
Fbxw7 Pluripotency Tip60 Myc Fgf5 Ectoderm 
H2afx Pluripotency Trrap Myc Nestin Ectoderm 
Lin28 Pluripotency Ezh2 PRC Arid3a Trophectoderm 
LSD1 Pluripotency Phc1 PRC Cdx2 Trophectoderm 
Nanog Pluripotency Rybp PRC Eomes Trophectoderm 
Pou5f1 Pluripotency Suz12 PRC Hand1 Trophectoderm 
Rest Pluripotency Dkk3 Endoderm Id2 Trophectoderm 
Zfp42 Pluripotency Gata4 Endoderm Krt8 Trophectoderm 
Sall4 Pluripotency Gata6 Endoderm Tead4 Trophectoderm 
Sox2 Pluripotency Sox17 Endoderm Actb Loading 
Tcf3 Pluripotency Bmp2 Mesoderm Gapdh Loading 
Tgif1 Pluripotency Bmp4 Mesoderm   
Tgif2 Pluripotency Gata2 Mesoderm   
 
Validation of signature based screen using Fluidigm 
We first compared the result of Fluidigm with regular qPCR result (Figure 3.3). 
Overall results are quite similar to each other in terms of their direction of regulation. For 
Figure 3.2 KD efficiency of shRNAs. Heatmap showing the KD efficiency of 46 
candidate genes. Expression levels of each genes were measured by RT-qPCR then normalized 
by Gadph levels. Grey color indicates that ES cells infected with the lentivirus did not survive 
upon selection with puromycin. 
Table 3.2 Gene list used in signature based screen. Primer sequences are in Appendix Table E. 
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example, KD of Dmap1 or P400 decreases expression levels of Myc, Gata6, Sox17, Zfp42, 
and Nanog according to both methods. However, the overall heatmap is brighter in Fludigm 
compared to qPCR result, indicating that relative mRNA abundance is amplified in 
Fludigm. This might be due to the pre-amplification step in Fludigm. The differences in 
variation between Fludigm and qPCR results suggest that small differences in Fludigm 
may need to be validated by other methods such as qPCR. 
 
 Next, we examined whether Fludigm results are consistent between technical and 
biological repeats (Figure 3.4). 4 technical repeats of each cDNA samples were placed in 
a row to monitor the variation between repeats. Blocks of 4 repeats are easily observed in 
the heatmap, indicating that technical repeats from same cDNA sample are quite consistent. 
However, we observed strikingly different data between biological repeats in 
differentiation conditions. Detailed analysis of screening results reveals that some external 
conditions may affect differentiation of ES cells. First, infection efficiencies of lentiviruses 
carrying shRNAs are not even across the candidate genes. If cells are infected with a low 
titer of lentivirus, then only a few cells will get infected. Applying selection with antibiotics 
Figure 3.3 Comparison between Fludigm and qPCR data. Heatmap showing the mRNA 
levels of selected screen samples. Same cDNAs samples were used in both systems to validate the 
results of Fluidigm with qPCR 
3
2
1
0
-1
 -2
 -3
 D
m
a
p
1
 E
p
4
0
0
 S
o
x
1
3
_
3
 T
g
if
2
_
4
 Z
fp
5
7
_
5
 E
z
h
2
_
c
 Z
fp
3
6
l1
_
4
 R
u
v
b
l1
 L
S
D
1
_
4
 H
2
a
fx
_
2
 G
b
x
2
_
4
 Z
ic
5
_
4
 E
tv
5
_
5
 D
n
m
t3
a
_
3
 F
u
b
p
3
_
3
 R
b
b
p
7
_
3
 H
e
s
1
_
5
 R
b
m
1
4
_
4
 M
e
d
1
9
_
1
 T
b
x
3
_
4
 S
e
t_
4
 H
2
a
fy
_
4
 Ezh2
 Suz12
 Krt8
 Pou5f1
 Cdx2
 Id2
 Myc
 Gata6
 Sox17
Zfp42
 Nanog
 Sox2
 D
m
a
p
1
 E
p
4
0
0
 S
o
x
1
3
_
3
 T
g
if
2
_
4
 Z
fp
5
7
_
5
 E
z
h
2
_
c
 Z
fp
3
6
l1
_
4
 R
u
v
b
l1
 L
S
D
1
_
4
 H
2
a
fx
_
2
 G
b
x
2
_
4
 Z
ic
5
_
4
 E
tv
5
_
5
 D
n
m
t3
a
_
3
 F
u
b
p
3
_
3
 R
b
b
p
7
_
3
 H
e
s
1
_
5
 R
b
m
1
4
_
4
 M
e
d
1
9
_
1
 T
b
x
3
_
4
 S
e
t_
4
 H
2
a
fy
_
4
log2
Fluidigm qPCR
 35 
will kill any uninfected cells. Thus, a tissue culture plate containing wells with an equal 
amount of starting cells but infected with different amounts of lentivirus will ultimately 
yield very uneven amounts of cells. Second, it is difficult to evenly seed the cells in small 
scale well. Cells may concentrate in the center of the well instead of forming an even 
distribution of spherical colonies, and this uneven distribution may ultimately affect gene 
expression. Lastly, cell densities affect differentiation efficiency. For example, the 
efficiency of neuronal differentiation of ES cells is high when seeding cells at low density 
(Ying et al., 2003b). Differentiation is already a heterogeneous process; if the density of 
the cells varies significantly across wells, each well may yield a different mix of the various 
differentiated lineages. 
Figure 3.4 Comparison between biological and technical repeats. Heatmap showing the 
Fluidigm results of the selected gene KD samples in differentiation condition. Left and right panels are 
2 biological repeats collected independently. Each panel contains 4 technical repeats of same cDNA 
samples. Sample and primer orders are consistent between panels. Each panels contains 4 technical 
repeats of each cDNA samples. 
 Myc
 Myc_2
 nMyc
 lMyc
 Tip60
 p400
 Trrap
 Dmap1
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Cell densities affect differentiation efficiency of ES cells 
To investigate the effect of cell densities on gene expression patterns of ES cells, 
we designed an experiment in which ES cells are serially diluted in self-renewing and 
differentiation conditions. Consistent with previous observations that cell-cell contact 
inhibits Myc expression, ES cells at high cell density significantly reduced Myc mRNA 
levels more than 100-fold compared to the cells at low density (Figure 3.5A) (Lee et al., 
1995). However, most of other tested genes are not significantly altered in self-renewing 
conditions (Figure 3.5B). On the other hand, many of the lineage specific regulators exhibit 
enormous changes in differentiation condition (Figure 3.5C). Expressions of all three germ 
layers as well as trophectoderm lineage are not increased at high cell density even when 
the cells are in differentiation media. In consistent with the idea that core factors and 
lineage specific regulators are repressing each other, some core factors including Zfp42, 
Esrrb, and Dax1 show opposite trend to lineage specific regulators at various cell densities. 
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Knockdown screen to identify novel regulators of ES cell self-renewal and 
differentiation potential 
Since most of the candidate genes are highly expressed in ES cells, we hypothesized 
that these genes may regulate self-renewal or differentiation potential of ES cells. We have 
performed KD screen with 134 shRNAs comprising 78 genes in self-renewing and 
differentiation conditions and simultaneously measured expression levels of 45 genes 
(Figure 3.6). To minimize the effect of cell density on gene expression profile, we prepared 
highly concentrated virus and tested their individual infection efficiency to confirm that 
they could infect most of the cells in each well. Each well of infected cells were carefully 
Figure 3.5 Cell density affects gene expressions in ES cells. (A) Relative Myc expression 
levels of serial diluted ES cells in self-renewing condition. Gene expression levels of serial diluted ES 
cells in self-renewing (A) and differentiation (B) condition measured by Fluidigm 
0
1
2
3
4
5
6
R
e
la
ti
v
e
 M
y
c
e
x
p
re
s
s
io
n
 (
lo
g
2
)
Cell density
A
 Actb
 Pou5f1
 Nanog
 Sox2
 Klf4
Zfp42
 Rest
 Tcf3
 Esrrb
 Dax1
 Rarg
 Sall4
 Lin28
 Myc
 nMyc
 Tip60
 p400
 Suz12
 Ezh2
 Rybp
 Cbx7
 Eed
 Prdm14
 Etv5
 Gata4
 Gata6
 Sox17
 Nodal
 Gata2
 T
 Isl1
 Chd9
 Gsc
 Pitx2
 Fgf5
 Gbx2
 Nes
 Zic5
 Arid3a
 Cdx2
 Gata3
 Eomes
 Hand1
 Tead4
 Krt8
 Id2
 Actb
 Pou5f1
 Nanog
 Sox2
 Klf4
Zfp42
 Rest
 Tcf3
 Esrrb
 Dax1
 Rarg
 Sall4
 Lin28
 nMyc
 Tip60
 p400
 Suz12
 Ezh2
 Rybp
 Cbx7
 Eed
 Prdm14
 Etv5
 Gata4
 Gata6
 Sox17
 Nodal
 Gata2
 T
 Chd9
 Gsc
 Pitx2
 Fgf5
 Gbx2
 Nes
 Zic5
 Arid3a
 Cdx2
 Gata3
 Eomes
 Hand1
 Tead4
 Krt8
 Id2
3
2
1
0
-1
 -2
 -3
log2
B CCell density Cell density
Self-renewal Differentiation
 38 
monitored to have similar cell density and even distribution. As expected, KD of well-
known core factors such as Pou5f1, Prdm14, and Nanog decreases overall core factor levels 
in self-renewing ES cells (Figure 3.6A). Consistent with previous reports, KD of Myc-
related factors such as Tip60, Dmap, Ep400, and Trrap induces some of lineage specific 
regulators such as Sox17, Bmp2, Isl1, and T. Although they are the subunits of histone 
acetyltransferase complex, which mainly activates targets through the acetylation of 
histone tail, they suppress lineage specific regulators in ES cells, possibly through the 
interaction with Hdac6 (Chen et al., 2013; Fazzio et al., 2008). We also identified novel 
regulators such as Myst2, Mybl2, Zfp428, Zic5, and Cbx7. KD of those genes induces 
lineage specific regulators in ES cells without altering core factor expressions. It would be 
interesting to examine whether these genes are associated with PRC which inhibits lineage 
specific regulators in self-renewing ES cells. However, aside from those few factors, the 
majority of the other candidates do not significantly alter core factor expression, lineage 
specific regulator expressions, cell morphology, or proliferation rate upon KD, suggesting 
that they are not required for self-renewal of ES cells.  
Next, we asked whether these genes affect differentiation potential of ES cells by 
checking gene expression signature in differentiation condition (Figure 3.6B). 
Surprisingly, we noticed that expression levels of tested genes are significantly altered 
compared to self-renewing condition, indicating that KD of candidate genes may have 
greater impact on differentiation than maintenance of ES cells. The expression profile can 
be grouped into three distinct clusters of genes based on their functions. Cluster 1 contains 
many of well-known ES cell core factors such as Pou5f1, Nanog, and Prdm14. Upon KD 
of these factors in cluster 1, expression levels of core factors are down-regulated while 
many of lineage specific regulators are induced. This means that suppression of these genes 
in ES cells stimulates differentiation. Interestingly, cluster 1 contains novel regulators such 
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as Xrn2, Zic5, and Bach1 that affect core factor expressions only in differentiation 
condition.  These data suggest that these factors are either inactive or possess functions 
unrelated to transcriptional regulation while ES cells are in self-renewing conditions, but 
their function changes after the exit from self-renewal to promote differentiation. 
Meanwhile, knocking down genes in cluster 2 leads to higher expression of histone 
acetylase and PRC complexes, and reduced induction of lineage specific regulators. Since 
PRC and histone acetylase complexes are known repressors of lineage specific regulators, 
our data is consistent with previous observation. We noticed that ectoderm lineage 
regulators such as Fgf5, Nestin, and Hobx1 expressions are rather increased, whereas other 
lineage specific regulators are decreased. This may indicate that KD of these genes favors 
one lineage over another during differentiation. However, it has not been studied whether 
PRC and histone acetylase complexes differentially regulate each lineage upon 
differentiation. It might be interesting to study whether these complexes differentially 
regulate each lineage specifications in vitro differentiation and in vivo embryonic 
development. Since KD of genes in cluster 2 induces PRC and histone acetylase 
complexes, further studies of the genes in this cluster will also help to reveal upstream 
regulators of the complexes. Lastly, KD of genes in cluster 3 results in significant inhibition 
of lineage specific regulators, accompanied by induction of core factors. This implies that 
these genes are important for up-regulation of lineage markers as well as down-regulation 
of core factors during differentiation. Cluster 3 includes Tcf3, a well-known core factor 
repressor, indicating that genes in cluster 3 may be required for the exit from self-renewal. 
In contrast to cluster 2, where ectoderm-specific lineage markers were favored over other 
lineages, upon KD of the genes in cluster 3, lineage markers from all three lineages 
including the trophectoderm failed to be induced. Early embryonic development requires 
very precise lineage specification; each cell in the ICM must ultimately differentiate into 
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the proper lineage in a consistent manner for the fetus to grow properly. These genes may 
be essential for that process and reveal insights about the nature of pluripotency itself. 
Signature-based KD screen with 78 genes provides rough idea on their functions in 
self-renewal and differentiation of ES cells. However, the novel regulators discovered in 
this study may need to be confirmed by other methods such as CRISPR/Cas9 knockout, 
siRNA, overexpression (OE), and functional assays. Investigation of the roles of tested 
genes in direct differentiation into specific lineages may also provide important 
information on regenerative medicine and developmental biology. The results also prove 
the advantage of the signature-based screen over single reporter system by discovering 
novel regulators that function independent of well-known core factors.  
 41 
 
Figure 3.6 Signature based KD screen. Heatmaps showing the relative gene expression levels 
upon KD of each genes in self-renewing. (A) and differentiation (B) condition. Each columns indicates 
tested primers of different category – core factors (green), histone acetylase (orange), PRC (blue), 
trophectoderm (red), endoderm (dark brown), mesoderm (light brown), ectoderm (purple), loading 
control (black). Each rows indicate KD samples. 
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DISCUSSION 
In summary, we performed small scale KD screen to identify novel regulators of 
ES cell characteristics. Compared to screens performed by other groups, we discovered 
numerous candidates that significantly disturbed ES cell differentiation potential without 
substantially affecting expression of core factors. This observation suggests that signature-
based screen can be a powerful tool to identify novel regulators of differentiation, which 
can be missed by single reporter system. Since ES cell has potential to be differentiated 
into all three germ layers as well as trophectoderm, simultaneous observation of several 
marker genes will be helpful to identify regulators of each lineages at once. In addition, 
when studying differentiation of ES cells external conditions must be carefully controlled 
to obtain consistent results. We have shown that cell density significantly affects 
differentiation of ES cells. Using siRNA or CRISPR-Cas9 may help to reduce cell density 
variations which can be caused by lentiviral efficiency. Culturing cells carefully to 
maintain an even density and consistent colony size can also improve reproducibility of 
differentiation. 
While analyzing the screen data we observed interesting gene expression patterns 
of lineage specific regulators. Whereas many of endodermal and mesodermal markers such 
as Gata6 and T display similar regulatory patterns across most of the samples, ectodermal 
markers such as Fgf5 and Nestin exhibit opposite gene expression patterns to other lineage 
specific regulators implying that there might be inhibitory mechanisms between ectoderm 
and other lineages. For example, Tet proteins regulate the balance between neuroectoderm 
and mesoderm by inhibiting Wnt signaling pathway (Li et al., 2016). Identifying factors 
that disrupt the inhibition of lineages may help to understand the underlying molecular 
mechanisms of embryonic development. 
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Since differentiation of ES cells is significantly affected by cell densities it is 
important to examine the mechanisms by which signaling pathway is involved in this 
process. Hippo signaling pathway senses cell-cell contact by transmembrane cadherin 
protein and activate downstream transcriptional activator Yap1 when cell density is low 
(Mo et al., 2014). However the roles of Yap1 on differentiation of ES cell has not been 
studied extensively, which prompted us to investigate the functions of Yap1 on ES cell 
identity. 
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CHAPTER 4: YAP1 IS DISPENSABLE FOR SELF-RENEWAL BUT 
REQUIRED FOR PROPER DIFFERENTIATION OF MOUSE 
EMBRYONIC STEM (ES) CELLS 
INTRODUCTION 
The Hippo signaling pathway, modulated by cell density and cell-cell contact, is 
implicated in diverse cellular processes including cell proliferation (Huang et al., 2005; 
Kim and Koh, 2011; Mori et al., 2014; Schlegelmilch et al., 2011; Silvis et al., 2011), 
apoptosis (Huang et al., 2005; Lee and Yonehara, 2012), and organ size control (Camargo 
et al., 2007; Zhao et al., 2007). Yap1, a transcriptional co-activator of the Hippo pathway, 
is known to play a crucial role in the segregation of inner cell mass (ICM) and 
trophectoderm (TE) during early embryogenesis (Cockburn et al., 2013; Hirate et al., 2013; 
Nishioka et al., 2009; Rayon et al., 2014; Wicklow et al., 2014). While Yap1 resides in the 
nucleus of trophectodermal cells and functions as a critical co-activator for TE 
development, it is mainly sequestered in the cytoplasm of the ICM as a phosphorylated 
inactive form due to active Hippo signaling (Nishioka et al., 2009). However, the role of 
Yap1 in ICM is still elusive (Cockburn et al., 2013; Nishioka et al., 2009). In addition to 
Yap1, Taz and Tead family members are also crucial players in the Hippo pathway. Taz, a 
homologue of Yap1, shares redundant functions with Yap1, such as controlling cell 
proliferation and sensing mechanical stress (Dupont et al., 2011; Imajo et al., 2014). Tead 
proteins play important roles in TE differentiation during early embryogenesis. They form 
a complex with Yap1, and are known to activate their downstream target genes (Li et al., 
2010b; Ota and Sasaki, 2008). 
 
This work was published in Chung H, Lee BK, Uprety N, Shen W, Lee J, Kim J. Yap1 is 
Dispensable for Self-Renewal but Required for Proper Differentiation of Mouse Embryonic Stem (ES) Cells, 
(2016) EMBO Reports 17, 519-29. HWC, NU, and WS performed the experiments. HWC and BKL analyzed 
RNA-seq data. HWC, BKL, JL, and JK conceived work and wrote the manuscript. Permission to reproduce 
the manuscript has been granted by the co-authors. 
 45 
Notably, there are two different observations on the roles of Yap1 in embryonic 
stem (ES) cells. Some recent studies have suggested that Yap1 plays an important role in 
the maintenance of mouse ES cells as an active factor in the nucleus (Lian et al., 2010; 
Tamm et al., 2011). These works showed KD of Yap1 promotes differentiation of ES cells 
while OE of Yap1 not only enhances self-renewal but also inhibits differentiation of ES 
cells even under neuronal differentiation conditions (Lian et al., 2010). However, the study 
showing nuclear-localized Yap1 in ES cells is somewhat contradictory to the function of 
the Hippo signaling since mouse ES cells grow as tightly packed colonies. It has been 
suggested that high cell density or cell-cell contact activates the Hippo signaling and 
subsequent sequestration of Yap1 in the cytoplasm of various cell lines such as HaCaT and 
NIH-3T3  (Kim and Koh, 2011; Mori et al., 2014; Varelas et al., 2010; Zhao et al., 2007).  
Accordingly, another recent study has claimed that both Yap1 and Taz are dispensable for 
the self-renewal of ES cells in 2i (Gsk3β and Mek inhibitors) culture condition (Azzolin et 
al., 2014). In this case, Yap1- and Taz-depleted ES cells maintained undifferentiated state 
under differentiation-promoting culture conditions (Azzolin et al., 2014). Consistent with 
this observation, studies of neuronal differentiation from ES cells have shown that high 
cell density, which activates the Hippo signaling and sequesters Yap1 in the cytoplasm, 
blocks differentiation of ES cells (Tropepe et al., 2001; Ying et al., 2003a), suggesting that 
nuclear localization of Yap1 might be important in normal differentiation of ES cells. 
In the current study, we show that Yap1 is dispensable for the maintenance of ES 
cells but critical in their differentiation. Additional testing of Yap1-associated factors 
including Tead family proteins and Taz also supports the dispensability of Yap1 for the 
self-renewal of ES cells. In line with gradual up-regulation of Yap1 level upon 
differentiation of ES cells, OE of Yap1 in ES cells enhances nuclear abundance of Yap1 
accompanied by induction of various lineage-specific marker genes. On the contrary, 
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Yap1-depleted ES cells showed impaired differentiation. Taken together, our data 
demonstrate a critical role of Yap1 in normal differentiation rather than self-renewal of ES 
cells.  
RESULTS AND DISCUSSION 
Yap1 is dispensable for self-renewal of mouse ES cells 
Previous studies reported the requirement of Yap1 in the maintenance of mouse ES 
cells by showing that KD of Yap1 promotes differentiation of ES cells (Lian et al., 2010; 
Tamm et al., 2011). Conversely, another study claimed that double KD of Yap1 and Taz 
in 2i media does not disrupt self-renewal of ES cells (Azzolin et al., 2014). To decipher the 
roles of Yap1 in self-renewal and pluripotency of ES cells, we first performed KD of Yap1 
using lentivirus-delivered shRNAs in J1 mouse ES cells (Figure 4.1A). In contrast to the 
previous reports (Lian et al., 2010; Tamm et al., 2011), we found that even with >85% of 
Yap1 KD, ES cells maintain normal colony morphology with high alkaline phosphatase 
Figure 4.1. Yap1 is dispensable for self-renewal of J1 mouse ES cells. (A) Yap1 mRNA levels 
measured by RT-qPCR upon shRNA-based KD. Five different shRNA sequences were tested and 
shRNAs 1 and 2 (KD1 and KD2) were used for further studies. (B) Cell proliferation rates of Yap1 KD 
cells and control cells. (C) mRNA levels of lineage-specific marker genes upon KD of Yap1. 
Differentiating ES cells (dESC) were used as control cells. 
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(AP) activity, whereas ES cells with KD of Pou5f1 undergo differentiation accompanied 
by loss of AP activity, as expected (Figure 4.2A). We additionally found that these Yap1-
depleted ES cells show comparable proliferation rate to that of control ES cells (Figure 
4.1B). In agreement with these observations, overall expression levels of ES cell core 
pluripotency factors, such as Pou5f1 and Nanog, as well as several lineage specific 
regulators were not significantly altered upon KD of Yap1 (Figures 4.2B-D, and 4.1C). We 
validated our observation by testing two additional ES cell lines (E14 and CJ7), and 
confirmed that KD of Yap1 does not significantly affect the features of normal self-
renewing ES cells (Figure 4.3A-F). 
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Figure 4.2. Yap1 is dispensable for self-renewal of J1 mouse ES cells. (A) Colony 
morphology and alkaline phosphatase (AP) activity of ES cells upon KD of Yap1 and Pou5f1. KD1 
and KD2 indicate two different shRNA sequences tested. All the following cell morphology and AP 
staining pictures were taken two passages (4 days) after lentivirus infection unless otherwise stated. 
Legend continued on next page. 
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(B-C) mRNA expression levels of Pou5f1, Nanog, Sox2, Esrrb (B), and Yap1 (C) upon KD of 
Yap1. All the following mRNA samples were harvested 4 days after lentivirus infection while passaged 
every 2 days unless otherwise stated. Data are represented as mean  SD. (D) Protein levels of Yap1, 
Pou5f1 and Nanog upon KD of Yap1. All the following protein samples were harvested 4 days after 
lentivirus infection while passaged every 2 days unless otherwise stated. (E) Colony morphology and 
AP activity of mouse embryonic stem cells (ESC) and three Yap1 KO clones (KO1-KO3). (F) mRNA 
levels of Pou5f1, Nanog, Sox2, and Esrrb upon KO of Yap1. Data are represented as mean  SD. (G) 
Protein levels of Yap1, Pou5f1 and Nanog in Yap1 KO clones. (H) A heatmap showing relative mRNA 
expression levels of 3,605 genes differentially expressed (> 2-fold) between ES cells and differentiating 
ES cells (dESC). Genes were sorted by the fold changes of gene expression between dESC and ES cells. 
Corresponding gene expression profiles obtained from Yap1 KO1, Yap1 KO2, and Yap1 KD cells are 
also shown. (I) mRNA expression levels of lineage-specific marker genes upon KD of Yap1. dESC 
were used as control cells. (J) A heatmap showing Pearson correlation coefficients of gene expression 
profiles obtained from ESC, control virus infected ES cells (Control), dESC, Yap1 KD cells, and Yap1 
KO cells. (K) Relative average module activities (Core and PRC) in Yap1 KD1 cells, KO cells and 
dESC. Module activities were normalized by the data obtained in ES cells. Data are represented as mean 
 SEM. (L) Scatter plots showing log10 (FPKM) values of genes in Yap1 KD1 cells and Control (upper 
left panel), dESC and ESC (bottom left panel), and Yap1 KO cells and ES cells (right two panels). 
Pearson’s correlation coefficients (R2) are indicated. ‘FPKM’ indicates Fragments Per Kilobase of 
transcript per Million fragments mapped. 
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 Figure 4.3. Yap1 is dispensable for self-renewal of E14 and CJ7 mouse ES cells. (A-C) Data 
from CJ7 ES cells. Colony morphology and AP activity of Yap1 KD cells (A), mRNA levels of Pou5f1, 
Nanog, Sox2, and Esrrb in Yap1 KD cells (B), protein expression levels of Yap1, Pou5f1, and Gapdh 
were measured in Yap1 KD cells (C). (D-F) Data from E14 ES cells. Colony morphology and AP 
activity of Yap1 KD cells (D), mRNA levels of Pou5f1, Nanog, Sox2, and Esrrb in Yap1 KD cells (E), 
protein expression levels of Yap1, Pou5f1, and Gapdh were measured in Yap1 KD cells (F). (G-I) Data 
from CJ7 ES cells (ESC). Colony morphology and AP activity of Yap1 KO clones (G), mRNA levels 
of Pou5f1, Nanog, Sox2, and Esrrb in Yap1 KO clones (H), protein expression levels of Yap1, Pou5f1, 
and Gapdh were measured in Yap1 KO clones (I). (J-L) Data from E14 ES cells. Colony morphology 
and AP activity of Yap1 KO clones (J), mRNA levels of Pou5f1, Nanog, Sox2, and Esrrb in Yap1 KO 
clones (K), protein expression levels of Yap1, Pou5f1, and Gapdh were measured in Yap1 KO clones 
(L). 
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To rule out the possibility of off-target effects and incomplete depletion due to 
shRNA-mediated KD strategies, we additionally established Yap1 KO ES cell lines 
harboring premature stop codons on both alleles by CRISPR-Cas9 based genome editing 
strategies (Cong et al., 2013; Mali et al., 2013). Consistent with the KD results, Yap1 KO 
ES cells sustained self-renewing status and showed normal ES colony morphology, high 
AP activity, and comparable levels of pluripotency-related genes to those of wild-type ES 
cells (Figures 4.2E-G and 4.3G-L). Yap1 KO ES cells were able to maintain self-renewal 
for more than a month in culture (Fig 4.4A-C). Taken together, these results indicate that 
Yap1 is dispensable for self-renewal of mouse ES cells. 
To further validate the dispensability of Yap1 in self-renewal of ES cells, we sought 
to monitor the global gene expression profiles of normal, differentiating, Yap1 KD, and 
Yap1 KO ES cells using RNA-seq approaches. As expected, comparison of expression 
profiles between ES and differentiating ES cells revealed many differentially expressed 
genes (DEGs) (Figure 4.2H). However, expression levels of these genes were not altered 
significantly upon KD or KO of Yap1 (Figure 4.2H) which was further confirmed by RT-
Figure 4.4 Yap1-depleted ES cells can maintain self-renewal for more than a month in culture. 
(A) Colony morphology and AP activity of Yap1 KO clones cultured for more than a month. (B) mRNA 
levels of Pou5f1, Nanog, Sox2, and Esrrb in Yap1 KO clones shown in (A). (C) Protein expression 
levels of Yap1, Pou5f1, and Gapdh were measured in Yap1 KO clones shown in (A). 
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qPCR (Figure 4.2I). Overall, these results indicate that the depletion of Yap1 does not 
trigger differentiation of ES cells.  
Unlike differentiating ES cells, a hierarchical clustering of global expression data 
revealed that Yap1 KD and Yap1 KO ES cells were clustered together with normal and 
control ES cells, indicating that Yap1-deficient ES cells have similar expression profiles to 
those of normal ES cells (Figure 4.2J). We also investigated the activity of previously 
defined functional modules in ES cells (Core and PRC) (Kim et al., 2010). Module activity 
is defined as an averaged expression of all genes in each module. Briefly, the Core module 
includes core pluripotency factors such as Pou5f1, Nanog, and Sox2, most of which are 
highly expressed in self-renewing ES cells. On the other hand, the PRC module includes 
many lineage-specific regulators, such as Fgf5, Bmp4, and Hand1, most of which are 
repressed in ES cells. Since differentiation of ES cells decreases the activity of Core 
module but increases the activity of PRC module (Kim et al., 2010), we sought to examine 
module activities upon KD or KO of Yap1 to test if cells maintain self-renewal. As shown 
in Fig 1K, ES cells with depletion of Yap1 did not show down-regulation of Core module 
activity or up-regulation of PRC module activity, suggesting that Yap1-depleted ES cells 
largely maintain self-renewing and undifferentiated states. Further correlation analyses 
verified that the global expression patterns of Yap1-depleted ES cells showed higher 
correlation with those of control ES cells (R2 = 0.978 for Yap1 KD, R2 = 0.977 for Yap1 
KO1, and R2 = 0.979 for Yap1 KO2) than differentiating ES cells (R2 = 0.781) (Figure 
4.2L). Collectively, these data provide strong evidence that the depletion of Yap1 does not 
significantly alter the self-renewal of ES cells. 
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Taz and Tead family proteins are not required for self-renewal of ES cells, and do 
not compensate Yap1 functions in Yap1-depleted ES cells  
Taz is homologous to Yap1 and has similar functions to Yap1, such as regulation 
of proliferation and activation of TE lineage markers (Home et al., 2012; Imajo et al., 
2014). To rule out the possibility of compensation by Taz in Yap1 KD ES cells, we 
performed both single and double KD of Yap1 and Taz using shRNAs under drug 
selections (Blasticidin and Puromycin, respectively). J1 ES cells with depletion of both 
Yap1 and Taz (>85% of KD for each) maintained typical colony morphology as well as 
high AP activity (Figure 4.5A, B). Additionally, the levels of pluripotency markers, such 
as Pou5f1 and Nanog as well as various lineage markers were not significantly affected by 
either single or double KD of Yap1 and Taz (Figure 4.5C, D), indicating that the 
dispensability of Yap1 in self-renewing ES cells is not due to the compensatory effect of 
Taz. 
Since Yap1 is known to require Tead family proteins to activate its downstream 
target genes in NIH-3T3 and MCF10A cell lines (Li et al., 2010b; Zhao et al., 2008, 2009), 
we investigated whether Tead proteins are also dispensable for the maintenance of ES cells. 
To do so, we first performed KD of Tead2 in ES cells. In contrast to the previous report 
(Tamm et al., 2011), we did not observe any significant alteration of cell morphology or 
reduced AP activity upon down-regulation of Tead2 (at least >90% of KD in mRNA levels) 
(Figure 4.6A-B). In accordance with the colony morphology, Tead2 KD ES cells expressed 
similar levels of pluripotency genes compared to wild-type ES cells (Figure 4.6C-D). These 
results were confirmed by generation of three independent Tead2 KO ES cell clones using 
CRISPR-Cas9 strategies. These Tead2 KO clones also maintained self-renewal without 
differentiation (Figure 4.6E-G). We additionally conducted triple KD of Tead1/3/4 with 
triple drug selection (at least >80% of KD for each), and did not observe any significant 
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alteration of cell morphology or AP activity which is in contrast to the previous report 
(Lian et al., 2010) (Figure 4.5E-F). Similar to the results obtained from the KD of Yap1, 
triple Tead KD ES cells expressed comparable levels of pluripotency genes shown in wild-
type ES cells without any significant activation of lineage-specific regulators (Figure 4.5G-
I). The results were further validated by double KD of Tead1/3 in Tead4 KO cells. ES cells 
with Tead4 KO and Tead1/3 KD also maintained self-renewal (Figure 4.6H-J). 
Collectively, our data suggest that both Yap1 and Yap1-associated proteins such as Taz 
and Tead are not required for self-renewal of ES cells. 
Yap1 is induced and translocated into the nucleus upon differentiation of ES cells 
In order to investigate the roles of Yap1 in differentiation of ES cells, we examined 
the expression level of Yap1 in self-renewing mouse ES cells as well as upon 
differentiation of ES cells. Analysis of published mRNA expression data obtained upon 
time-course differentiation of embryoid body (EB) (Hailesellasse Sene et al., 2007) 
revealed that Yap1 is moderately expressed in ES cells while its expression gradually 
increases upon differentiation (Figure 4.7A). We differentiated mouse J1 ES cells by the 
withdrawal of leukemia inhibitory factor (LIF) in the culture media and examined the level 
of Yap1. Consistent with the results from the EB differentiation, both mRNA and protein 
levels of Yap1 were moderately increased upon spontaneous differentiation (Figure 4.7B, 
C).  
Since active Hippo signaling leads to phosphorylation and cytoplasmic 
sequestration of Yap1, thereby blocking Yap1’s function as a transcriptional coactivator 
(Cockburn et al., 2013; Nishioka et al., 2009; Zhao et al., 2007), we examined the levels of 
phospho-Yap1 and its subsequent localization in both self-renewing and differentiating ES 
cells.  
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Figure 4.5 Taz and Tead family proteins are not required for the self-renewal of J1 mouse ES 
cells. (A) Colony morphology and AP activity of ES cells upon KD of Yap1 and Taz. (B-D) mRNA 
expression levels of Yap1 and Taz (B), Pou5f1, Nanog, Sox2, and Esrrb (C), and lineage-specific marker 
genes upon KD of Yap1 and Taz. Data are represented as mean  SD. (E) Colony morphology and AP 
activity of ES cells upon KD of Tead 1/3/4. (F-G) mRNA expression levels of Tead1, Tead3, and Tead4 
(F) and Pou5f1, Nanog, Sox2, and Esrrb (G) upon KD of Tead 1/3/4. Data are represented as mean  
SD. (H) Protein levels of Tead1, Tead3, Tead4, and Pou5f1 upon KD of Tead 1/3/4. (I) mRNA 
expression levels of lineage-specific marker genes upon KD of Tead 1/3/4. 
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Figure 4.6 Tead family proteins are not required for the self-renewal of ES cells. (A) Colony 
morphology and AP activity of Tead2 KD ES cells. (B) mRNA levels of Tead2 measured by RT-qPCR 
upon shRNA-based KD. (C) mRNA expression levels of Pou5f1, Nanog, Sox2, and Esrrb upon KD of 
Tead2. Data are represented as mean  SD. (D) Protein levels of Pou5f1 and Nanog upon KD of Tead2. 
(E) Colony morphology of three Tead2 KO clones (KO1-KO3) and control ES cells. (F) mRNA levels 
of Pou5f1, Nanog, Sox2, and Esrrb upon KO of Tead2. Data are represented as mean  SD. (G) Protein 
levels of Pou5f1 and Nanog in Tead2 KO clones. (H) Colony morphology of ES cells upon KO of Tead4 
and KD of Tead1/3. (I) mRNA levels of Pou5f1, Nanog, Sox2, and Esrrb upon KO of Tead4 and KD of 
Tead1/3. Data are represented as mean  SD. (J) Protein levels of Pou5f1 and Nanog in Tead4 KO and 
Tead1/3 KD ES cells. 
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  Figure 4.7. Yap1 is up-regulated and translocated into nucleus during ES cell differentiation. 
(A) Relative mRNA levels of Yap1, Pou5f1 and Gata6 during time-course embryoid body (EB) 
differentiation. Gene expression data were obtained from GSE3749. Pou5f1 and Gata6 serve as 
representative ES cell marker and lineage-specific marker, respectively. (B) Relative Yap1 mRNA 
levels in ES cells (ESC) and differentiating ES cells (dESC) (LIF withdrawal for 4 days) and data are 
represented as mean  SD. To differentiate ES cells, cells were incubated in LIF withdrawn medium for 
4 days. Both ESC and dESC were passaged every 2 days. (C) Protein levels of Yap1 and Pou5f1 during 
time-course differentiation upon LIF withdrawal. Legend continued on next page 
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(D) Phospho-Yap1 levels during time-course differentiation. Samples were normalized by total 
Yap1 level. (E-G) Immunofluorescence (IF) images depicting localization of Yap1 in J1 (D), 
CJ7 (E), and E14 (F) mouse ESC (top) and dESC (bottom). The white arrow indicates 
nucleolus. Bottom panels represent higher magnification of the above panels. Dashed circle 
indicates nucleus border. (H) A schematic diagram depicting a Yap1 responsive luciferase 
reporter (8xGTIIC) construct. (I) Luciferase reporter assay using Yap1 responsive luciferase 
reporter (8xGTIIC) upon transient OE Yap1 in ES cells. P-values were calculated using 
Student’s t-test. Two asterisks indicate P<0.01. ‘Control’ indicates ES cells infected with 
control virus not expressing any specific shRNA sequence and all RT-qPCR data are 
represented as mean  SD (I-K). (J) Relative activity of Yap1 responsive luciferase reporter 
gene in ESC and dESC. P-values were calculated using Student’s t-test. (K) Relative Yap1 
mRNA levels in Control and Pou5f1 KD ES cells. (L) IF images depicting localization of Yap1 
in Control and Pou5f1 KD ES cells. (M) Relative activity of Yap1 responsive luciferase reporter 
gene upon Pou5f1 KD in ES cells. P-values were calculated using Student’s t-test. 
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Western blot analysis showed that Yap1 is highly phosphorylated in self-renewing 
ES cells but the level of phospho-Yap1 is reduced in differentiating ES cells (Figure 4.7D). 
Given the fact that phospho-Yap1 is sequestered in the cytoplasm (Cockburn et al., 2013; 
Nishioka et al., 2009; Zhao et al., 2007), we examined Yap1 localization by 
immunofluorescence (IF). Consistent with hyper-phosphorylation of Yap1 in ES cells, IF 
results revealed that Yap1 resides primarily in the cytoplasm of self-renewing ES cells 
(Figure 4.7E-G). However, upon differentiation of multiple mouse ES cell lines we tested 
(J1, CJ7, and E14), Yap1 was translocated into the nucleus (Figures 4.7E-G and 4.8A-D). 
Cytoplasmic Yap1 in ES cells could be attributed to compact ES cell colonies with active 
Hippo signaling (Zhao et al., 2007), while lower cell density of differentiating ES cells 
growing in a monolayer leads to inactive Hippo signaling, resulting in the nuclear 
localization of Yap1.  
 We further investigated the activity of nuclear Yap1 using a synthetic Yap1-
responsive luciferase (8xGTIIC) construct as previously designed for the measurement of 
Yap1 transcriptional activity in mechanical stress condition (Figure 4.7H) (Dupont et al., 
2011; Mahoney et al., 2005; Tamm et al., 2011; Xiao et al., 1991). The luciferase construct 
Figure 4.8. Yap1 is translocated into the nucleus upon differentiation of ES cells. (A) 
Immunofluorescence (IF) images depicting Yap1 signals in J1 ES cells (ESC) and Yap1 KO clone. (B-
D) Quantification of relative Yap1 localization between ESC and differentiating ES cells (dESC) from 
three different cell lines: J1 (B), CJ7 (C), and E14 (D). See material and methods for detailed 
quantification method. 
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contains repeated Yap1-Tead binding motifs (8 times) in front of the minimal cTNT 
promoter followed by a luciferase reporter gene (Dupont et al., 2011; Farrance et al., 1992; 
Mahoney et al., 2005). As shown in Figure 4.7I and J, we observed a significant increase 
in luciferase activity in both ES cells with transient OE of Yap1 and in differentiating ES 
cells compared to the reporter activity in self-renewing ES cells, indicating the increased 
level of nuclear Yap1 either by OE of Yap1 or ES cell differentiation promotes 
transcription of the reporter gene. An induced level and nuclear localization of Yap1 were 
also confirmed along with the increased Yap1 activity in Pou5f1 KD ES cells undergoing 
TE differentiation (Figure 4.7K-M). 
Yap1 is required for normal differentiation of ES cells 
As we observed increased expression levels and nuclear localization of Yap1 in 
differentiating ES cells (Figure 4.7), we hypothesized that Yap1 may have critical roles in 
differentiation of ES cells. To address this, we tested differentiation potential of Yap1 KD 
ES cells. Upon 3 days of differentiation, completely differentiated and mono-layered 
cellular morphology with reduced AP activity were observed in control ES cells. However, 
Yap1 KD cells maintained typical colony morphology with high AP activity comparable 
to that of self-renewing ES cells even after 2-3 days of differentiation (Figure 4.9A). We 
further found that expression levels of some pluripotency factors such as Sox2 and Esrrb 
were relatively highly maintained in Yap1-depleted cells upon differentiation, although the 
expression of other core factors, Pou5f1 and Nanog, were decreased similar to their levels 
in control cells upon differentiation (Figure 4.10A). Moreover, up-regulation of various 
lineage-specific markers, such as Nes, T, Gsc, Gata6, Cdx2, and Gata3 was significantly 
impaired during differentiation of Yap1-depleted cells (Figure 4.10B), suggesting that the 
depletion of Yap1 affects differentiation potential of ES cells. 
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In order to get further insight into the roles of Yap1 in global transcriptional 
regulation during differentiation, we analyzed gene expression profiles obtained from 
RNA-seq of normal ES cells and Yap1-depleted ES cells before and after differentiation. 
As shown in Figure 4.9B, gene expression patterns of DEGs (Yap1 KD ES cells/wild-type 
ES cells) upon differentiation showed an inverse correlation with the expression patterns 
of wild-type differentiating cells over self-renewing ES cells. The heatmap results clearly 
revealed that Yap1-depleted ES cells are not properly differentiated. Additional analyses 
of the Core and PRC module activity consistently indicated that Yap1 depletion causes 
stronger Core module activity with weaker PRC module activity during differentiation, 
indicating that KD of Yap1 delayed or impaired proper differentiation of ES cells (Figure 
4.9C). Gene ontology (GO) term analysis of the list of genes that were not properly induced 
in Yap1-depleted cells compared to wild-type ES cells upon differentiation also revealed 
that these genes are implicated in various development-related processes, such as blood 
vessel development, chordate embryonic development, and in utero embryonic 
development (Figure 4.10C). All these collectively demonstrate that the adequate level of 
Yap1 is critical in normal differentiation of ES cells. 
Ectopic expression of Yap1 in ES cells is sufficient to induce up-regulation of lineage 
marker genes 
To further test roles of Yap1 in ES cell differentiation, we performed OE of Yap1 
in ES cells. Yap1 mainly resides in the cytoplasm of self-renewing ES cells. While OE of 
Yap1 increases both nuclear and cytoplasmic Yap1 levels, we detected more nuclear Yap1 
in Yap1 OE cells, indicating that exogenous Yap1 can translocate into the nucleus and act 
on its target genes (Figure 4.10D-E). Yap1 OE cells also showed flattened morphology 
similar to that of differentiating ES cells with reduced AP activity even in the presence of 
LIF (Figure 4.9D). We further examined global gene expression profiles of Yap1 OE cells, 
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and a clustering analysis showed that the DEGs upon OE of Yap1 (Yap1 OE/ES cells) are 
highly similar to the DEGs of differentiating ES cells over self-renewing ES cells (Figure 
4.9E). Consistently, the activity of the Core module was significantly decreased upon OE 
of Yap1, while the PRC module activity was dramatically increased (Figures 4.9F and 
4.10F). These results suggest that OE of Yap1 is sufficient to trigger ES cell differentiation. 
Additional GO term analysis revealed that genes up-regulated upon OE of Yap1 are 
significantly enriched in developmental processes, such as chordate embryonic 
development, skeletal system development, and embryonic organ development (Figure 
4.9G), further demonstrating that the ectopic expression of Yap1 promotes differentiation 
of ES cells.  
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  Figure 4.9 Yap1 is required for differentiation of ES cells. (A) Colony morphology and AP 
activity of Control and Yap1 KD ES cells upon differentiation. Morphology and AP staining pictures 
were taken 2 days after differentiation. (B) A heatmap showing relative mRNA expression levels of 
1,995 genes differentially expressed (> 2-fold) between Yap1 KD ES cells and Control upon 4 days of 
differentiation. Genes were sorted by the fold changes of gene expression between Yap1 KD ES cells 
and Control (first column). Corresponding gene expression profiles obtained from differentiating ES 
cells (dESC) are shown in the second column. Legend continued on next page. 
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(C) Relative average module activities (Core and PRC modules) between Yap1 KD ES cells 
and Control upon differentiation. Data are represented as mean  SEM. (D) Colony morphology 
and AP activity in Yap1 OE cells. Two different Yap1 OE clones (OE1 and OE2) and pool of 
Yap1 OE (OE pool) were used. Cell morphology and AP staining pictures were taken 3 weeks 
after electroporation. (E) A heatmap showing relative mRNA expression levels of 2,137 genes 
differentially expressed (>2-fold) between Yap1 OE ES cells and control ES cells. Genes were 
sorted by the fold changes of gene expression between Yap1 OE ES cells and control ES cells 
(first column) and corresponding gene expression profiles obtained from dESC are shown. (F) 
Relative average module activities (Core and PRC modules) between Yap1 OE cells and control 
cells are shown. Data are represented as mean  SEM. (G) Genes up-regulated in Yap1 OE cells 
were tested using David 6.7. Significantly enriched gene ontology (GO) terms (biological 
functions) are shown. Developmental process-related GO terms are highlighted in red. 
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Figure 4.10 Alteration of Yap1 affects differentiation of ES cells. (A-B) mRNA levels of ES 
cell core factors (A) and lineage-specific markers (B) in Yap1 KD1 cells upon 4 days of differentiation. 
White bars indicate the levels of genes tested in control virus infected ES cells (Control) upon 
differentiation. (C) Bar graphs showing significantly enriched gene ontology (GO) terms (biological 
functions). GO analysis of genes down-regulated in Yap1 KD cells upon differentiation was performed 
using David 6.7 tools. Developmental process-related terms are highlighted in red. (D) IF images 
showing localization of Yap1 in control and Yap1 OE cells. (E) Quantification of nuclear Yap1 in 
control and Yap1 OE cells. (F) mRNA levels of ES cell (ESC) core factors and lineage-specific marker 
genes in Yap1 OE cells and Yap1 OE pool. 
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Unlike the well-established functions of the Hippo signaling pathway in the first 
cell fate decision, the roles of Yap1 in ES cells, ICM, and during differentiation of ES cells 
or ICM are still not well understood. Here, we reveal that Yap1, a transcriptional effector 
of Hippo pathway, is a crucial factor implicated in differentiation rather than self-renewal 
of ES cells. In contrast to the previous reports (Lian et al., 2010; Tamm et al., 2011), a 
depletion of Yap1 does not show any significant effect on the maintenance of multiple ES 
cells we tested. This is consistent with the dispensability of Yap1 for maintaining the 
stemness of ES cells grown under the 2i condition (Azzolin et al., 2014). In agreement with 
the dispensability of Yap1 in ES cells, other key effectors of the Hippo pathway (Tead 
family proteins and Taz) do not compensate for depletion of Yap1, and are also not 
necessary for the maintenance of ES cells, implying that the transcriptional effectors of the 
Hippo pathway are at least dispensable for self-renewal of mouse ES cells. In addition, we 
show that Yap1 is mainly sequestered in the cytoplasm of self-renewing ES cells, while it 
localizes in the nucleus upon differentiation. The predominant nuclear localization of Yap1 
in differentiating ES cells may be due to inactive Hippo signaling in the cells growing with 
lower density. Consistently, OE of Yap1 in ES cells triggers nuclear localization of Yap1 
and induces differentiation along with activation of diverse lineage markers. Our global 
expression analyses further suggest that Yap1 may promote differentiation by activating 
differentiation-related genes rather than repressing pluripotency-related genes, which is 
consistent with the observation of Yap1 KO embryo, which dies around E10 due to the 
defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation 
(Morin-Kensicki et al., 2006). Noticeably, a recent study done in human ES cells suggested 
that YAP1 represses mesendoderm differentiation (Beyer et al., 2013), possibly due to the 
differences in signaling pathways between human and mouse ES cells (Amit et al., 2000; 
Nichols et al., 2001). In-depth investigation of the impaired regulation of three lineage-
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specific genes as well as TE-related genes in Yap1 KD ES cells upon differentiation may 
provide further insights into the functions of Yap1 in early embryogenesis. Together, our 
data establish that Yap1 is a critical regulator for proper differentiation but dispensable for 
self-renewal of ES cells. 
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CHAPTER 5: THE ROLES OF POU5F1 REPRESSORS ON 
EMBRYONIC STEM CELLS DIFFERENTIATION 
 
INTRODUCTION 
Core transcription factors such as Pou5f1, Sox2, and Nanog maintain pluripotency 
of ES cells by activating themselves as well as other core transcription factors (reviewed 
in Orkin, 2005). The maintenance of specific and precise levels of core factors is critical 
for the pluripotency of ES cells. For example, slight increase of Pou5f1 differentiates ES 
cells into primitive endoderm and mesoderm (Niwa et al., 2000). Thus, there must be 
negative regulators that tone down any over-activation of core factors by this 
autoregulatory and feedforward loop. However, only a few repressors that repress core 
factors in ES cells have successfully been identified so far. Tcf3 and Tgif1 are two notable 
examples (Lee et al., 2015; Pereira et al., 2006). Tcf3, transcriptional regulator of Wnt 
signaling pathway, co-occupies downstream target genes with Pou5f1 and Nanog, thus 
being an integral member of core pluripotency network (Cole et al., 2008). However, unlike 
other core factors which form a positive feedforward loop, Tcf3 represses Pou5f1 and 
Nanog and sustains optimal core factor levels to maintain the pluripotency of ES cells 
(Pereira et al., 2006). Recently, we reported that Tgif1, the terminal transcriptional 
repressor of TGFβ signaling pathway, also counterbalances the activity of core factors (Lee 
et al., 2015). Similar to Tcf3, Tgif1 co-occupies downstream targets with other core factors 
but represses their activities.  
The precise level of Pou5f1 expression determines not only whether ES cell self-
renewal can be successfully maintained, but also whether ES cells can successfully 
differentiate. Elevated levels of Pou5f1 impair the differentiation potential of ES cells and 
embryonic carcinoma cells by activating core factors and inhibiting lineage specific 
 69 
regulators. Conversely, depletion of repressors of Pou5f1 seems to have similar 
physiological effects as OE of Pou5f1. ES cells in which Tcf3 has been depleted, for 
example, are resistant to differentiation when incubated in LIF withdrawal differentiation 
media and maintain round shape morphology and high alkaline phosphatase activity 
(Pereira et al., 2006). In line with this, several lineage specific regulators failed to become 
induced in Tcf3 KO ES cells during differentiation. Aside from attaining a greater 
understanding of gene regulation before and after self-renewal, studying Pou5f1 repressors 
has also provided insight into mammalian development. In agreement with in vitro 
differentiation assays where Tcf3-depleted ES cells do not express mesodermal marker, 
Tcf3 KO mouse display neonatal death due to a lack of B cells in fetal liver (Merrill, 2003). 
Despite the importance of Pouf51 repressors in differentiation of ES cells, only a 
few such factors have been identified so far. Furthermore, most of the screens in ES cells 
are focused on identifying activators of core factors, which may be implicated in the 
regulation of ES cell self-renewal rather than pluripotency. Here, we report that our 
shRNA-mediated screen identifies Rbpj, Gli2, and Taf6 as negative regulators of Pou5f1 
in ES cells. In addition, depletion of Rbpj, downstream effector of Notch signaling 
pathway, delays differentiation by sustaining expression of core factors and inhibiting 
induction of lineage specific regulators. 
 
 70 
RESULTS 
Small scale shRNA mediated screen identifies Pou5f1 repressors in ES cells 
Previously, Ding et al., performed genome wide RNAi screen to identify Pou5f1 
modulators in ES cells (Ding et al., 2009). Their primary goal was to identify genes 
essential for the maintenance of ES cell identity. From the screen, KD of 21 genes with 
esiRNA reduced Pou5f1 promoter driven GFP levels greater than 2 times of standard 
deviation. The list includes two of Pol II-associating factor 1 complex (Paf1C), which is 
essential for the maintenance of ES cells. However, there are also 32 genes that induce 
Pou5f1 expression more than standard deviation upon esiRNA mediated KD (Figure 5.1). 
We further narrow down the list by filtering out low expression levels in ES cells. Finally, 
we only selected genes that have known potential repressor function (Table 5.1). This list 
contains the previously identified Pou5f1 repressor, Tgif1, validating its potential to find 
other Pou5f1 repressors. In addition, some of the candidates have been reported to have 
repressive roles in other cellular contexts, but their roles in ES cells have not yet been well 
characterized. To rule out the possibility that induction of Pou5f1 is due to any off-target 
effects of shRNA, we tested 5 different shRNA targeting different regions of each genes 
Figure 5.1 Z-score of esiRNA mediated Pou5f1 promoter reporter assay. Data adapted from 
Ding et al., 2009. GFP was placed under the control of a Pou5f1 promoter. Hits in the green circle 
correspond to genes that cause reduced fluorescence upon knockdown. These genes therefore sustained 
Pou5f1 expression, and their reduction caused a drop in Pou5f1 expression (and therefore the GFP 
reporter). Hits in the red circle correspond to genes that cause increased fluorescence upon knockdown. 
Ergo, these genes likely repressed Pou5f1 expression, and their reduction caused an increase in Pou5f1 
expression.  
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(Appendix Table C). Each lentivirus containing shRNA was used to infect J1 mouse ES 
cells. Then, we measured Pou5f1 levels by RT-qPCR (Figure 5.2). Initial screen identifies 
Rbpj, Taf6, Gli2, and Med26 as Pou5f1 repressors that induce Pou5f1 upon KD by each 
shRNAs. However, core factor repression by Med26 was not reproducible in a subsequent 
validation with top 2 shRNAs (Figure 5.3A), narrowing down final candidate repressors to 
Rbpj, Taf6, and Gli2.   
Rbpj is a transcriptional regulator belonging to the Notch signaling pathway. Notch 
signaling pathway is activated upon binding with its ligand, which is a transmembrane 
protein of neighboring cells. Upon activation, the intracellular domain of Notch is cleaved 
by γ-secretase and then translocates into the nucleus to bind with Rbpj and activate 
downstream target genes. Though traditionally studied as an activator, in the absence of 
Gli2 Trip4 Taf1b 
Rai14 Zfp13 Mycbp 
Sirt6 Med26 Taf6 
Phf12 Taf12 Nr6a1 
Rbpj Gli1 Zfp198 
Mphospho8 Trip13 Bcl3 
Table 5.1 List of candidate Pou5f1 repressors 
Figure 5.2 shRNA mediated screen to identify Pou5f1 repressor. Heatmap shows relative 
Pou5f1 levels upon KD of each genes with 5 different shRNAs 
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the Notch intracellular domain, Rbpj can function as a transcriptional repressor (Blaess, 
2006). In somatic stem cells, activation of Notch signaling increases cell proliferation, but 
its role in ES cells have not been studied yet. Gli2 is a transcriptional effector of HH 
signaling pathway. The binding of HH ligand to its receptor causes maturation of Gli2 to 
its activator form, while the absence of the ligand causes it to be proteolytically processed 
into its repressive form (Pan et al., 2006). Although Gli2 is mainly processed into activator, 
the existence of a repressive form Gli2 may also have significant effects on downstream 
gene expression. It has been reported that Gli2 binds to Pou5f1 in ES cells and increases 
proliferation rate of ES cells but it is not yet clear whether Gli2 functions as an activator or 
repressor in ES cells (Li et al., 2013). Taf6 is a subunit of basal transcription factor TFIID. 
Interestingly, its level is high in ES cells compared to other somatic cells such as NIH 3T3 
or fibroblast cell line (Pijnappel et al., 2013). TFIID has been known to play an important 
role in the pluripotent transcriptional circuitry but the functions of its individual subunits 
have not been explored yet. 
 
Figure 5.3 The effect of candidate repressors on core factors. (A)RT-qPCR results showing the 
relative expression levels of core factors and Med26 upon KD of Med26. (B)RT-qPCR results showing 
the relative expression levels of Pou5f1, Nanog, and Sox2 upon depletion of Rbpj, Taf6, and Gli2 with 
top 2 shRNAs. (A) KD efficiency of each shRNAs measured by RT-qPCR. 
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Rbpj, Taf6, and Gli2 repress core factors 
Core factors such as Pou5f1, Nanog, and Sox2 form an autoregulatory and 
feedforward loop by activating their own expression as well as that of other core factors 
(Cole et al., 2008). In agreement with the interconnected positive regulation of core factors, 
Tgif1, a known Pou5f1 repressor, not only down-regulates Pou5f1, but also represses 
multiple other core factors such as Nanog, Sox2, and Tbx3. We investigated whether 
candidate Pou5f1 repressors can also suppress Nanog and Sox2. KD of Rbpj, Taf6, or Gli2 
with top 2 shRNAs induces all the tested core factors such as Pou5f1, Nanog, and Sox2, 
indicating that these factors affect the autoregulatory loop of core factors (Figure 5.3B, C). 
Interestingly, even though we have initially screened the genes that repress Pou5f1 levels, 
KD of Rbpj, Taf6, or Gli2 induces Nanog levels more than Pou5f1. This might be because 
copy numbers of Pou5f1 mRNA (~1000 RPKM) is significantly higher than Nanog (~200 
RPKM). It also suggests that Pou5f1 level is tightly regulated in ES cells so that it is 
resistant to any changes. Since core factors are co-regulating each other, lower variation of 
Pou5f1 levels are indirect consequence of Nanog repression of the candidate repressors. 
We further validated repressive roles of Rbpj, Taf6, and Gli2 by luciferase assays, 
which measures Pou5f1 enhancer activity. After infection of ES cells with lentivirus 
containing shRNA against Rpbj, Taf6, or Gli2, luciferase vector containing the enhancer 
loci of Pou5f1 as well as the Renilla luciferase internal control were co-transfected into the 
cells, and luminescence was measured to examine the activity of Pou5f1 enhancer (Figure 
5.4A) (Lee et al., 2015). Consistent with Pou5f1 mRNA levels, induction of Pou5f1 
enhancer activities upon KD of repressors are relatively minor. We also confirmed that 
Pou5f1 protein level increased after KD of these factors, supporting the repressive roles of 
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Rbpj, Taf6, and Gli2 (Figure 5.4B). Collectively, we conclude that KD of Rbpj, Taf6, or 
Gli2 induces Pou5f1 and other associated core factors. 
 
Depletion of Rbpj impairs ES cell differentiation 
Since depletion of Tcf3 delays differentiation of ES cells due to lack of proper core 
factor downregulation (Pereira et al., 2006), we hypothesized that depletion of Rbpj, Taf6, 
or Gli2 may also inhibit proper differentiation. After shRNA-mediated KD of Rbpj, Taf6, 
or Gli2, ES cells were incubated in LIF withdrawn media to induce spontaneous 
differentiation. After 4 days, cell morphology as well as AP activity were examined to 
analyze the differentiation status of each samples (Figure 5.5A). As expected, control ES 
cells display flattened and spiky morphology and weak AP activities, indicating that they 
are undergoing differentiation. However, Rbpj KD ES cells maintain round shape 
morphology and high AP activity comparable to that of self-renewing ES cells. Similar to 
self-renewing condition, Rbpj KD ES cells in differentiation condition have high Pou5f1 
levels compared to differentiated control ES cells, suggesting that Rbpj is critical for 
Figure 5.4 The effect of candidate repressors on Pou5f1. (A) Relative activity of Pou5f1 
enhancer containing luciferase. Firefly activities are normalized by Renilla luciferase activities. (B) 
Western blot analysis showing Pou5f1 protein levels upon KD of each candidate repressors. 
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repressing Pou5f1 to increase differentiation efficiency after the exit from self-renewal. 
Additionally, the expression levels of other core factors such as Nanog, Sox2, Klf, and 
Esrrb are significantly higher after Rbpj KD compared to differentiated control ES cells. 
Along with sustained level of core factors, lineage specific regulators are not properly 
induced, meaning that Rbpj KD cells had a severe differentiation defect. The results 
suggest that repression of core factors via Rbpj is essential for differentiating into the three 
germ layers after withdrawal of LIF. Surprisingly, KD of Taf6 and Gli2, did not affect the 
differentiation efficiency of ES cells. This might be because Taf6 and Gli2’s functions in 
repression of Pou5f1 are redundant with other regulators and the subsequent induction of 
Pou5f1 upon KD of Taf6 or Gli2 is not enough to inhibit differentiation (Figures 5.4B, 
5.5B). In contrast, Rbpj may be a more crucial repressor of Pou5f1, so much so that KD of 
Rbpj is sufficient to disrupt ES cell pluripotency. It would be worthwhile to study whether 
there is a threshold of core factor expression that inhibits proper differentiation of ES cells, 
and whether Rbpj alone (but not Taf6 or Gli2) is sufficient to reduce Pou5f1 expression 
beneath this threshold to enable proper differentiation. 
Inhibition of Notch1 synergizes with KD of Rbpj in self-renewing ES cells, but does 
not further affect differentiation of ES cells 
Notch1 is a transmembrane protein of Notch signaling pathway. Upon binding with 
the ligand, Notch1 intracellular domain (NICD) is cleaved by γ-secretase and translocates 
into the nucleus (reviewed in Artavanis Tsakonas et al., 1999). Then, it binds to Rbpj to 
activate downstream target genes. In ES cells, activation of Notch by transient OE of NICD 
inhibits early mesodermal differentiation (Schroeder et al., 2006). On the other hand, 
inhibition of Notch1 by small molecule N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-
phenylglycine-1,1-dimethylethyl ester (DAPT), induces intestinal differentiation when 
treated with Wnt activator BIO (Ogaki et al., 2013). However, it has not been studied 
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whether Rbpj is involved in the Notch-mediated differentiation of ES cells. To examine 
the genetic interaction of Notch1 and Rbpj in ES cells, we first administered DAPT to 
control and Rbpj KD ES cells. Interestingly, inhibition of Notch by DAPT further increases 
Pou5f1 and Nanog expression levels in Rbpj KD ES cells, indicating a synergistic effect 
(Figure 5.6A). The result supports the idea that Rbpj can function as a repressor when it is 
not bound by NICD, specifically as a repressor of core factor genes (Borggrefe and Oswald, 
2009). Then, we tested the effect of DAPT on ES cells in differentiating conditions. Similar 
to treatment of ES cells in self-renewing conditions, DAPT alone was insufficient to 
increase expression of core factors, but in stark contrast, it did not seem to synergize with 
KD of Rbpj in negative affecting their expression (Figure 5.6B). In contrast, DAPT 
treatment alone slightly inhibited the induction of a few lineage markers such as Cdx2 and 
T, but KD of Rbpj had a far greater effect on lineage marker expression and DAPT did not 
show any synergistic effect (Figure 5.6B). These data seem to suggest that inhibition of 
Notch1 has a greater effect in self-renewing compared to differentiating ES cells, and that 
the presence of Rbpj takes precedence over the inhibition of Notch in supporting 
differentiation. Additional studies may want to address the roles of other Notch signaling 
pathway members as well as the NICD-independent vs. NICD-dependent gene regulatory 
functions of Rbpj in differentiating ES cells. Furthermore, it would be intriguing to figure 
out why Notch1 inhibition induces intestinal differentiation but does not seem to affect  
the efficiency of pan differentiation in ES cells.  
DISCUSSION 
Since ES cell core factors form a positive feedforward loop but excessive 
expression of these core factors compromises ES cell identity, there must be other factors 
which repress these core factors and thereby maintain a moderate level of expression (Niwa 
 77 
et al., 2000). Until recently, only a few factors have been identified that repress Pou5f1 and 
thereby regulate ES cell pluripotency (Cole et al., 2008; Lee et al., 2015; Merrill, 2003). 
Here, we report that Rbpj, Taf6, and Gli2 repress core factors in ES cells. Lentiviral 
shRNA-mediated KD of any of these genes increases expression of core factors such as 
Pou5f1 and Nanog at the RNA and protein levels.   
Consistent with previous observations of Tcf3-deficient ES cells, which are 
resistant to differentiation, KD of Rbpj delays proper differentiation of ES cells. Identifying 
global targets of Rbpj will help to understand how Rbpj regulates differentiation. 
Comparing the binding loci of Rbpj with other core factor repressors such as Tcf3 and 
Tgif1 will provide an idea whether Rbpj shares regulatory mechanisms with Tcf3 and 
Tgif1. Previous report of global binding sites of Rbpj in mouse myogenic cells demonstrate 
that Rbpj binding sites can be divided into constant and inducible regions (Castel et al., 
2013). They further showed that the inducible binding sites largely overlap with NICD 
binding sites. However, it is not yet clear whether binding of Rbpj can repress its targets. 
Identifying sites that are occupied by Rbpj but not by NICD will help to understand 
repressive roles of Rbpj. In addition, it is important to know whether binding patterns of 
Rbpj changes upon differentiation. Although we have shown that several lineage specific 
regulators are not properly induced in Rbpj-depleted differentiating ES cells, it is not clear 
whether it is caused by direct inhibition of sustained Pou5f1. Rbpj has been known to 
directly activate a neuronal marker Hes1 (Castel et al., 2013), implying that Rbpj may 
directly activate lineage specific regulators independent of Pou5f1. 
Since Rbpj is a transcriptional regulator of Notch signaling pathway, we examined 
the effect of Notch signaling pathway on the roles of Rbpj in ES cells. Treatment with 
Notch1 inhibitor synergistically increased expression of core factors in self-renewing, but 
not differentiating conditions. This suggests that Notch1 is active in self-renewing 
 78 
condition so that inhibition of Notch1 has synergistic effect with Rbpj KD. On the other 
hand, ineffectiveness of the Notch inhibitor in differentiating ES cells implies that Notch1 
becomes inactive in this condition so that inhibitor may have lost its target. This is 
consistent with previous report that Rbpj acts as a repressor in the absence of NICD (Li et 
al., 2012). It is important to examine the roles of other Notch signaling components such 
as Notch ligands, γ-secretase, Notch family proteins to understand general roles of Notch 
signaling on ES cell differentiation. 
Surprisingly, KD of each of these repressors does increase Pou5f1 levels high 
enough to induce premature differentiation to primitive endoderm. Previous report showed 
that Pou5f1 must be increased at least 50% to induce differentiation (Niwa et al., 2000), 
indicating that other Pou5f1 repressors may be able to partially compensate for the 
depletion of any of these repressors. Even though we are able to identify three repressors 
of Pou5f1 in ES cells, depletion of each of them does not strongly perturb Pou5f1 mRNA 
levels due to the tight intrinsic regulation of Pou5f1 levels to maintain ES cell 
identity(Kellner and Kikyo, 2010). As a future direction it might be advantageous to use 
other core factors such as Zfp42 or Esrrb, which may have a wider range of variation in 
expression, as a reporter gene to identify repressors of core factors. 
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Figure 5.5 KD of Rbpj impairs differentiation of ES cells. (A) Colony morphology and AP 
activity of differentiating ES cells. ES cells infected with each shRNAs are induced differentiation by 
withdrawal of LIF. Colony morphology and AP activity pictures were taken 4 days (2 passages) after 
differentiation. (B)Western blot analysis showing Pou5f1 protein levels of (A). Core factors (C) and 
lineage specific regulator (D) expression levels upon KD of Rbpj in differentiation condition 
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Figure 5.6 Inhibition of Notch synergizes with Rbpj KD in self-renewing, but not differentiating 
conditions. (A)RT-qPCR data showing Pou5f1 and Nanog mRNA levels upon treatment of DAPT in 
control and Rbpj KD self-renewing ES cells. RT-qPCR data showing core factors (B) and lineage 
specific regulators (C) upon treatment of DAPT in control and Rbpj KD differentiating ES cells 
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CHAPTER 6: SUMMARY AND FUTURE DIRECTIONS 
During my doctoral studies, we have investigated regulatory mechanisms of mouse 
ES cell differentiation. To this end, we have employed a broad range of cellular and 
biological approaches, along with high-throughput genomics approach. With this, we have 
found several novel regulators of ES cell differentiation and broadened our understanding 
of how transcription factors and signaling pathways regulate differentiation. 
First, we developed a signature-based screen that can simultaneously monitor the 
expression of 48 genes that are essential for ES cell identity and differentiation, and we 
used this screen to analyze more than 100 KD samples. We quantified mRNA levels of 
several different classes of genes, including core factors, PRC, 3 lineage specific 
regulators, and trophectoderm, all of which strongly influence the transcriptional and 
epigenetic landscape of ES cells. Technical, but not biological, replicates were highly 
consistent with one another. We have found that cell densities significantly affect 
differentiation efficiency of ES cells, and surprisingly used this obstacle to develop a 
project that analyzed the role of density in differentiation. We optimized the screen to 
maintain even cell density and distribution even after antibiotic selection by concentrating 
lentivirus titer. As a result of the screen, candidate genes, many of which remain poorly 
characterized in the literature, are clustered into 3 distinct groups. We discovered that many 
genes can affect differentiation potential without disrupting self-renewal of ES cells 
suggesting that self-renewal and pluripotency are functionally separable. Our screen serves 
as a fruitful resource for future investigators who are interested in genes that affect ES cell 
differentiation via transcriptional regulation. Further studies are required to understand 
how each genes affect differentiation of each lineages. 
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Even though we have optimized the signature-based screen, there are several points 
that need to be considered for subsequent rounds of screening in different contexts. First, 
the list of primers must be carefully chosen. Some of the well-known lineage specific 
regulators of developmental biology are not suitable for monitoring differentiation of ES 
cells. For example, Gata4 and Gata6, well-known endodermal markers of embryonic 
development, are not significantly induced upon LIF withdrawn-mediated early 
differentiation. Even though Pou5f1 protein levels rapidly decrease upon differentiation, 
Pou5f1 mRNA remains high in early differentiation of ES cells. Using primer sets that are 
rapidly changing upon differentiation can enhance the credibility of the screen system. 
Second, pre-amplification cycles must be carefully chosen based on the primer sets. Since 
this signature-based screen use two rounds of PCR reactions, the signals can be rapidly 
saturated. Lastly, since cell densities significantly affect the differentiation efficiency, we 
recommend to avoid any RNAi methods that rely on drug selection and maximize KD 
efficiency without the use of selection. Maintaining an even cell number and distribution 
is the key to generate reproducible data. Transient transfection of siRNA or CRISPR/Cas9 
can be a suitable alternative to shRNA mediated KD. 
 
In order to unravel the molecular mechanisms of density-mediated differentiation 
regulation, we studied Yap1, a transcriptional co-activator of Hippo signaling pathway, 
which senses cell densities and regulates cellular process accordingly. We discovered that 
Yap1 is essential for proper ES cell differentiation thanks to its co-activator activities in 
concert with its binding partners, the Tead family proteins. In stark contrast to previous 
observation, we have shown that Yap1 is completely dispensable for self-renewal of ES 
cells. Normally, the Hippo pathway sequesters Yap1 and renders it inactive in response to 
high cell density. Since ES cells form a compact colony with high cell density and become 
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flattened upon differentiation, we reasoned that Hippo signaling pathway would be active 
in ES cells, thus inactivating Yap1, and deactivated upon differentiation, thus leading to 
the liberation of Yap1. Indeed, we have observed that Yap1 is induced and translocated 
into the nucleus upon differentiation. Consistent with the activity and localization of Yap1, 
Yap1-depleted ES cells fail to differentiate, and ectopic OE of Yap1 is sufficient to force 
ES cells to exit self-renewal and undergo spontaneous differentiation. 
Since Yap1 is a co-activator, its biological activity depends on its ability to bind to 
proteins that can then bind to DNA. Despite the crucial roles of Yap1 for differentiation, 
we do not yet know the direct chromosomal targets and the binding partners of Yap1 in 
differentiating ES cells. ChIP-seq will identify global targets of Yap1, which will likely 
include lineage markers and other genes that are capable of moderating the vast 
transcriptional changes that occur during changes in cell identity. In addition to Tead 
family proteins, which are essential for Yap1’s transcriptional regulatory activities, it is 
important to understand whether upstream Hippo signaling pathway components such 
Lats, Mats kinases and Cadherin proteins are also involved in differentiation of ES cells. 
While studying the functions of Yap1 on ES cell differentiation, we observed that Yap1-
depleted ES cells undergo significant cell death upon differentiation. Since Yap1 is a well-
known oncogene that protects the cell from apoptosis and it has been shown that low levels 
of apoptosis are critical for efficient differentiation, understanding how Yap1 negatively 
controls apoptosis during ES cell differentiation and how this influences lineage 
specification may be an informative future endeavor. Finally we also need to explore how 
Yap1 and Hippo signaling pathways translate cell density signals into inhibition of 
differentiation. It is known that Yap1 influences Wnt signaling in other cellular contexts. 
Thus, density may indirectly affect numerous other signaling pathways due to its inhibitory 
effects on Yap1 activation through the Hippo pathway. 
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Lastly, we studied the roles of Pou5f1 repressors on ES cell differentiation. Even 
though maintaining an optimal level of Pou5f1 is critical for preserving ES cell identity 
and preventing inappropriate differentiation, only few repressors have been identified until 
now. Using a shRNA-mediated screen, we have identified three novel Pou5f1 repressors 
in ES cells. KD of Rbpj, Taf6, and Gli2, positive hits of the screen, increases the expression 
of not only Pou5f1, but also other core factors such as Nanog and Sox2. This is critical, 
because these core factors orchestrate global gene expression programs in ES cells, but it 
was previously unclear what upstream factors control them. Among these three candidate 
repressors, depletion of Rbpj caused ES cells to fail to differentiate normally and maintain 
stemness even in the absence of LIF due to heightened expression of Pou5f1. However, the 
other two candidate repressors were dispensable for differentiation. This implies that there 
might be a critical threshold of Pou5f1 levels that allow to maintain normal differentiation 
of ES cells. In addition, there may be unknown targets that are regulated by only Rbpj but 
not by Taf6 or Gli2, which help to repress core factors. Since Rbpj is a transcriptional 
regulator of Notch signaling pathway, we asked how Notch1 affects Rbpj-mediated 
differentiation. It is known that activation of Notch1 leads to the liberation of the NICD 
fragment, which can bind to Rbpj and cause it to function as an activator, rather than as a 
repressor. We inhibited Notch1 and found that in self-renewing ES cells, combined 
inhibition of Notch1 and KD of Rbpj synergized to activate expression of core factors. 
However, inhibition of Notch1 does not exhibit any synergistic effect with Rbpj KD in 
differentiating ES cells, implying that Notch1 may become inactive upon differentiation. 
Overall, my doctoral research has led to advances in our understanding of pluripotency and 
its upstream regulators, and this knowledge can be applied to technologies that demand 
precise regulation of cell fate, including medicine and stem cell therapy.  
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APPENDIX 
Appendix Table A. shRNA used in chapter 3 
 
Gene Clone sequence 
Fubp3 1 CCGGCATAGGAAGGAACGGAGAAATCTCGAGATTTCTCCGTTCCTTCCTATGTTTTTG 
Fubp3 2 CCGGCATCACTGGAGACCCATTTAACTCGAGTTAAATGGGTCTCCAGTGATGTTTTTG 
Fubp3 3 CCGGGCCTGGCTTTCACAACGATATCTCGAGATATCGTTGTGAAAGCCAGGCTTTTTG 
Fubp3 4 CCGGGACCCTAACCTGCGGATATTTCTCGAGAAATATCCGCAGGTTAGGGTCTTTTTG 
Fubp3 5 CCGGACTAAACATTGCTGGTAATTTCTCGAGAAATTACCAGCAATGTTTAGTTTTTTG 
Asxl1 1 CCGGGTGGAAAGCTGTGGGTCTAATCTCGAGATTAGACCCACAGCTTTCCACTTTTTG 
Asxl1 2 CCGGGTCGGCCCACTTACCAGATATCTCGAGATATCTGGTAAGTGGGCCGACTTTTTG 
Asxl1 3 CCGGTGCCACCCACCCATCATATTTCTCGAGAAATATGATGGGTGGGTGGCATTTTTG 
Asxl1 4 CCGGTCAGCGGCAGTGCACTCAATACTCGAGTATTGAGTGCACTGCCGCTGATTTTTG 
Asxl1 5 CCGGGTGCCACAGGCCTACTCATAACTCGAGTTATGAGTAGGCCTGTGGCACTTTTTG 
Zfp36l1 1 CCGGCCACATACAATATCTGTGTAACTCGAGTTACACAGATATTGTATGTGGTTTTTG 
Zfp36l1 2 CCGGCCGCTGCCACTTCATTCATAACTCGAGTTATGAATGAAGTGGCAGCGGTTTTTG 
Zfp36l1 3 CCGGAGACATTCCGCTCGCAGATTTCTCGAGAAATCTGCGAGCGGAATGTCTTTTTTG 
Zfp36l1 4 CCGGCAGCTTCTCAGCAGCCTTAAGCTCGAGCTTAAGGCTGCTGAGAAGCTGTTTTTG 
Zfp36l1 5 CCGGTGTGCCGTCCCTTCGAAGAAACTCGAGTTTCTTCGAAGGGACGGCACATTTTTG 
Cbx1 1 CCGGCCTGACCTTATTGCTGAGTTTCTCGAGAAACTCAGCAATAAGGTCAGGTTTTTG 
Cbx1 2 CCGGTCTTCTAAAGTGGAAGGGTTTCTCGAGAAACCCTTCCACTTTAGAAGATTTTTG 
Cbx1 3 CCGGCAGAGCGGATTATTGGAGCTACTCGAGTAGCTCCAATAATCCGCTCTGTTTTTG 
Cbx1 4 CCGGGAGTTTCTACAGTCACAGAAACTCGAGTTTCTGTGACTGTAGAAACTCTTTTTG 
Cbx1 5 CCGGGAGGTACTAGAAGAAGAGGAACTCGAGTTCCTCTTCTTCTAGTACCTCTTTTTG 
Mybl2 1 CCGGCCAGAATCTCTCAAGCGTGAACTCGAGTTCACGCTTGAGAGATTCTGGTTTTTG 
Mybl2 2 CCGGGTCAAGAAGTATGGCACCAAACTCGAGTTTGGTGCCATACTTCTTGACTTTTTG 
Mybl2 3 CCGGGCTCTCGACATTATGGATGAACTCGAGTTCATCCATAATGTCGAGAGCTTTTTG 
Mybl2 4 CCGGGAGACAACAGATGTAAGGTTACTCGAGTAACCTTACATCTGTTGTCTCTTTTTG 
Mybl2 5 CCGGTCTGCTAAAGAACTCGGACATCTCGAGATGTCCGAGTTCTTTAGCAGATTTTTG 
Msc 1 CCGGGTAACCAAAGAAAGCCCAGTTCTCGAGAACTGGGCTTTCTTTGGTTACTTTTTG 
Msc 2 CCGGGCTTTGTGGAACTTCCGCTTACTCGAGTAAGCGGAAGTTCCACAAAGCTTTTTG 
Msc 3 CCGGCGACATTTCTTCTGCGGAAGACTCGAGTCTTCCGCAGAAGAAATGTCGTTTTTG 
Msc 4 CCGGCGCGGGAGGATGCAAGAGGAACTCGAGTTCCTCTTGCATCCTCCCGCGTTTTTG 
Msc 5 CCGGCCAACAGGCTTTGTGGAACTTCTCGAGAAGTTCCACAAAGCCTGTTGGTTTTTG 
Msh6 1 CCGGGTGGTAAATTCAGACAACATTCTCGAGAATGTTGTCTGAATTTACCACTTTTTG 
Msh6 2 CCGGCCCGTAATCTACCTGAAGAATCTCGAGATTCTTCAGGTAGATTACGGGTTTTTG 
Msh6 3 CCGGGCTGGCCTTGATTAACGGATTCTCGAGAATCCGTTAATCAAGGCCAGCTTTTTG 
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Msh6 4 CCGGGCAGCTCAAGTCTCAGAACTTCTCGAGAAGTTCTGAGACTTGAGCTGCTTTTTG 
Msh6 5 CCGGGCAGGGTTTGACTCTGATTATCTCGAGATAATCAGAGTCAAACCCTGCTTTTTG 
Kdm2b 1 CCGGGCGTAGTCCACCTCGTGTTATCTCGAGATAACACGAGGTGGACTACGCTTTTTG 
Kdm2b 2 CCGGTAGAGTCCCTTCCGGAGAATACTCGAGTATTCTCCGGAAGGGACTCTATTTTTG 
Kdm2b 3 CCGGGTTGGATCCATGCGGTTTATACTCGAGTATAAACCGCATGGATCCAACTTTTTG 
Kdm2b 4 CCGGGCGGCTCATTATTCGCCATATCTCGAGATATGGCGAATAATGAGCCGCTTTTTG 
Kdm2b 5 CCGGCGCTGTGGAAATATCTGTCATCTCGAGATGACAGATATTTCCACAGCGTTTTTG 
Bach1 1 CCGGGCTCCTTCAAAGTCCAGCATTCTCGAGAATGCTGGACTTTGAAGGAGCTTTTTG 
Bach1 2 CCGGGCGTACACAATATCGAGGAATCTCGAGATTCCTCGATATTGTGTACGCTTTTTG 
Bach1 3 CCGGTATAGAATGACCAGGTAATAACTCGAGTTATTACCTGGTCATTCTATATTTTTG 
Bach1 4 CCGGGAAATTGGAAACTACGATTATCTCGAGATAATCGTAGTTTCCAATTTCTTTTTG 
Bach1 5 CCGGGCTCGACTGTATCCATGACATCTCGAGATGTCATGGATACAGTCGAGCTTTTTG 
Phc1 1 CCGGGCTTATTAGCTCAGCCACATACTCGAGTATGTGGCTGAGCTAATAAGCTTTTT 
Phc1 2 CCGGCCTCCAAACAGTGATCTAGTACTCGAGTACTAGATCACTGTTTGGAGGTTTTT 
Phc1 3 CCGGGCCTGGCTGTTCAGGTTATAACTCGAGTTATAACCTGAACAGCCAGGCTTTTTG 
Phc1 4 CCGGCACCTGAACCAACCTCTAAACCTCGAGGTTTAGAGGTTGGTTCAGGTGTTTTTG 
Phc1 5 CCGGGCAACCTAATGCGGCTCAATACTCGAGTATTGAGCCGCATTAGGTTGCTTTTT 
Hes1 1 CCGGTCTCTTCTGACGGACACTAAACTCGAGTTTAGTGTCCGTCAGAAGAGATTTTTG 
Hes1 2 CCGGGAGGCGAAGGGCAAGAATAAACTCGAGTTTATTCTTGCCCTTCGCCTCTTTTTG 
Hes1 3 CCGGTCAACACGACACCGGACAAACCTCGAGGTTTGTCCGGTGTCGTGTTGATTTTTG 
Hes1 4 CCGGGAAAGATAGCTCCCGGCATTCCTCGAGGAATGCCGGGAGCTATCTTTCTTTTTG 
Hes1 5 CCGGTGACCCAGATCAACGCCATGACTCGAGTCATGGCGTTGATCTGGGTCATTTTTG 
Rbbp7 1 CCGGCCTTTGATTCAACTGTCATTTCTCGAGAAATGACAGTTGAATCAAAGGTTTTTG 
Rbbp7 2 CCGGGCGTGTCATCAACGAAGAGTACTCGAGTACTCTTCGTTGATGACACGCTTTTTG 
Rbbp7 3 CCGGGAGAAGTGAATCGTGCTCGTTCTCGAGAACGAGCACGATTCACTTCTCTTTTTG 
Rbbp7 4 CCGGCCGTTTCTGTATGACCTGGTTCTCGAGAACCAGGTCATACAGAAACGGTTTTTG 
Rbbp7 5 CCGGCGCCTGAATGTGTGGGATTTACTCGAGTAAATCCCACACATTCAGGCGTTTTTG 
Id1 1 CCGGGCAGCATGTAATCGACTACATCTCGAGATGTAGTCGATTACATGCTGCTTTTTG 
Id1 2 CCGGGCATGTGTTCCAGCCGACGATCTCGAGATCGTCGGCTGGAACACATGCTTTTTG 
Id1 3 CCGGGAGCTGAACTCGGAGTCTGAACTCGAGTTCAGACTCCGAGTTCAGCTCTTTTTG 
Id1 4 CCGGGCGAGGTGGTACTTGGTCTGTCTCGAGACAGACCAAGTACCACCTCGCTTTTTG 
Id1 5 CCGGCGGCTGCTACTCACGCCTCAACTCGAGTTGAGGCGTGAGTAGCAGCCGTTTTTG 
Cited2 1 CCGGCCTTAGTGATAGAAATGGGTTCTCGAGAACCCATTTCTATCACTAAGGTTTTTG 
Cited2 2 CCGGGAAGCTCAACAACCAGTATTTCTCGAGAAATACTGGTTGTTGAGCTTCTTTTTG 
Cited2 3 CCGGCCACCAGATGAACGGGACAAACTCGAGTTTGTCCCGTTCATCTGGTGGTTTTTG 
Cited2 4 CCGGGCACGCCTTCAACGCCCTCATCTCGAGATGAGGGCGTTGAAGGCGTGCTTTTTG 
Cited2 5 CCGGGTCAGCTGTTGACTCGGTTAACTCGAGTTAACCGAGTCAACAGCTGACTTTTTG 
Hnrnpu 1 CCGGCCTGGGAAATACAACATTCTTCTCGAGAAGAATGTTGTATTTCCCAGGTTTTTG 
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Hnrnpu 2 CCGGGCGAGGAAATAATCGTGGCTACTCGAGTAGCCACGATTATTTCCTCGCTTTTTG 
Hnrnpu 3 CCGGCCATAACTGTGCAGTTGAATTCTCGAGAATTCAACTGCACAGTTATGGTTTTTG 
Hnrnpu 4 CCGGCAGTGGTTTGTCTTGATACTTCTCGAGAAGTATCAAGACAAACCACTGTTTTTG 
Hnrnpu 5 CCGGGCAATAAGAATAAGAGTGGCACTCGAGTGCCACTCTTATTCTTATTGCTTTTTG 
Rbm14 1 CCGGGCGCGATACTTAAGGTTGTTTCTCGAGAAACAACCTTAAGTATCGCGCTTTTTG 
Rbm14 2 CCGGGCAATGTATCGGCTGCATGTACTCGAGTACATGCAGCCGATACATTGCTTTTTG 
Rbm14 3 CCGGCGCTATTCGGGCTCCTATAATCTCGAGATTATAGGAGCCCGAATAGCGTTTTTG 
Rbm14 4 CCGGTGCAGCTTCTTCGCTTAATTCCTCGAGGAATTAAGCGAAGAAGCTGCATTTTTG 
Rbm14 5 CCGGTATGGTTCCGACCGGCGTTTACTCGAGTAAACGCCGGTCGGAACCATATTTTTG 
Eno1 1 CCGGCAATCATGTGATTGGTCTGAACTCGAGTTCAGACCAATCACATGATTGTTTTTG 
Eno1 2 CCGGCGGCACAGAGAATAAATCTAACTCGAGTTAGATTTATTCTCTGTGCCGTTTTTG 
Eno1 3 CCGGCCCGGCTTTCAATGTGATCAACTCGAGTTGATCACATTGAAAGCCGGGTTTTTG 
Eno1 4 CCGGCCTAACATCCTGGAGAACAAACTCGAGTTTGTTCTCCAGGATGTTAGGTTTTTG 
Eno1 5 CCGGCTGGTTAGCAAGAAAGTGAATCTCGAGATTCACTTTCTTGCTAACCAGTTTTTG 
Med19 1 CCGGTGACGGGCAGCACCAATTTAACTCGAGTTAAATTGGTGCTGCCCGTCATTTTTG 
Med19 2 CCGGACCTGGAGCAGGCCTATAATACTCGAGTATTATAGGCCTGCTCCAGGTTTTTTG 
Med19 3 CCGGCAGTGTCGTCTGATGCATATTCTCGAGAATATGCATCAGACGACACTGTTTTTG 
Med19 4 CCGGTGAGCCACAATCACGGATATACTCGAGTATATCCGTGATTGTGGCTCATTTTTG 
Med19 5 CCGGTTCTACCTGATGCGGGAATTGCTCGAGCAATTCCCGCATCAGGTAGAATTTTTG 
Nolc1 1 CCGGGCAGTGACAACTCCTAAGCAACTCGAGTTGCTTAGGAGTTGTCACTGCTTTTTTG 
Nolc1 2 CCGGGCAGTGACGATTCTGATTCAACTCGAGTTGAATCAGAATCGTCACTGCTTTTTTG 
Nolc1 3 CCGGCAAAGGTGAAGTTACAGTCAACTCGAGTTGACTGTAACTTCACCTTTGTTTTTTG 
Nolc1 4 CCGGGATTCCAGTGAAGAGGAGAAACTCGAGTTTCTCCTCTTCACTGGAATCTTTTTTG 
Nolc1 5 CCGGCAAGCCAGTCAGTACAACCAACTCGAGTTGGTTGTACTGACTGGCTTGTTTTTTG 
Prdm14 1 CCGGGCCGTAGCTCCTGCGATATTTCTCGAGAAATATCGCAGGAGCTACGGCTTTTTG 
Prdm14 2 CCGGACCTTGAATTACAGGATTAAGCTCGAGCTTAATCCTGTAATTCAAGGTTTTTTG 
Prdm14 3 CCGGACAATCTGCCCTGGTACAAATCTCGAGATTTGTACCAGGGCAGATTGTTTTTTG 
Prdm14 4 CCGGTTAAGTCGTCCCAGTCAATATCTCGAGATATTGACTGGGACGACTTAATTTTTG 
Prdm14 5 CCGGACTCCCGAAGTACCACGATTTCTCGAGAAATCGTGGTACTTCGGGAGTTTTTTG 
Dnmt3a 1 CCGGCCAGATGTTCTTTGCCAATAACTCGAGTTATTGGCAAAGAACATCTGGTTTTTG 
Dnmt3a 2 CCGGGCAGACCAACATCGAATCCATCTCGAGATGGATTCGATGTTGGTCTGCTTTTTG 
Dnmt3a 3 CCGGCCACCAGGTCAAACTCTATAACTCGAGTTATAGAGTTTGACCTGGTGGTTTTTG 
Dnmt3a 4 CCGGCCAGAACTGTAAGAACTGCTTCTCGAGAAGCAGTTCTTACAGTTCTGGTTTTTG 
Dnmt3a 5 CCGGCCCGTGATGATTGACGCCAAACTCGAGTTTGGCGTCAATCATCACGGGTTTTTG 
Klf2 1 CCGGCCTAAACAACGTGTTGGACTTCTCGAGAAGTCCAACACGTTGTTTAGGTTTTTG 
Klf2 2 CCGGCCTTATCATTGCAACTGGGAACTCGAGTTCCCAGTTGCAATGATAAGGTTTTTG 
Klf2 3 CCGGGACCGATTGTATTTCTATAAGCTCGAGCTTATAGAAATACAATCGGTCTTTTTG 
Klf2 4 CCGGGACCCTTTCAGTGCCACTTGTCTCGAGACAAGTGGCACTGAAAGGGTCTTTTTG 
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Klf2 5 CCGGCCTAAACAACGTGTTGGACTTCTCGAGAAGTCCAACACGTTGTTTAGGTTTTTG 
Rlim 1 CCGGGCCCTGAAGAATGGACCATATCTCGAGATATGGTCCATTCTTCAGGGCTTTTTG 
Rlim 2 CCGGGCAGAATCTTAAATACTGGATCTCGAGATCCAGTATTTAAGATTCTGCTTTTTG 
Rlim 3 CCGGCGAGAGTAGCTCAGAGATGTTCTCGAGAACATCTCTGAGCTACTCTCGTTTTTG 
Rlim 4 CCGGCCTCCAACCATAGTTCTTGATCTCGAGATCAAGAACTATGGTTGGAGGTTTTTG 
Rlim 5 CCGGGAGTACTATCAGGATTCCTATCTCGAGATAGGAATCCTGATAGTACTCTTTTTG 
Zfp146 1 CCGGGCATTTCCATAGTAGAGAGAACTCGAGTTCTCTCTACTATGGAAATGCTTTTTG 
Zfp146 2 CCGGTCAGCCACAAATCGAATCTTACTCGAGTAAGATTCGATTTGTGGCTGATTTTTG 
Zfp146 3 CCGGAGCACGAGCATTTCCATAGTACTCGAGTACTATGGAAATGCTCGTGCTTTTTTG 
Zfp146 4 CCGGAGCTCATCTCTAACCGTGCATCTCGAGATGCACGGTTAGAGATGAGCTTTTTTG 
Zfp146 5 CCGGCGTCGCTGATTGTGCATGTGACTCGAGTCACATGCACAATCAGCGACGTTTTTG 
Creb3 1 CCGGGCGGAGGAAGATTCGTAACAACTCGAGTTGTTACGAATCTTCCTCCGCTTTTTG 
Creb3 2 CCGGGCTAGAGGAAAGCGGAGATTTCTCGAGAAATCTCCGCTTTCCTCTAGCTTTTTG 
Creb3 3 CCGGCAGCCCTTCTTTGGTCATCTTCTCGAGAAGATGACCAAAGAAGGGCTGTTTTTG 
Creb3 4 CCGGACAGGAGATGTCTAGGCTGATCTCGAGATCAGCCTAGACATCTCCTGTTTTTTG 
Creb3 5 CCGGCGAGGAAGAGAAGAAGCTCTTCTCGAGAAGAGCTTCTTCTCTTCCTCGTTTTTG 
Rybp 1 CCGGCCACCGAGTTTGTAGTGCTTACTCGAGTAAGCACTACAAACTCGGTGGTTTTTG 
Rybp 2 CCGGCCAGGAAACCTCGCATCAATTCTCGAGAATTGATGCGAGGTTTCCTGGTTTTTG 
Rybp 3 CCGGCAGCAGTGAATGATGAATCTTCTCGAGAAGATTCATCATTCACTGCTGTTTTTG 
Rybp 4 CCGGGCATACAGTCTGCTAACGCTACTCGAGTAGCGTTAGCAGACTGTATGCTTTTTG 
Rybp 5 CCGGGCATACAGTCTGCTAACGCTACTCGAGTAGCGTTAGCAGACTGTATGCTTTTTG 
Zfp280c 1 CCGGGCTCGCATTATCCAGCTCTTTCTCGAGAAAGAGCTGGATAATGCGAGCTTTTTG 
Zfp280c 2 CCGGCCCTTATATGAATCACTACATCTCGAGATGTAGTGATTCATATAAGGGTTTTTG 
Zfp280c 3 CCGGCGACCCAAGATATACCGTCTTCTCGAGAAGACGGTATATCTTGGGTCGTTTTTG 
Zfp280c 4 CCGGCCGTAACTTCTGAATCCGCTTCTCGAGAAGCGGATTCAGAAGTTACGGTTTTTG 
Zfp280c 5 CCGGCCCGAAATGCAGACTACAATTCTCGAGAATTGTAGTCTGCATTTCGGGTTTTTG 
Rbbp5 1 CCGGCGTTTGAATAATCATGGCTTTCTCGAGAAAGCCATGATTATTCAAACGTTTTTG 
Rbbp5 2 CCGGGCTCTATTGTATTTACCCATTCTCGAGAATGGGTAAATACAATAGAGCTTTTTG 
Rbbp5 3 CCGGCCGGATTGTTATTTGGGATTTCTCGAGAAATCCCAAATAACAATCCGGTTTTTG 
Rbbp5 4 CCGGCCGACCCATCATAGCTTCTATCTCGAGATAGAAGCTATGATGGGTCGGTTTTTG 
Rbbp5 5 CCGGGCCTTCTGTAGCAGTGATGAACTCGAGTTCATCACTGCTACAGAAGGCTTTTTG 
Tbx3 1 CCGGCCTCCTAAACAAACTAACAAACTCGAGTTTGTTAGTTTGTTTAGGAGGTTTTTG 
Tbx3 2 CCGGGCGAATGTTCCCTCCGTTTAACTCGAGTTAAACGGAGGGAACATTCGCTTTTTG 
Tbx3 3 CCGGCGGCCAAGATTTCCACCACTACTCGAGTAGTGGTGGAAATCTTGGCCGTTTTTG 
Tbx3 4 CCGGGAAACAGAATTCATCGCCGTTCTCGAGAACGGCGATGAATTCTGTTTCTTTTTG 
Tbx3 5 CCGGGCTGACGACTGTCGATATAAACTCGAGTTTATATCGACAGTCGTCAGCTTTTTG 
H2afy2 1 CCGGGTTCACAGTTTCTGTGTCTTTCTCGAGAAAGACACAGAAACTGTGAACTTTTTG 
H2afy2 2 CCGGGCGATAAAGAAGGAACATCAACTCGAGTTGATGTTCCTTCTTTATCGCTTTTTG 
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H2afy2 3 CCGGCCAGAGTGACATCAGCCATATCTCGAGATATGGCTGATGTCACTCTGGTTTTTG 
H2afy2 4 CCGGCGATAAAGAAGGAACATCAAACTCGAGTTTGATGTTCCTTCTTTATCGTTTTTG 
H2afy2 5 CCGGGCTACTGAAAGGAGTGACTATCTCGAGATAGTCACTCCTTTCAGTAGCTTTTTG 
Pou5f1 1 CCGGGCCGACAACAATGAGAACCTTCTCGAGAAGGTTCTCATTGTTGTCGGCTTTTT 
Ash2l 4 CCGGGCCGGACACCTACAAAGATAACTCGAGTTATCTTTGTAGGTGTCCGGCTTTTTG 
Dmap1 5 CCGGTGCTTTGCTTTACTCTGACAACTCGAGTTGTCAGAGTAAAGCAAAGCATTTTTG 
Htatip 4 CCGGCCTCCTATCCTACCGAAGTTACTCGAGTAACTTCGGTAGGATAGGAGGTTTTTG 
Gcn5l2 1 CCGGGCTACCTACAAAGTCAATTATCTCGAGATAATTGACTTTGTAGGTAGCTTTTTG 
Trrap 3 CCGGCGCTGAACTTTACTCTCTGTTCTCGAGAACAGAGAGTAAAGTTCAGCGTTTTTG 
Tcf3 5 CCGGCGGGACTCCAAGTAGTAATGACTCGAGTCATTACTACTTGGAGTCCCGTTTTTG 
Ep400 5 CCGGCGGAAGAATCTCAATGGCATACTCGAGTATGCCATTGAGATTCTTCCGTTTTTG 
Myc 4 CCGGCATCCTATGTTGCGGTCGCTACTCGAGTAGCGACCGCAACATAGGATGTTTTTG 
Nanog 4 CCGGGCCAACCTGTACTATGTTTAACTCGAGTTAAACATAGTACAGGTTGGCTTTTTG 
p53 1 CCGGCCGACCTATCCTTACCATCATCTCGAGATGATGGTAAGGATAGGTCGGTTTTT 
Ruvbl2 2 CCGGCCGAGAACAGATCAATGCAAACTCGAGTTTGCATTGATCTGTTCTCGGTTTTTG 
Ruvbl1 3 CCGGGCCACAGAGTTTGACCTTGAACTCGAGTTCAAGGTCAAACTCTGTGGCTTTTTG 
Ing3 1 CCGGCGATTGGACTTACGACCCAAACTCGAGTTTGGGTCGTAAGTCCAATCGTTTTTG 
Brd8 2 CCGGCCACACTTGATCTTAGTCAAACTCGAGTTTGACTAAGATCAAGTGTGGTTTTTG 
Epc2 2 CCGGCCTGTCAATGTGCATATCAATCTCGAGATTGATATGCACATTGACAGGTTTTTG 
Tgif 4 CCGGGATGGCAAGAGATGCATTATTCTCGAGAATAATGCATCTCTTGCCATCTTTTTTGAAT 
Fbxw7 4 CCGGCGCATAGTTAGTGGTTCTGATCTCGAGATCAGAACCACTAACTATGCGTTTTT 
Arid3a 4 CCGGTGAGGGAGATAGGCATTTGATCTCGAGATCAAATGCCTATCTCCCTCATTTTTG 
LSD1 4 CCGGGCTACATCTTACCTTAGTCATCTCGAGATGACTAAGGTAAGATGTAGCTTTTTG 
LSD1 5 CCGGCCACGAGTCAAACCTTTATTTCTCGAGAAATAAAGGTTTGACTCGTGGTTTTTG 
E2F4 3 CCGGCATCGGTCTGATCGAGAAGAACTCGAGTTCTTCTCGATCAGACCGATGTTTTTG 
E2F4 4 CCGGCCACGATTACATCTACAACCTCTCGAGAGGTTGTAGATGTAATCGTGGTTTTTG 
Zfp57 1 CCGGCCTGACATTTGTCGGAAGCAACTCGAGTTGCTTCCGACAAATGTCAGGTTTTTG 
Zfp57 5 CCGGCCAACACACTCAGAATGCAAACTCGAGTTTGCATTCTGAGTGTGTTGGTTTTTG 
Max 2 CCGGGCAACAGAGTATATCCAGTATCTCGAGATACTGGATATACTCTGTTGCTTTTTG 
Max 3 CCGGCCCAAATCCTAGACAAAGCAACTCGAGTTGCTTTGTCTAGGATTTGGGTTTTTG 
Tcfap2c 1 CCGGCGCAGTGCAGAATTATATCAACTCGAGTTGATATAATTCTGCACTGCGTTTTTG 
Tcfap2c 5 CCGGGCAGCTACTTACCAGTGGTATCTCGAGATACCACTGGTAAGTAGCTGCTTTTTG 
H2afx 2 CCGGCGAGTACCTCACTGCCGAGATCTCGAGATCTCGGCAGTGAGGTACTCGTTTTTG 
H2afx 3 CCGGGCTCGAGTACCTCACTGCCGACTCGAGTCGGCAGTGAGGTACTCGAGCTTTTTG 
Nmyc 2 CCGGCCTCACTCCTAATCCGGTCATCTCGAGATGACCGGATTAGGAGTGAGGTTTTTG 
Nmyc 4 CCGGGCAGCAGCAGTTGCTAAAGAACTCGAGTTCTTTAGCAACTGCTGCTGCTTTTTG 
Rps19 2 CCGGCCCATATGATGAGAACTGGTTCTCGAGAACCAGTTCTCATCATATGGGTTTTTG 
Rps19 4 CCGGCGGTGTCAGACCCAGCCATTTCTCGAGAAATGGCTGGGTCTGACACCGTTTTTG 
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Surf6 2 CCGGCAGGAACAGAAAGCTATGGATCTCGAGATCCATAGCTTTCTGTTCCTGTTTTTTG 
Gbx2 1 CCGGGATGTGGATTACAGCTCAGATCTCGAGATCTGAGCTGTAATCCACATCTTTTTG 
Gbx2 4 CCGGCGAGTCAAAGGTGGAAGATGACTCGAGTCATCTTCCACCTTTGACTCGTTTTTG 
Xrn2 1 CCGGCCAGAGGATAACGTCAGGTTACTCGAGTAACCTGACGTTATCCTCTGGTTTTTG 
Xrn2 4 CCGGCAACGATACTACAAGAACAAACTCGAGTTTGTTCTTGTAGTATCGTTGTTTTTG 
Tgif2 2 CCGGGCAGATATGTAACTGGTTCATCTCGAGATGAACCAGTTACATATCTGCTTTTTG 
Tgif2 4 CCGGGCTGCAGATATGTAACTGGTTCTCGAGAACCAGTTACATATCTGCAGCTTTTTG 
Ezh2 b CCGGGCACAAGTCATCCCGTTAAAGCTCGAGCTTTAACGGGATGACTTGTGCTTTTTG 
Ezh2 c CCGGGCGTATAAAGACACCACCTAACTCGAGTTAGGTGGTGTCTTTATACGCTTTTTG 
Cdx2 1 CCGGGTTTCACTTTAGTCGATACATCTCGAGATGTATCGACTAAAGTGAAACTTTTTG 
Rarg 1 CCGGAGGGAGCAGAAAGGGCTATAACTCGAGTTATAGCCCTTTCTGCTCCCTTTTTT 
Rarg 2 CCGGGCTCAGCATTGCCGACCAGATCTCGAGATCTGGTCGGCAATGCTGAGCTTTTT 
Rarg 3 CCGGCAATGACAAGTCTTCTGGCTACTCGAGTAGCCAGAAGACTTGTCATTGTTTTT 
Rarg 4 CCGGCATTTGAGATGCTGAGCCCTACTCGAGTAGGGCTCAGCATCTCAAATGTTTTT 
Rarg 5 CCGGCGGGTCTATAAGCCATGCTTTCTCGAGAAAGCATGGCTTATAGACCCGTTTTT 
Sox13 1 CCGGCCTGGTTGTATCCCAAGGAAACTCGAGTTTCCTTGGGATACAACCAGGTTTTTG 
Sox13 2 CCGGGCTTTACCTATTCAGCCCATTCTCGAGAATGGGCTGAATAGGTAAAGCTTTTTG 
Sox13 3 CCGGGCTGATTCAACAGCAGCACAACTCGAGTTGTGCTGCTGTTGAATCAGCTTTTTG 
Sox13 4 CCGGCACTTGTAGATACATTCCCAACTCGAGTTGGGAATGTATCTACAAGTGTTTTTG 
Sox13 5 CCGGGCACTTGTAGATACATTCCCACTCGAGTGGGAATGTATCTACAAGTGCTTTTTG 
Tcea3 1 CCGGGCCTCAGAAATAGAAGACCATCTCGAGATGGTCTTCTATTTCTGAGGCTTTTTG 
Tcea3 2 CCGGCCATATCTATCAAGAACTCAACTCGAGTTGAGTTCTTGATAGATATGGTTTTTG 
Tcea3 3 CCGGGCGGTGTAGCAAGTGCAAGAACTCGAGTTCTTGCACTTGCTACACCGCTTTTTG 
Tcea3 4 CCGGGAAGCTGAACAGTTGCCAGATCTCGAGATCTGGCAACTGTTCAGCTTCTTTTTG 
Tcea3 5 CCGGCTCAGAAATAGAAGACCATATCTCGAGATATGGTCTTCTATTTCTGAGTTTTTG 
Hnrpdl 1 CCGGGCGTAAAGATTAAAGTGGAAACTCGAGTTTCCACTTTAATCTTTACGCTTTTTG 
Hnrpdl 2 CCGGGCTATGATTATACTGGGTATACTCGAGTATACCCAGTATAATCATAGCTTTTTG 
Hnrpdl 3 CCGGCCAGAACAATTACCAGCCCTACTCGAGTAGGGCTGGTAATTGTTCTGGTTTTTG 
Hnrpdl 4 CCGGGAGCCAGTAAAGAAACTGTTACTCGAGTAACAGTTTCTTTACTGGCTCTTTTTG 
Hnrpdl 5 CCGGGAGCCAGTAAAGAAACTGTTACTCGAGTAACAGTTTCTTTACTGGCTCTTTTTG 
Zic5 1 CCGGCCATGTCCTAACCTGAAACAACTCGAGTTGTTTCAGGTTAGGACATGGTTTTTG 
Zic5 2 CCGGGCTTCAGAATATGACAGGCTTCTCGAGAAGCCTGTCATATTCTGAAGCTTTTTG 
Zic5 3 CCGGGATCGAAAGAAACACTCCCATCTCGAGATGGGAGTGTTTCTTTCGATCTTTTTG 
Zic5 4 CCGGGTAAGATTCGAGGCTGTGATACTCGAGTATCACAGCCTCGAATCTTACTTTTTG 
Zic5 5 CCGGCCTGAAGTCATGCGGACGATACTCGAGTATCGTCCGCATGACTTCAGGTTTTTG 
Tcfcp2l1 1 CCGGCCCGCCTTTGAATCACTAATTCTCGAGAATTAGTGATTCAAAGGCGGGTTTTTG 
Tcfcp2l1 2 CCGGGCACTGTATCAGCACGGAATTCTCGAGAATTCCGTGCTGATACAGTGCTTTTTG 
Tcfcp2l1 3 CCGGACCTTAACATACCTCAATCAACTCGAGTTGATTGAGGTATGTTAAGGTTTTTTG 
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Tcfcp2l1 4 CCGGCGTGGTGGTAAGCAATGAGATCTCGAGATCTCATTGCTTACCACCACGTTTTTG 
Tcfcp2l1 5 CCGGCGGCTCAAGAGAAGGAGAAATCTCGAGATTTCTCCTTCTCTTGAGCCGTTTTTG 
Etv5 1 CCGGGCGACCTTTGATTGACAGAAACTCGAGTTTCTGTCAATCAAAGGTCGCTTTTTG 
Etv5 2 CCGGACAACTATTGTGCCTACGATACTCGAGTATCGTAGGCACAATAGTTGTTTTTTG 
Etv5 3 CCGGCAGTCTGATAACTTGGTGCTTCTCGAGAAGCACCAAGTTATCAGACTGTTTTTG 
Etv5 4 CCGGAGGAAGTTTGTGGACACAGATCTCGAGATCTGTGTCCACAAACTTCCTTTTTTG 
Etv5 5 CCGGAGCTTGCCCTTTGAGTATTATCTCGAGATAATACTCAAAGGGCAAGCTTTTTTG 
Zfp219 1 CCGGCTGGTTTCTCAAGGGTCACATCTCGAGATGTGACCCTTGAGAAACCAGTTTTTG 
Zfp219 2 CCGGCTCAAGTATCACCTTCAGCGTCTCGAGACGCTGAAGGTGATACTTGAGTTTTTG 
Zfp219 3 CCGGGCGGCTACATCTACGCCTGAACTCGAGTTCAGGCGTAGATGTAGCCGCTTTTTG 
Zfp219 4 CCGGCTGGTTTCTCAAGGGTCACATCTCGAGATGTGACCCTTGAGAAACCAGTTTTTG 
Zfp219 5 CCGGGCGGCTACATCTACGCCTGAACTCGAGTTCAGGCGTAGATGTAGCCGCTTTTTG 
Cbx7 1 CCGGCCTGAATGTATTGGGAGGAATCTCGAGATTCCTCCCAATACATTCAGGTTTTTG 
Cbx7 2 CCGGCCTCAAGTGAAGTTACCGTGACTCGAGTCACGGTAACTTCACTTGAGGTTTTTG 
Cbx7 3 CCGGGCAAAGTTGAATATCTGGTGACTCGAGTCACCAGATATTCAACTTTGCTTTTTG 
Cbx7 4 CCGGCGTGACTGACATCACCGCCAACTCGAGTTGGCGGTGATGTCAGTCACGTTTTTG 
Cbx7 5 CCGGCGGAAGGGCAAAGTTGAATATCTCGAGATATTCAACTTTGCCCTTCCGTTTTTG 
Otx2 1 CCGGCCACTGATTGCTTGGATTATACTCGAGTATAATCCAAGCAATCAGTGGTTTTTTG 
Otx2 2 CCGGGCATGGACTGTGGATCTTATTCTCGAGAATAAGATCCACAGTCCATGCTTTTTTG 
Otx2 3 CCGGGCTGACTGCTTGGATTATAAACTCGAGTTTATAATCCAAGCAGTCAGCTTTTTTG 
Otx2 4 CCGGCCTGATTTGCAAATGATTGATCTCGAGATCAATCATTTGCAAATCAGGTTTTTTG 
Zfp428 1 CCGGCTATAAGGTGAAACAGCGAATCTCGAGATTCGCTGTTTCACCTTATAGTTTTTTG 
Zfp428 2 CCGGCGAATATGACCCTGGCTATAACTCGAGTTATAGCCAGGGTCATATTCGTTTTTTG 
Zfp428 3 CCGGGAGGAAGATGATGAAGACCTTCTCGAGAAGGTCTTCATCATCTTCCTCTTTTTTG 
Zfp428 4 CCGGGCTATAAGGTGAAACAGCGAACTCGAGTTCGCTGTTTCACCTTATAGCTTTTTTG 
Zfp428 5 CCGGCTATAAGGTGAAACAGCGAATCTCGAGATTCGCTGTTTCACCTTATAGTTTTTG 
Myst2 1 CCGGCCCATGCTTTCCTTTGTATTTCTCGAGAAATACAAAGGAAAGCATGGGTTTTTG 
Myst2 2 CCGGGCCCTTCAGATGCTCAAGTATCTCGAGATACTTGAGCATCTGAAGGGCTTTTTG 
Myst2 3 CCGGCGAAAGCTACAATTTCAACATCTCGAGATGTTGAAATTGTAGCTTTCGTTTTTG 
Myst2 4 CCGGGACCTGATAGATGAGTGGATACTCGAGTATCCACTCATCTATCAGGTCTTTTTG 
Myst2 5 CCGGCCTGACAAGTGAATATGACTTCTCGAGAAGTCATATTCACTTGTCAGGTTTTTG 
Zfp532 1 CCGGAGCATTTGACATACCAGATATCTCGAGATATCTGGTATGTCAAATGCTTTTTTG 
Zfp532 2 CCGGGATCAAGGACCCTGATGTAAACTCGAGTTTACATCAGGGTCCTTGATCTTTTTG 
Zfp532 3 CCGGGCCAAATGTTCTGGTACTTAACTCGAGTTAAGTACCAGAACATTTGGCTTTTTG 
Zfp532 4 CCGGCGGTGAAAGCCACGGTCATATCTCGAGATATGACCGTGGCTTTCACCGTTTTTG 
Zfp532 5 CCGGACATCAGGCCACACGGATAAACTCGAGTTTATCCGTGTGGCCTGATGTTTTTTG 
Tgif 1 CCGGCCATTTCATTCCTGCGTAGTTCTCGAGAACTACGCAGGAATGAAATGGTTTTTG 
Tgif 2 CCGGGATCCAAATCAGTTCACGATTCTCGAGAATCGTGAACTGATTTGGATCTTTTTG 
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Tgif 3 CCGGAGTACAGATGTACCGCAAATACTCGAGTATTTGCGGTACATCTGTACTTTTTTG 
Tgif 4 CCGGGATGGCAAGAGATGCATTATTCTCGAGAATAATGCATCTCTTGCCATCTTTTTTGAAT 
Tgif 5 CCGGATTTCAGAAGCTAGCTCTATTCTCGAGAATAGAGCTAGCTTCTGAAATTTTTTG 
Gbx2 1 CCGGGATGTGGATTACAGCTCAGATCTCGAGATCTGAGCTGTAATCCACATCTTTTTG 
Gbx2 2 CCGGTCACGTTAGCAGGTTCGCTATCTCGAGATAGCGAACCTGCTAACGTGATTTTTG 
Gbx2 3 CCGGGCCTGGTCAGACTGCTCATAACTCGAGTTATGAGCAGTCTGACCAGGCTTTTTG 
Gbx2 4 CCGGCGAGTCAAAGGTGGAAGATGACTCGAGTCATCTTCCACCTTTGACTCGTTTTTG 
Gbx2 5 CCGGCGGACTGCCTTCACCAGCGAACTCGAGTTCGCTGGTGAAGGCAGTCCGTTTTTG 
Xrn2 1 CCGGCCAGAGGATAACGTCAGGTTACTCGAGTAACCTGACGTTATCCTCTGGTTTTTG 
Xrn2 2 CCGGCCATTCCATTATGCACCATTTCTCGAGAAATGGTGCATAATGGAATGGTTTTTG 
Xrn2 3 CCGGCCAAATGATGTGGAGTTTGATCTCGAGATCAAACTCCACATCATTTGGTTTTTG 
Xrn2 4 CCGGCAACGATACTACAAGAACAAACTCGAGTTTGTTCTTGTAGTATCGTTGTTTTTG 
Xrn2 5 CCGGGCTATTACATAGCTGATCGTTCTCGAGAACGATCAGCTATGTAATAGCTTTTTG 
Tcea1 2 CCGGGAATATTCCTCCTGATCTATTCTCGAGAATAGATCAGGAGGAATATTCTTTTTG 
Set 2 CCGGCCCGACATGGATGATGAAGAACTCGAGTTCTTCATCATCCATGTCGGGTTTTTG 
Set 4 CCGGGAGAGCTTCTTTACCTGGTTTCTCGAGAAACCAGGTAAAGAAGCTCTCTTTTTG 
 
Appendix Table B. shRNA used in chapter 4 
 
Gene Clone sequence 
Yap1 1 CCGGGAAGCGCTGAGTTCCGAAATCCTCGAGGATTTCGGAACTCAGCGCTTCTTTTTG 
Yap1 2 CCGGTGAGAACAATGACAACCAATACTCGAGTATTGGTTGTCATTGTTCTCATTTTTG 
Yap1 3 CCGGACTTGGAGGCGCTCTTCAATGCTCGAGCATTGAAGAGCGCCTCCAAGTTTTTTG 
Yap1 4 CCGGCGGTTGAAACAACAGGAATTACTCGAGTAATTCCTGTTGTTTCAACCGTTTTTG 
Yap1 5 CCGGTCCAACCAGCAGCAGCAAATACTCGAGTATTTGCTGCTGCTGGTTGGATTTTTG 
Tead1 1 CCGGCAGAAGGAAATCTCGTGATTTCTCGAGAAATCACGAGATTTCCTTCTGTTTTTG 
Tead2 1 CCGGCTCGAAGGAAATCGAGAGAAACTCGAGTTTCTCTCGATTTCCTTCGAGTTTTTG 
Tead3 1 CCGGGTGCGAGTACATGATCAATTTCTCGAGAAATTGATCATGTACTCGCACTTTTTG 
Tead4 1 CCGGGCTGAAACACTTACCCGAGAACTCGAGTTCTCGGGTAAGTGTTTCAGCTTTTTG 
Taz 1 CCGGCCTGCATTTCTGTGGCAGATACTCGAGTATCTGCCACAGAAATGCAGGTTTTTG 
 
Appendix Table C. shRNA used in chapter 5 
 
Gene Clone sequence 
Mphospho8 1 CCGGCCTACCTAGTTGTAAACTTAACTCGAGTTAAGTTTACAACTAGGTAGGTTTTTG 
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Mphospho8 2 CCGGGCCGGATTTCTCAACAGATTTCTCGAGAAATCTGTTGAGAAATCCGGCTTTTTG 
Mphospho8 3 CCGGGCCAAGGTTAAGTTGCTAATACTCGAGTATTAGCAACTTAACCTTGGCTTTTTG 
Mphospho8 4 CCGGGCGAGGGAGGTAAGAATCTTTCTCGAGAAAGATTCTTACCTCCCTCGCTTTTTG 
Mphospho8 5 CCGGCACCTCTGAAATAATCGGTTTCTCGAGAAACCGATTATTTCAGAGGTGTTTTTG 
Med26 1 CCGGGCTACCAGTTTACTAACGATTCTCGAGAATCGTTAGTAAACTGGTAGCTTTTTG 
Med26 2 CCGGTGTTAAACCTGTGCGGTTAAACTCGAGTTTAACCGCACAGGTTTAACATTTTTG 
Med26 3 CCGGCGCACCACTTTATGGCTGAATCTCGAGATTCAGCCATAAAGTGGTGCGTTTTTG 
Med26 4 CCGGGCGCTTGAACATTCTGCCTTACTCGAGTAAGGCAGAATGTTCAAGCGCTTTTTG 
Med26 5 CCGGCCTGAAGAATCGCAACGACATCTCGAGATGTCGTTGCGATTCTTCAGGTTTTTG 
Gli2 1 GTACCGGTATGTTTACCCGCTCCTATTTCTCGAGAAATAGGAGCGGGTAAACATATTTTTTG 
Gli2 2 CCGGCACCAACCCTTCAGACTATTACTCGAGTAATAGTCTGAAGGGTTGGTGTTTTTG 
Gli2 3 CCGGTGTGGAGGACTGCCTACATATCTCGAGATATGTAGGCAGTCCTCCACATTTTTG 
Gli2 4 CCGGTCGACCTACAACGCATGATTCCTCGAGGAATCATGCGTTGTAGGTCGATTTTTG 
Gli2 5 CCGGTATCTCCTTGATACGACTTTCCTCGAGGAAAGTCGTATCAAGGAGATATTTTTG 
Nr6a1 1 CCGGGCATTGGACCAGTCCAGATATCTCGAGATATCTGGACTGGTCCAATGCTTTTT 
Nr6a1 2 CCGGCCAGATGATCGAGCTGAACAACTCGAGTTGTTCAGCTCGATCATCTGGTTTTT 
Nr6a1 3 CCGGGCCTCCACATTATCAATACATCTCGAGATGTATTGATAATGTGGAGGCTTTTT 
Nr6a1 4 CCGGCCAGTAGGTCTGTGGAACTAACTCGAGTTAGTTCCACAGACCTACTGGTTTTT 
Nr6a1 5 CCGGCCAAACCGCTTTCCTGATCTTCTCGAGAAGATCAGGAAAGCGGTTTGGTTTTT 
Rai14 1 CCGGCGAACACTGTGGACGCCTTAACTCGAGTTAAGGCGTCCACAGTGTTCGTTTTTG 
Rai14 2 CCGGACTGCTCTGTTATCGAGAATACTCGAGTATTCTCGATAACAGAGCAGTTTTTTG 
Rai14 3 CCGGGAAACTGAAGGACACGCTAAACTCGAGTTTAGCGTGTCCTTCAGTTTCTTTTTG 
Rai14 4 CCGGAGGATTTGCCACGGGACTTAACTCGAGTTAAGTCCCGTGGCAAATCCTTTTTTG 
Rai14 5 CCGGATCACGGCGCAGATGTCAATTCTCGAGAATTGACATCTGCGCCGTGATTTTTTG 
Sirt6 1 CCGGCATGTCCAACACAGCTCCTTTCTCGAGAAAGGAGCTGTGTTGGACATGTTTTTG 
Sirt6 2 CCGGGCATGTTTCGTATAAGTCCAACTCGAGTTGGACTTATACGAAACATGCTTTTTG 
Sirt6 3 CCGGGTTTGACACCACCTTCGAGAACTCGAGTTCTCGAAGGTGGTGTCAAACTTTTTG 
Sirt6 4 CCGGTCCCAAGTGTAAGACGCAGTACTCGAGTACTGCGTCTTACACTTGGGATTTTTG 
Sirt6 5 CCGGAGAGGAATGTCCCAAGTGTAACTCGAGTTACACTTGGGACATTCCTCTTTTTTG 
Taf1b 1 CCGGCGATAAGTCCGTCGCATATAACTCGAGTTATATGCGACGGACTTATCGTTTTTG 
Taf1b 2 GTACCGGACGTTTGATCCTATAGCTAAACTCGAGTTTAGCTATAGGATCAAACGTTTTTTTG 
Taf1b 3 CCGGAGGATCATATTCCGTACATAACTCGAGTTATGTACGGAATATGATCCTTTTTTG 
Taf1b 4 CCGGGACTATGAAGACATCTATAAACTCGAGTTTATAGATGTCTTCATAGTCTTTTTG 
Taf1b 5 GTACCGGTTAACCTGTCAAGTAGTAAAGCTCGAGCTTTACTACTTGACAGGTTAATTTTTTG 
Trip13 1 CCGGCCGAGTAGTCAATGCTGTGTTCTCGAGAACACAGCATTGACTACTCGGTTTTT 
Trip13 2 CCGGCGTACTCTTCTCAGACAAGAACTCGAGTTCTTGTCTGAGAAGAGTACGTTTTT 
Trip13 3 CCGGGAAGATATAAAGTCGAGTGTTCTCGAGAACACTCGACTTTATATCTTCTTTTT 
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Trip13 4 CCGGGACACAGAACTAAAGGCTAAACTCGAGTTTAGCCTTTAGTTCTGTGTCTTTTT 
Trip13 5 CCGGGACAAACAGTTTGAGGAGAAACTCGAGTTTCTCCTCAAACTGTTTGTCTTTTT 
Bcl3 1 CCGGCCTCAAGAACTGTCACAATGACTCGAGTCATTGTGACAGTTCTTGAGGTTTTTG 
Bcl3 2 CCGGACGTGAACGCTCAGATGTATTCTCGAGAATACATCTGAGCGTTCACGTTTTTTG 
Bcl3 3 CCGGCCCGAAAGATGCTCCTGGCTTCTCGAGAAGCCAGGAGCATCTTTCGGGTTTTTG 
Bcl3 4 CCGGCCTTTACTACCAGGGACCTTTCTCGAGAAAGGTCCCTGGTAGTAAAGGTTTTTG 
Bcl3 5 CCGGCGCAATTATGAAGGGCTCACTCTCGAGAGTGAGCCCTTCATAATTGCGTTTTTG 
Gli1 1 CCGGCCTATCCTGATCCACCAGAAACTCGAGTTTCTGGTGGATCAGGATAGGTTTTTG 
Gli1 2 CCGGCCTGTGTACCACATGACTCTACTCGAGTAGAGTCATGTGGTACACAGGTTTTTG 
Gli1 3 CCGGCCACATCAACAGTGAGCATATCTCGAGATATGCTCACTGTTGATGTGGTTTTTG 
Gli1 4 CCGGCGACTTGAGCATTATGGACAACTCGAGTTGTCCATAATGCTCAAGTCGTTTTTG 
Gli1 5 CCGGGCATGGGAACAGAAGGACTTTCTCGAGAAAGTCCTTCTGTTCCCATGCTTTTTG 
Mycbp 1 CCGGCCTAGAATTGGCAGAAATGAACTCGAGTTCATTTCTGCCAATTCTAGGTTTTTG 
Mycbp 2 CCGGGAATAGCTTGTATAGTATATGCTCGAGCATATACTATACAAGCTATTCTTTTTG 
Mycbp 3 CCGGGAGAAATATGAAGCTACTGTACTCGAGTACAGTAGCTTCATATTTCTCTTTTTG 
Mycbp 4 CCGGCCTTATATGAAGAACCAGAGACTCGAGTCTCTGGTTCTTCATATAAGGTTTTTG 
Mycbp 5 CCGGCCTTATATGAAGAACCAGAGACTCGAGTCTCTGGTTCTTCATATAAGGTTTTTG 
Phf12 1 CCGGCCTGAACCGAATCCACAAGAACTCGAGTTCTTGTGGATTCGGTTCAGGTTTTTG 
Phf12 2 CCGGCGGAGAAATCGAGATAAATATCTCGAGATATTTATCTCGATTTCTCCGTTTTTG 
Phf12 3 CCGGCCAACTCACTTCGAGCATTTACTCGAGTAAATGCTCGAAGTGAGTTGGTTTTTG 
Phf12 4 CCGGGCTACTGTGTATATGGACAAACTCGAGTTTGTCCATATACACAGTAGCTTTTTG 
Phf12 5 CCGGCCCAAGCAGTATTGTTGCCAACTCGAGTTGGCAACAATACTGCTTGGGTTTTTG 
Rbpj 1 CCGGCTGTATCACAACTCCACAAATCTCGAGATTTGTGGAGTTGTGATACAGTTTTTG 
Rbpj 2 CCGGGCAGACTCATTGGGCTACATTCTCGAGAATGTAGCCCAATGAGTCTGCTTTTTG 
Rbpj 3 CCGGCCAGACAGTTAGTACCAGGTACTCGAGTACCTGGTACTAACTGTCTGGTTTTTG 
Rbpj 4 CCGGCCAGTGACTTTGGTCCGAAATCTCGAGATTTCGGACCAAAGTCACTGGTTTTTG 
Rbpj 5 CCGGCCCTGTGCGTTTATTGGAATACTCGAGTATTCCAATAAACGCACAGGGTTTTTG 
Taf12 1 CCGGCCAGGTATTGACCAAGAAGAACTCGAGTTCTTCTTGGTCAATACCTGGTTTTTG 
Taf12 2 CCGGGCTACAGATCGCTGATGATTTCTCGAGAAATCATCAGCGATCTGTAGCTTTTTG 
Taf12 3 CCGGGTAAGAGAAGTAGATCCTAATCTCGAGATTAGGATCTACTTCTCTTACTTTTTG 
Taf12 4 CCGGGCTTTACAGAGAAGCATATATCTCGAGATATATGCTTCTCTGTAAAGCTTTTTG 
Taf12 5 CCGGTGTACCACAGAGGCTCACAAACTCGAGTTTGTGAGCCTCTGTGGTACATTTTTG 
Taf6 1 CCGGCCCGAATCACTAAGACCTTTACTCGAGTAAAGGTCTTAGTGATTCGGGTTTTTG 
Taf6 2 CCGGCTGAGCAACATCGACCGTATTCTCGAGAATACGGTCGATGTTGCTCAGTTTTTG 
Taf6 3 CCGGCCAGTGACATTGACTATGCATCTCGAGATGCATAGTCAATGTCACTGGTTTTTG 
Taf6 4 CCGGCCAGCAGTAATGACCTGCATTCTCGAGAATGCAGGTCATTACTGCTGGTTTTTG 
Taf6 5 CCGGGTGTGAATGTAGTTCAGAATACTCGAGTATTCTGAACTACATTCACACTTTTTG 
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Trip4 1 CCGGCGTGGGAAAGATGTGGAGTTTCTCGAGAAACTCCACATCTTTCCCACGTTTTTG 
Trip4 2 CCGGCGAGAATATGTGACAGACCTTCTCGAGAAGGTCTGTCACATATTCTCGTTTTTG 
Trip4 3 CCGGCCCAAGTTATTGACGATGAATCTCGAGATTCATCGTCAATAACTTGGGTTTTTG 
Trip4 4 CCGGCCTGGATGTCAGCGAGGAAATCTCGAGATTTCCTCGCTGACATCCAGGTTTTTG 
Trip4 5 CCGGGTGGAGTTTCCAAATGACTATCTCGAGATAGTCATTTGGAAACTCCACTTTTTG 
Zfp13 1 CCGGCCTGAGAGAGAGCAGTGAGAACTCGAGTTCTCACTGCTCTCTCTCAGGTTTTTG 
Zfp13 2 CCGGCGCTCCAATCTCATCGCACATCTCGAGATGTGCGATGAGATTGGAGCGTTTTTG 
Zfp13 3 CCGGTCCAATCTCATCGCACATAATCTCGAGATTATGTGCGATGAGATTGGATTTTTG 
Zfp13 4 CCGGCCAGGTAATGTGCAACACTGTCTCGAGACAGTGTTGCACATTACCTGGTTTTTG 
Zfp13 5 CCGGTCAGGAGTCAACACACATCAACTCGAGTTGATGTGTGTTGACTCCTGATTTTTG 
Zfp198 1 CCGGGCTCCAAAGAAACTCTGTGTTCTCGAGAACACAGAGTTTCTTTGGAGCTTTTTG 
Zfp198 2 CCGGGCGTGGAAACATTGGGTCAAACTCGAGTTTGACCCAATGTTTCCACGCTTTTTG 
Zfp198 3 CCGGCCAGTAACTTTGGTGTGAATACTCGAGTATTCACACCAAAGTTACTGGTTTTTG 
Zfp198 4 CCGGGCATAGTTACATATTGCGAATCTCGAGATTCGCAATATGTAACTATGCTTTTTG 
Zfp198 5 CCGGGCTGAGCTTAACTATGGGTTACTCGAGTAACCCATAGTTAAGCTCAGCTTTTTG 
 
Appendix Table D. RT-qPCR primers used in chapter 3 
 
Gene Forward Reverse 
Tip60 CGAAAGCTTTTCTATGTCCATTACA TCTTGGGAAATTGGATCTTCTTTA 
p400 TTTACAAGCGTATCTTAGGCAGAAT GTGCTCATCGTTGATAACTTCAGAT 
Trrap GATTTCTTACCTTTCTCCAAGATGG GGAATCCTGTGGAGTATCTCAAGTA 
Myc ACTACGACTCCGTACAGCCCTAT TTTCTTCCAGATATCCTCACTGG 
Fbxw7 AGACTTCATCTCCTTGCTTCCTAA AAATTCTCCAGTATCGACAAGTCTG 
Ash2L TGGGATATGTACAAAATGGTTCAC GAAAGTAGGTATTCCCACTGTGATG 
Ezh2 GGGAGAGAACAATGATAAAGAAGAAG ATTCTCAGGAGGTTCAATATTTGG 
Suz12 GGAAATGGAAGAATGTCCAATAAGT TAATGTAGGTCCCTGAGAAAATGTC 
Rybp AAGAAAAACACCAACAAGAAAACAA GTCTTTGTTGTAGCGTTAGCAGACT 
Phc1 CTACAGCCTCCTCTCCTGTTGT CTCTCCTCCTCAGACTCAGCTTT 
Tgif1 GAACACAGATACAACGCCTATCC CGTTGATGAACCAGTTACAGACC 
Tgif2 AGTCTCTCTGGACAGACCAACCT AGATGGTGAACTGATTAGGGTCTTT 
Arid3a AGGTTATCAACAAGAAACTGTGGAG TACTTCATGTACTGTGTCCGAAGTG 
LSD1 CGGGCCAAGGTAGAATACAG GGGGAAGCTTCTTTTCCTTC 
H2afx AGTACCTCACTGCCGAGATCC AGCTTGTTGAGCTCCTCGTC 
Nestin AGGACCAGGTGCTTGAGAGA TTCGAGAGATTCGAGGGAGA 
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Bmp2 CGCTTCTTCTTCAATTTAAGTTCTG AACTACTGTTTCCCAAAGCTTCCT 
Bmp4 GAGTTTCCATCACGAAGAACATCT AGGAGATCACCTCATTCTCTGG 
Sall4 AAAACTGCCTGTTTCCTAGTGG AAGGTCTTTGGGTCTTGGAATAA 
Zfp42 CAGTCCAGAATACCAGAGTGGAA ACTCTAGGTATCCGTCAGGGAAG 
Lin28 CAGAAGCGAAGATCCAAAGG GATGCTTTGGCAAAAGTGG 
Rest ACTTCTCAGAAAGTGAAGGAGAAGG GGTTCTACAGCACTTAGCTCCAA 
Tcf3 TCATGTTGTATATGAAGGAGATGAGG CTGTTCTTCTCTTGACAGGTTGTG 
Gapdh AAATTCAACGGCACAGTCAAG CACCCCATTTGATGTTAGTGG 
Actb_1 CACCACACCTTCTACAATGAGC AACATGATCTGGGTCATCTTTTC 
Actb_2 GATCTGGCACCACACCTTCTACAATG CGTACATGGCTGGGGTGTTGAAG 
Dmap1 CTTTACTCTGACAAAAAGGATGCAC AGTAAAAGGCATCCATTTCCAA 
Gcn5l2 GAATGTGTCAGAGGACGAGATTAAC ATAGACTTGTTTGGTGTCTGTGTCC 
Ep400 TTTACAAGCGTATCTTAGGCAGAAT GTGCTCATCGTTGATAACTTCAGAT 
p53 GTCATCTTTTGTCCCTTCTCAAAA AGAGTACGTGCACATAACAGACTTG 
Ruvbl2 ATGAGCAAGACTGAGGCTCTAAC GTCAATCTGGATCTCTACCACCTC 
Ruvbl1 AGGAGACTAAGGAGGTTTATGAAGG TATGATCACATGGCTGATAGTTTTG 
Ing3 AAGAGCAAAAACAACACCAAGTCT ACTACAGTTGAAGACGATGAACACA 
Brd8 AAGGAGAAGTGGTAGAAACTGTTGA TCTCTCCTGTGTCTCCTTTATGACT 
Epc2 CTCTACCAACAATGATCCTTACGTT CTCAGCTTCAGCATCTTTTCATAA 
E2F4 AGCTCAAGGCAGAGATCGAG TGTTCTGGACGTCCTCAGTG 
Zfp57 ACCTGACATTTGTCGGAAGC TGGTCCACCTTTGAATACCC 
Max GGCAGAATGCTCTTCTGGAG GCGTTGGTGTAGAGGCTGTT 
Tcfap2c CCACGTCGAAGTACAAAGTAACTG TTTTTGGACTTTGCTCTTCTGAG 
Nmyc ACTCAGATGATGAGGATGACGAG CACAGTGATCGTGAAAGTGGTTA 
Rps19 ATAAAGAGCTTGCCCCATATGAT ATCTTGGTCATGGAACCAACC 
Surf6 AGGAATCAGGGCTGATCTTTAAC GTGTCAGGTTCCCTTTCACTTT 
Xrn2 AAAGATTCCAGTTGATGCCAGTA TGGTTTGTCTTCAGGATGAGTG 
Fubp3 AGGAACTTCTTATCCCTGCATCT TGGATCATGACCATTTTCACAC 
Asxl1 ATGCTACATTCCAACTCAAGAGG CATCCACTGTAGCTGCATTTCTA 
Zfp36l1 AGGGTAACAAGATGCTCAACTACAG GTTCTGATGGAACTTGGAGCTG 
Cbx1 TTCTCAGATGAGGACAACACTTG GCCTCCCTCTGACTTATCTGTCT 
Mybl2 GGACTCTTGTAACAGCCTCACC CTCCAGGGTATCCTGTTTGTTC 
Msc GACACCAAGCTTTCCAAACTG GTGCACATAGCTGTCCTCGTAG 
Msh6 TTTGGGCTAAGATGGAAGGTTAC TGTACATGAACACGGACAGATTT 
Rarg GTCTACAATCGGTGGAGACACAG GTAGCCAGAAGACTTGTCATTGC 
Tcea3 ACTGCTCAGACAAGGAAGTGGT CTCTTTCTTCTCTTTCTCCTTTGGT 
Hnrpdl GGACATGAATGAGTACAGCAACA AGCTCAAGCCTCCAATAAACATT 
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Zic5 TTGACGGTTGTGATAGGAAGTTT ATCACAGCCTCGAATCTTACAGT 
Tcfcp2l1 GGTGAAGCTACATGAAGAGACCTTA TATTTCGTGTTCAGATCTTGGAAGT 
Etv5 TGGAGAAAAGTGCCTCTACAACT GGGAAATAGGGAATTCTGATGG 
Zfp219 GCATCACTTAAAAGTGCATCTCC GTGACGCTGAAGGTGATACTTGA 
Cbx7 AAGGGCAAAGTTGAATATCTGGT CTCTCTCCTCCTTCTCCTCGTAG 
Otx2 AAGTGAGTTCAGAGAGTGGAACAAG CTCCAGATAGACACTGGAGCACT 
Zfp428 GGAGGAAGATGATGAAGACCTTT CACCTTATAGCCAGGGTCATATTC 
Myst2 AGCATACAGACAGTTCAGAGAGTGA ATTTTTAGTTTCTTGGGAACTCTGG 
Zfp532 ACCAGTGGACAACAAATGAAGAA TAAACTTTCCTGATGCCTTTGTG 
Kdm2b GAAGGCCCAGAAGAGAAGAAA TTTTGGATCTCATGGTTGAGC 
Bach1 GCAGAAGGAGTAAGAACAGAATCG CAGCAAGCTCTCCTTTTCACTTT 
Hes1 GAAGGGCAAGAATAAATGAAAGTCT TTCCAGAATGTCTGCCTTCTCTA 
Rbbp7 GTAAAATTGGAGAAGAACAATCAGC ATTCCAGCTGAAGTCAGAAATCTT 
Id1 TCCTGCAGCATGTAATCGAC GATCGTCGGCTGGAACAC 
Cited2 CAGGTTTAACAACTCCCAGTTCAT GTAGGGGTGATGGTTGAAATACTG 
Hnrnpu GACACAGAAGAAGGCAGAAGTAGAG TTCAACATAGGTTATTTCATCAAAGC 
Rbm14 GCTGCATGTACAAGTCAGGAAT CTTCCTTCTCCATGTGAACAAAC 
Eno1 CCTAGAACTCCGAGACAATGATAAG ATTCACTTTCTTGCTAACCAGAGC 
Med19 GTGGCTCTTTTAATCCAATCACA TGCTTATGCTTATTCTTCTTCTTGG 
Nolc1 CAGTGACCAAGAAGGCTAAGAAA CAGCCTTCTGTGTGGGAAGT 
Prdm14 GCCTCCGGATCCATATTCTT TGCTTGTTCAGGCTGGAAG 
Dnmt3a CCTACTACATCAGCAAACGGAAA GTTCTCTTCCACAGCATTCATTACT 
Klf2 CATACTTGCAGCTACACCAACTG CCAGTTGCAATGATAAGGCTTC 
Rlim AGAAGTCAAATGGATCGCTTG CCCAGCAAATTGTTGTCTCTC 
Tcea1 CTTGTCGATCACACTCTGGACTT AAAACCCACCTGAAGACACTTG 
Zfp146 CAGGCGATAAGCCTTACGAG CGTAGGGTTTCTCACCCGTAT 
Creb3 TCCATTCTCCATGATCACAACTAC CAGTATCAGCCTAGACATCTCCTGT 
Zfp280c AGCCAGAAGACTCACACCACTT CCAGGTCTCGTTGTTCTGCT 
Rbbp5 AGGCGAGGGGAATATATTTATACAG GTATTGCTTGTCCCAGTTGTTACTC 
Tbx3 AGTACTTTTCGAACCTACCTGTTCC GCAAAGGGATTGTTGTCTATTTTTA 
H2afy TCAAGTACAGGATCAGCGTAGGT CTATCCGTGCCTTCTTGTTGTC 
Set GACGCAGGTGCTGATGAGT GCCTCTCCTTCTTCATCATCC 
Chd9 CAAAGAGCAGCACTCTCAAAAA GACTGCCTTTCACTTCTTCTTCA 
Esrrb TAAAAAGCCATTGACTAAGATCGTC CAATTCACAGAGAGTGGTCAGG 
Nanog AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 
Pou5f1 TCTGGAGACCATGTTTCTGAAGT TACAGAACCATACTCGAACCACAT 
Sox2 GCGGAGTGGAAACTTTTGTC TATTTATAATCCGGGTGCTCCT 
Trp53 GTCATCTTTTGTCCCTTCTCAAAA AGAGTACGTGCACATAACAGACTTG 
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Dkk3 GAAGTTCACAAGATAACCAACAACC AATGATACATTCATGGCTCCTCTT 
Gata4 TTCTCAGAAGGCAGAGAGTGTGT ATGCCGTTCATCTTGTGATAGAG 
Gata6 GACGGCACCGGTCATTACC ACAGTTGGCACAGGACAGTCC 
Sox17 CTAAGCAAGATGCTAGGCAAGTCT GTACTTGTAGTTGGGGTGGTCCT 
Gata2 GCCTCTACCACAAGATGAATGG GTCTGACAATTTGCACAACAGG 
Gsc AGAAGGTGGAGGTCTGGTTTAAG GAGGACGTCTTGTTCCACTTCT 
Isl1 GGGATGGGAAAACCTACTGTAAAAGAGA GTCGTTCTTGCTGAAGCCTATGCTG 
T CTTCAAGGAGCTAACTAACGAGATG GTCCAGCAAGAAAGAGTACATGG 
Fgf5 CAAAGTCAATGGCTCCCACGAA CTACAATCCCCTGAGACACACAGC 
Cdx2 GCGAAACCTGTGCGAGTGGATG CGGTATTTGTCTTTTGTCCTGGTTTTCA 
Eomes ATAAGATGTACGTTCACCCAGAATC GCACCTTTGTTATTGGTGAGTTTTA 
Hand1 CCTTCAAGGCTGAACTCAAAAA GCGCCCTTTAATCCTCTTCT 
Id2 ATCACCAGAGACCTGGACAGAAC GCTATCATTCGACATAAGCTCAGA 
Krt8 AGAACATGAGCATTCATACGAAGA GAGCTCATTCCGTAGCTGAAG 
Tead4 CTATGACAAGTTCCCAGAGAAGAAG GTCATCGATGTTGGTATTGAGGT 
 
Appendix Table E. RT-qPCR primers used in chapter 4 
 
Gene Forward Reverse 
Amot GTGTCATAGCTGGTGTTAGGAGAGT GGAAGAGAATGTGATGAGACACTTT 
Cdx2 GCGAAACCTGTGCGAGTGGATG CGGTATTTGTCTTTTGTCCTGGTTTTCA 
Chd9 CAAAGAGCAGCACTCTCAAAAA GACTGCCTTTCACTTCTTCTTCA 
Cited1 AGTAGGCCAGAGAGTTCATCTCC TCTGAAATGCCAACTATGTCGAG 
Edn1 CAACCTTCGTAGTTTCCTTCCTT CAGAAAAGCTTAAAAGACTCCAAGA 
Eomes ATAAGATGTACGTTCACCCAGAATC GCACCTTTGTTATTGGTGAGTTTTA 
Esrrb TAAAAAGCCATTGACTAAGATCGTC CAATTCACAGAGAGTGGTCAGG 
Fgf5 CAAAGTCAATGGCTCCCACGAA CTACAATCCCCTGAGACACACAGC 
Fzd6 ACAGTGTGGCAATCTGTTACATTC GTCGGAAATTGTGTGAGAAAATAGT 
Gata2 GCCTCTACCACAAGATGAATGG GTCTGACAATTTGCACAACAGG 
Gata3 TGGGCTGTACTACAAGCTTCATAA CTTTTTCGATTTGCTAGACATCTTC 
Gata4 TTCTCAGAAGGCAGAGAGTGTGT ATGCCGTTCATCTTGTGATAGAG 
Gata6 GACGGCACCGGTCATTACC ACAGTTGGCACAGGACAGTCC 
Gbx2 AAGACGAGTCAAAGGTGGAAGAT CAGTCTGACCAGGCAAATTGT 
Gsc AGAAGGTGGAGGTCTGGTTTAAG GAGGACGTCTTGTTCCACTTCT 
Hand1 CCTTCAAGGCTGAACTCAAAAA GCGCCCTTTAATCCTCTTCT 
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Id2 ATCACCAGAGACCTGGACAGAAC GCTATCATTCGACATAAGCTCAGA 
Isl1 GGGATGGGAAAACCTACTGTAAAAGAGA GTCGTTCTTGCTGAAGCCTATGCTG 
Klf4 GTGCAGCTTGCAGCAGTAAC AGCGAGTTGGAAAGGATAAAGTC 
Krt18 TTTGCGAATTCTGTGGACAA GCGCATGGCTAGTTCTGTCT 
Krt8 AGAACATGAGCATTCATACGAAGA GAGCTCATTCCGTAGCTGAAG 
Msx2 CTCTTGCAGTCTTTTCGCCTTAG CTCTTGCAGTCTTTTCGCCTTAG 
Nanog AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 
Nes AGGACCAGGTGCTTGAGAGA TTCGAGAGATTCGAGGGAGA 
Nodal CATGTTGAGCCTCTACCGAGA AAGAGAAGTCAAACGTGAAAGTCC 
Pitx2 CTTGGACTCCTCCAAACATAGACT CACATCCTCATTCTTTCCTTGCT 
Pou5f1 TCTGGAGACCATGTTTCTGAAGT TACAGAACCATACTCGAACCACAT 
Sox13 AGTGACTGGAAGGAGAGGTTTCT CAAAAGCTGGAGTTCCTTCTCAG 
Sox17 CTAAGCAAGATGCTAGGCAAGTCT GTACTTGTAGTTGGGGTGGTCCT 
Sox2 GCGGAGTGGAAACTTTTGTC TATTTATAATCCGGGTGCTCCT 
T CTTCAAGGAGCTAACTAACGAGATG GTCCAGCAAGAAAGAGTACATGG 
Taz ACCAACAGTAGCTCAGATCCTTTC AGGAAGTCTTCTGGAGTTGTGG 
Tead1 TTGATAGCCAGATACATCAAACTCA TTTCTCGAACTTTCTTTCTTGCTAA 
Tead2 GTCAGATGAGGGCAAGATGTATG AAAACCTGAATATGGCTGGAGAC 
Tead3 AAAACCAGGACAAGAAAACAGGT GAGAGCTTTGTCCTTGGAGACTT 
Tead4 CTATGACAAGTTCCCAGAGAAGAAG GTCATCGATGTTGGTATTGAGGT 
Tgfb2 CTGCTTTAGAAATGTGCAGGATAAT CACAGAAGTTAGCATTGTACCCTTT 
Yap1 GAGCAAGCCATGACTCAGGA TCTGGAGACCATGTTTCTGAAGT 
 
Appendix Table F. RT-qPCR primers used in chapter 5 
 
Gene Forward Reverse 
Mphosph8 AGCAGTCAGGAAAGATATTCAGAGA TGGTGAAATATCTTCTTTTGTGTCA 
Med26 GTGTTGGAAGTGATCTCCAGTCT AGCTCCTCATTCTTGGTTTTCTT 
Gli2 AGAGAGAGAAGCTCAAGTCACTGAA GTATTGTTGAAGTTTTCCAGGACAG 
Nr6a1 ACAGGAAGGCTATCAGAGAAGATG CCAGACATGATTCTTTCAATTTCTT 
Rai14 TGCAGGAATTCAAAACCTTCTATTA CCACTTCGTTCTGAGCTTATTTTAG 
Sirt6 TGTTTGTTTGTTTGTTTGTTTGTTT CTAGGGAGTCCTGGTCTCAAAAA 
Taf1b TAAGCTTTTTCCAGAAGAGATGAAA ATATGGCAAGTTCAATCATGTTTTT 
Trip13 TACTGGAAAAACATCCCTTTGTAAG TAGAAAATAGGCTGTGGCTGTTTAT 
Bcl3 CTTTACTACCAGGGACCTTTGATG CATATCATGGAGTAGGGGTGAGTAG 
Gli1 TGAGCCTGAGTCTGTGTATGAGA ATATGCTCACTGTTGATGTGGTG 
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Mycbp TGGTAGCCTTATATGAAGAACCAGA ATTCTAGGCGAAGCAGCTCTATT 
Phf12 AACTGACCTGTACCACTGCACTAC TATGGTCTAACTCATGCTGTGTCC 
Rbpj CTCCACAAATGTGCATTTTACCT TATTTTGTTCTTTTGGACATGGAGT 
Taf12 TTGACCAAGAAGAAATTACAAGACC CTCTCAATAAAATCATCAGCGATCT 
Taf6 AGTTAAAGAATGTGGAGCCACTGTA TTCCTTCTCTTCATAGAAGTACAGCTC 
Trip4 CGCAAAATTGTTTCTATGTATCCTT TTAAAGTGCTAAAACAGAAGGCACT 
Zfp13 CAGAGATGTACTACAGGGGAAAAAC TAGTCCTTATCGATTTTGTGTCCTC 
Zfp198 GAAACAGTAAATTTCTCTGGCGTTA GTTGCAGGTAACACATCTTAATCCT 
Neurog1 GCTTCAGAAGACTTCACCTATGG CTAGTGGTATGGGATGAAACAGG 
Flt1 TCTACCAAATCATGTTGGATTGCTG  ATGTAATCTTTCCCATCCTGTTGGA  
Egfr TCGAGGACTCCCCTCTTGAGT AGGCGTCTTCTTTGACACGG 
Nefm AGAATACCAGGATCTCCTTAACGTC CTGAAAATGTGCTAAATCTGGTCTC 
Pou5f1 TCTGGAGACCATGTTTCTGAAGT TACAGAACCATACTCGAACCACAT 
Nanog AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 
Sox2 GCGGAGTGGAAACTTTTGTC TATTTATAATCCGGGTGCTCCT 
Klf4 GTGCAGCTTGCAGCAGTAAC AGCGAGTTGGAAAGGATAAAGTC 
Esrrb TAAAAAGCCATTGACTAAGATCGTC CAATTCACAGAGAGTGGTCAGG 
Zfp42 CAGTCCAGAATACCAGAGTGGAA ACTCTAGGTATCCGTCAGGGAAG 
Cdx2 GCGAAACCTGTGCGAGTGGATG CGGTATTTGTCTTTTGTCCTGGTTTTCA 
Hand1 CCTTCAAGGCTGAACTCAAAAA GCGCCCTTTAATCCTCTTCT 
T CTTCAAGGAGCTAACTAACGAGATG GTCCAGCAAGAAAGAGTACATGG 
Krt8 AGAACATGAGCATTCATACGAAGA GAGCTCATTCCGTAGCTGAAG 
Sox17 CTAAGCAAGATGCTAGGCAAGTCT GTACTTGTAGTTGGGGTGGTCCT 
Pitx2 CTTGGACTCCTCCAAACATAGACT CACATCCTCATTCTTTCCTTGCT 
Gsc AGAAGGTGGAGGTCTGGTTTAAG GAGGACGTCTTGTTCCACTTCT 
Isl1 GGGATGGGAAAACCTACTGTAAAAGAGA GTCGTTCTTGCTGAAGCCTATGCTG 
Bmp2 CGCTTCTTCTTCAATTTAAGTTCTG AACTACTGTTTCCCAAAGCTTCCT 
Gata3 TGGGCTGTACTACAAGCTTCATAA CTTTTTCGATTTGCTAGACATCTTC 
Fgf5 CAAAGTCAATGGCTCCCACGAA CTACAATCCCCTGAGACACACAGC 
Nes AGGACCAGGTGCTTGAGAGA TTCGAGAGATTCGAGGGAGA 
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